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                                                           ABSTRACT 
  
 The development of an enantioselective organocatalytic hydrogenation reaction 
utilizing the LUMO-lowering activation of α,β-unsaturated aldehydes has been developed.  
This strategy employs an imidazolidinone catalyst to activate the alkene towards conjugate 
reduction of the pendant β,β-disubstituted alkene by a Hantzsch dihydropyridine.  This is 
the first general methodology that utilizes disubstituted alkenes for iminiuim activation 
chemistry and stereoconvergently reduces mixtures of olefin geometric isomers to favor an 
enantioenriched product.  Furthermore, the reagents are air and moisture stable making this 
new process operationally trivial. 
 By exploiting the aforementioned mode of reactivity, enones have been 
successfully reduced utilizing a privileged imidazolidinone catalyst.  These studies led to 
the discovery of a novel Hantzsch dihydropyridine that exhibits a dramatic increase in 
reactivity.  Further comparison of these Hantzsch derivatives provides interesting physical 
and structural data that may account for the observed differences.   
 A rapid entry into the tetracyclic framework of minfiensine utilizing our group’s 
organocascade cyclization methodology was undertaken.  This strategy demonstrates the 
first example of a 2,3-dialkyl substituted indole starting material successfully reacting 
under our pyrroloindoline-forming conditions.  Various strategies for introducing an allyl 
silane moiety for use as a SOMOphile to furnish the final ring of the pentacycle were 
pursued.  Numerous attempts were unsuccessful, and studies for introducing the allylsilane 
post-cyclization were undertaken.  These experiments have led to the construction of a 
vicinal diol that should be two transformations away from attempting the key SOMO 
cyclization.  If successful, the resulting intermediate will be six steps away from the final 
natural product. 
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Chapter 1 
 
LUMO-Lowering Enantioselective Organcatalysis 
 
Introduction 
During the last 30 years, the field of organic chemistry has responded to the 
challenges of developing new methods to access single-enantiomer products.1  
Underlying this challenge is the emphasis placed on atom economical processes,2 the 
need for alternative chiral building blocks, and the desire of fine chemical and 
pharmaceutical industries to utilize enantiopure materials (Fig. 1).3  Accordingly, the 
field of asymmetric catalysis has grown dramatically and has culminated with rewarding 
the pioneers of this vast body of chemistry–Sharpless, Noyori, and Knowles–with the 
2001 Nobel Prize in Chemistry.4   
 
While the majority of these powerful transformations utilize transition metals and 
chiral-ligands, recent advancements into the readily available chiral pool employ organic 
molecules, such as amino acids and sugars (Fig. 2).  In an early example, the Hajos-
Parrish group reported a desymmetrizing intramolecular aldol cyclization using the amino 
                                                
(1) Jacobsen, E. N. P., A., Yamamoto, H. Comprehensive Asymmetric Catalysis; Springer: Heidelberg, 1999. 
(2) (a) Trost, B. M. Angew. Chem. Int. Ed. Eng. 1995, 34, 259-281. (b) Trost, B. M. Science 1991, 254, 1471-1477. 
(3) http://www.fda.gov/cder/guidance/stereo.htm 
(4) (a) Sharpless, K. B. Angew. Chem. Int. Ed. 2002, 41, 2024-2032. (b) Noyori, R. Adv. Synth. Cat. 2003, 345, 15-32. (c) 
Knowles, W. S. Angew. Chem. Int. Ed. 2002, 41, 1999-2007. 
Figure 1.  Single Enantiomer Drugs
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2 
acid proline.5  Furthermore, the groups of Shi, Yang, and Denmark have utilized chiral 
ketones, in this case derived from fructose, to catalyze enantioselective epoxidations.6 
This seminal work has laid the foundation for the burgeoning field of organocatalysis, by 
influencing the development of a broad range of new reaction methods and inspiring the 
creation of new catalyst architectures.   
 
 
 
 
 
 
 
 
 
 
Development of LUMO-Lowering Iminium Activation 
 The idea for iminium activation of α,β-unsaturated carbonyl was influenced by 
related transition-metal induced methods of alkene activation (eq. 1).  Specifically, we 
planned to mimic the LUMO-lowering activation of an olefin by reversible coordination 
of a Lewis acid to a carbonyl lone pair (eq. 1).  It was envisioned that the equilibrium 
condensation between a secondary amine and an aldehyde to produce an electron- 
                                                
(5) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1612-1615. 
(6) (a) Frohn, M.; Shi, Y. Synthesis 2000, 1979-2000. (b) Yang, D.; Wang, X. C.; Wong, M. K.; Yip, Y. C.; Tang, M. W. J. Am. 
Chem. Soc. 1996, 118, 11311-11312. (c) Denmark, S. E.; Wu, Z. C. Synlett 1999, 847-859. 
!  Enantioselective catalytic epoxidations:  Shi, Yang, Denmark
10 mol%
catalyst
OxoneTM
O
50–99% ee
O
O
O
O
O
BzO
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!  Intramolecular aldol:  Hajos–Parrish J. Org. Chem.  1974, 39, 1615
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Figure 2.  Examples of Chiral Pool Derived Catalysts
  
3 
deficient intermediate would similarly activate the conjugated π-system towards 
nucleophilic additions (eq. 2). 
 
 
 
  
In order to make this process enantioselective, two structural requirements need to 
be fulfilled (Fig. 3).  The first is to control iminium ion geometry and, the second, to 
influence the trajectory of the incoming nucleophile to one enantioface of the π-system. 
 
In order to fulfill these necessities, imidazolidinone catalysts were developed 
bearing the requisite chiral functionality.  These organocatalysts are readily assembled 
from the chiral pool and are typically air and moisture stable allowing for straightforward 
storage and implementation.  In the event of a condensation reaction with an α,β-
unsaturated carbonyl compound, the activated intermediate favors the s-trans geometry 
about the iminium by selectively partitioning the bulkier alkyl group under the benzyl 
group while orienting the smaller hydrogen beneath the sterically more demanding t-
butyl moiety.  In 2000, our group reported the first successful demonstration of this 
O O
LALewis acid (LA)
O
R
N
H
R
+
+ N
R
R
+
+
•HCl
substrate catalyst LUMO–activation
(1)
(2)
Re–face activated
to cycloadditions
Me O
N
N
H
O Me
Ph
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•HCl
+
!  Iminium ion geometry control
!  Enantiofacial discrimination
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Figure 3.  Engineering the Requirements for Enantioselectivity
and nucleophiles
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4 
concept in the context of a Diels-Alder cyloaddition utilizing α,β-unsaturated aldehydes 
as dienophiles in conjunction with a variety of dienes (Fig. 4).7  
 
 
 
 
 
Indeed, this mode of activation has revitalized the field of organocatalysis and has led to 
the development of many powerful catalytic asymmetric transformations  (Fig. 5).8  
These new methods include cycloadditions, heteroconjugate additions, 
cyclopropanations, Mukaiyama-Michael additions, Friedel-Crafts alkylations, cascade 
reactions, and conjugate addition of boron reagents.9   
 
 
 
 
 
 
 
 
 
                                                
(7) Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243-4244. 
(8) Web of Knowledge search, “organocatalysis” or “organocatalytic” in topic. 
(9) (a) Lelais, G.; MacMillan, D. W. C. Aldrichim Acta 2006, 39, 79-87. (b) Lee, S.; MacMillan, D. W. C. J. Am. Chem. Soc. 
2007, 129, 15438. 
Figure 4.  The First Example of Imidazlidinone Iminium Activation
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Figure 5.  Organocatalysis Publication Trend Starting in 2000
  
5 
Summary of Thesis Research 
 The following chapters detail research efforts that focus on further establishing 
iminium activation as a powerful mode of activation.  Chapter 2 discusses the 
development of a novel mode of catalytic asymmetric hydrogenation of α,β-unsaturated 
aldehydes utilizing Hantzsch dihydropyridines.10  Chapter 3 focuses on the extension of 
this technology toward α,β-unsaturated ketones utilizing a different imidazolidinone 
catalyst in conjunction with a novel Hantzsch analogue.11  Finally, Chapter 4 details the 
efforts made towards the total synthesis of (+)-minfiensine utilizing an organocatalytic 
cascade cyclization reaction for rapid entry into the pyrroloindoline core of this natural 
product. 
 
 
 
 
 
 
 
 
 
                                                
(9)  Ouellet, S. G.; Tuttle, J. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 32-33. 
(10) Tuttle, J. B.; Ouellet, S. G.; MacMillan, D. W. C. J. Am. Chem. Soc. 2006, 128, 12662-12663. 
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Chapter 2 
 
Development of an Enantioselective Organocatalytic Hydride Reduction 
Reaction of α ,β-Unsaturated Aldehydes 
 
Introduction 
Within the vast chemical architecture known as stereogenicity, hydrogen is the 
most common, discrete substituent. Not surprisingly, therefore, the field of 
enantioselective catalysis has focused great attention on the invention of hydrogenation 
technologies over the last 50 years,1 the importance of which has culminated in the Nobel 
Prize for the pioneers of this important transformation (Fig. 1).2 
Figure 1.  Hydrogen-Bearing Stereocenters and Transition-Metal Catalyzed Hydrogenation
H
most common
chiral substituent OY
X
H
Y O
X OH P
P
Ph
Ph
M
Ph
Ph
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O
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H
H
Y
X
M = Pd, Rh, Ir
Hydrogenation
Typical Organometallic Method to Generate Hydrogen-Bearing Stereocenters
 
While the field of hydrogenation chemistry has matured as an integral methodology in 
the realms of industrial and academic chemistry,3 this reaction platform is not the most 
common method for asymmetric hydrogenation.  Indeed, biological systems have 
                                                
(1) (a) Akabori, S.; Sakurai, S.; Izumi, Y.; Fujii, Y. Nature 1956, 178, 323-324. (b) Okhuma, T. K., M.; Noyori, R. Catalytic 
Asymmetric Synthesis; Wiley-VCH: New York, 2000. (c) Noyori, R.; Ohkuma, T. Angew. Chem. Int. Ed. 2001, 40, 40-73. 
(2) (a) Knowles, W. S. Angew. Chem. Int. Ed. 2002, 41, 1999-2007. (b) Noyori, R. Angew. Chem. Int. Ed. 2002, 41, 2008-2022. 
(3) (a) Shimizu, H.; Nagasaki, I.; Matsumura, K.; Sayo, N.; Saito, T. Acc. Chem. Res. 2007, 40, 1385-1393. (b) Genet, J. P. 
Acc. Chem. Res. 2003, 36, 908-918. 
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developed highly efficient tools for performing enantioselective hydrogenation.4  
Specifically, substrates are reduced in the enzymatic active site in the presence of co-
factors such as NAD(P)H and FADH (Fig. 2).5  For example, the enzyme alanine 
dehydrogenase utilizes a series of hydrogen bonds to both activate and sequester pyruvate 
imine for an enantiospecific hydride delivery to the iminium carbon.6  
 
 
 
 
 
 
 
 
 
From these conceptual blueprints, a related alternative strategy was envisioned 
utilizing our iminium activation technology and an alternative dihydropyridine that 
functions as an NADH mimic (Fig. 3).     
 
 
                                                
(4) Alberts, B. B., D.; Lewis, J.; Raff, M.; Roberts, K.; Watson, J. D. Molecular Biology of the Cell; Garland: New York & 
London, 2002. 
(5) You, K.-S.; Oppenheimer, N. J. Crit. Rev. Biohem. Mol. Bio. 1985, 17, 313 - 451. 
(6)  (a) Alizade, M. A.; Bressler, R.; Brendel, K. Biochim. Biophys. Acta 1975, 397, 5-8. (b)  Sedelnikova, S.; Rice, D. W.; 
Shibata, H.; Sawa, Y.; Baker, P. J. Acta Crystallogr., Sect. D: Biol. Crystallogr. 1998, 54, 407-408. (c) Matsui, K.; Tamegai, Y.; 
Miyano, A.; Kameda, Y. Chem. Pharm. Bull. 1977, 25, 2061-2066. 
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 Dr. Stephane Ouellet performed the preliminary investigations into developing an 
analogous reaction (eq. 1).  Initial use of N-benzylnicotinamide 1 gave a low conversion 
and a good ee.  We were pleased to find the ethyl Hantzsch dihydropyridine 27 provided 
the desired product with an improved yield and comparable ee.8  The increased yield is 
attributed to the ability of the dihydropyridine to provide a proton to the intermediate 
enamine to complete the catalytic cycle (vide infra).  
 
                                                
(7) Hantzsch, A. Hantzsch, A. Liebigs Ann. Chem. 1882, 215. 
(8) (a) Pandit, U. K.; Mascabre, F. R.; Gase, R. A.; Deniesarink, M. J. J. Chem. Soc., Chem. Commun.1974, 627-628. (b) 
Niesarink, M. J. D.; Pandit, U. K. Tetrahedron Lett. 1978, 1335-1338. (c) Pandit, U. K.; Gase, R. A.; Mascabre, F. R.; 
Deniesarink, J.  J. Chem. Soc., Chem. Commun. 1975, 211-212. 
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The proposed catalytic cycle begins with condensation of imidazolidinone catalyst salt 2 
onto α,β-unsaturated aldehyde 7 to provide iminium intermediate 8 (Fig. 4).  Conjugate 
reduction by dihydropyridine 9 forms both pyridinium 10 and enamine 11.  Importantly, 
this step is irreversible due to the aromatization of Hantzsch 9 and is the proposed driving 
force for this reaction.  Protonation of 11 by either pyridinium 6 or acid co-catalyst 
(formed via re-protonated conjugate base) gives iminium 13 that undergoes hydrolysis to 
provide the desired aldehyde 14 and releases catalyst 2 back into the cycle.  In this 
chemistry, the enal substrates are reduced with high 1,4 chemoselectivity whereas 1,2 
alcohol products are never observed. This suggests the dihydropyridine is a soft hydride 
donor, preferentially reacting at the softer site on the iminium acceptor.  Fortuitously, 
pyridine by-product 12 does not interfere with the catalytic cycle. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  A Proposed Catalytic Cycle for EOHR
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Optimizing the Reaction 
A range of solvents and co-catalysts were surveyed for their effects on this 
transformation (Table 1).  Solvents having lower dielectric constants provided the desired 
product with optimal conversion and enantioexcess (Table 1, entries 1–4).  A survey of 
acids indicated less acidic co-catalysts increased the conversion and ee (Table 1, entries 
5-8).  This is attributed to a greater propensity for the weaker conjugate base to function 
as a better hydrogen shuttle, facilitating faster catalytic turnover. 
 
 
 
 
 
 
 
 
Next, a variety of hydride sources were subjected to these optimal conditions 
(Table 2).  Surprisingly, NADH did not react under standard conditions (Table 2, entry 
1).  Nicotinamide, the “business-end” of NADH, gave similar conversion but an 
increased ee compared to the original conditions (Table 2, entry 2, 15% conversion, 88% 
ee).  In general, improved reactivity was achieved in the Hantzsch dihydropyridine series 
(Table 2, entries 3-6).  Interestingly, the reactivity is strongly influenced by the 
electronics of the substituents found on the dihydropyridine 3,5-positions.  For instance, 
ketone functionality provided the desired product in low yields but good 
entry %eeb% conversionatime (h)acid co-catalyst
1
3
4
5
6
TFA
TFA
p-TsOH
2
6.5
1
7
1
85
39
61
85
89
86
90
85
Ph
Me
O N
H
EtO2C CO2Et
MeMe Ph
Me
O
• acid
solvent (0.1M) 0 °C
20 mol%
Table 1.  Effect of Catalyst and Co-Catalyst on Hydrogenation
1 95 83
1 54 87
7 2 96 85
8 2 94 84
TFA
TFA
TFA
TCA
TBA
solvent
toluene
CH2Cl2
THF
CHCl3
CHCl3
CHCl3
Et2O
CHCl3
aConversion determined by GC analysis comparison to an internal standard.
bEnantiomeric excess determined by chiral GC analysis.
catalyst 2
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enantioselectivity (Table 2, entries 3-4).  The problem of low conversion was solved by 
introducing less electronegative ester moieties, as shown by an increased yield with good 
levels of enantioexcess (Table 2, entries 5-6).  The ethyl ester analogue provided the 
highest ee with good conversion and was used to expand the substrate scope (Table 2, 
entry 6). 
 
 
 
 
 
 
 
 
Substrate Scope 
 Having identified the optimal reductant for this transformation, we next examined 
the scope of α,β–unsaturated aldehydes amenable to this new methodology (Table 3).  A 
broad range of compounds was reduced in high yield and with good enantioselectivity.  
The catalyst can distinguish between subtle steric differences between methyl and ethyl 
substituents found on the β-center (Table 3, entries 1, 2 and 3, 4).  Sterically dense side-
chains increase substrate reactivity as indicated by lower catalyst loading and reduced 
reaction time (Table 3, entry 7).  Moreover, iminium stabilizing aldehydes (Table 3, 
entries 1, 2, 8) as well as enals that do not readily participate in iminium formation (Table 
3, entry 5) are readily reduced under these conditions.  Importantly, this mild hydride 
entry %eeb% conversionatime (h)hydrogen component
1
3
4
5
6
NADH
N-Bn-Nicotinamide
R = CO2Et
R = CO2Bn
2
24
26
7
7
---
15
92
94
---
88
92
88
Ph
Me
O N
H
R R
MeMe Ph
Me
O
• TCA
CHCl3, –30 °C
20 mol%
Table 2.  Assessing Various Dihydrpyridine NADH Mimics
R = COMe 26 45 86
R = COPh 24 54 80
aConversion determined by GC analysis comparison to an internal standard.  
bEnantiomeric excess determined by chiral GC analysis.
catalyst 2
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delivery system is compatible with substrates that are susceptible to over-reduction 
(Table 3, entries 5, 8).9    
 
 
 
 
 
 
 
 
 
Analysis of the Catalyst: Explaining the t-Butyl Imidazolidinone 
 A unique aspect to this chemistry is the nature of the organocatalyst. The majority 
of imidazolidinone-mediated iminium activation publications utilize catalysts that are 
functionalized on the 2,5-carbons.10  For example, a broad-range of enantioselective 
transformations has been discovered utilizing our second-generation catalyst 15 bearing t-
butyl and benzyl moieties, respectively, in these positions.  Intriguingly, in this 
methodology, we discovered the t-butyl catalyst 2 exhibited a clear difference in 
reactivity and selectivity compared to the second-generation catalyst 15. (Fig. 5, 2nd 
generation gives 82% yield, 76% ee; t-butyl gives 91% yield, 93% ee).   This effect is 
non-intuitive considering less Si-face shielding occurs in iminium MM3-2 formed with 
the t-butyl imidazolidinone catalyst compared to that of MM3-1.  
                                                
(9) Keinan, E.; Greenspoon, N. J. Am. Chem. Soc. 1986, 108, 7314. (b) Cortese, N. A.; Heck, R. F. J. Org. Chem. 1978, 43, 
3985.  
(10) Lelais, G.; MacMillan, D. W. C. Aldrichimica Acta 2006, 39, 79-87. 
entry %eea% yieldtime (h)
1
3
4
5
6
2
23
16
72
26
74
74
83d
94
87
91e
R2
R1
O N
H
EtO2C CO2Et
MeMe R2
R1
O
• TCA
CHCl3, –30 °C
20 mol%
Table 3.  Substrate Scope for the EOHR
10 91 96b
23 95 91c
7
8
0.5
16
R1 R2
Me
Et
Me
Et
Me
Me
Me
Me
c-hex
c-hex
CH2OTIPS
t-Bu
3,4-Cl2Ph
91
95d
92
93b
97f
97
aEnantiomeric excess determined by chiral GC analysis. bPerformed at –45 °C.
cUsing 10 mol % catalyst. dYield determined by NMR. ePerformed at –50 °C.
fUsing 5 mol % catalyst at 23 °C.
E / Z ratio
> 20 / 1
> 20 / 1
5 / 1
3 / 1
> 20 / 1
> 20 / 1
> 20 / 1
> 20 / 1
Ph
Ph
CO2Me
catalyst 2
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Figure 5.  Comparing the 2nd-Generation Catalyst to the Hydrogenation Catalyst
N
H
N
N
H
N
Greater Si face shielding Less Si face shielding
O Me
Me
Me
Me
Ph
O Me
Me
Me
Me
O
Me
82% yield
76% ee
91% yield
93% ee
15 2
MM3-1 MM3-2
 
 
Transition state analysis provides insight into the nature of this effect.  The 
dihydropyridine can approach the activated iminium species by two pathways. One 
possibility is in an exo-orientation.  In this transition state, the nitrogen of the Hantzsch 
ester is oriented distal from the stereodefining t-butyl moiety of the imidazolidinone and 
hydride is delivered with minimal substrate-catalyst interaction (eq. 2).  In this case, the 
hydride could be delivered to either face of the π-system, resulting in a decreased 
enantioselectivity.  Alternatively, the dihydropyridine could approach in an endo- 
orientation where interaction with the catalyst is now enhanced (eq. 3).  In this stacked 
transition state, one π-face is favored because now the catalyst has greater control over 
the approaching dihydropyridine, and directs the hydride delivery to one stereoface, 
providing higher levels of enantiocontrol. 
  
14 
 
 
 
 
 
 
 
 
 
 
 Indeed, we believe the endo-transition state (eq. 3) operates in this chemistry for 
two reasons.  The first supporting evidence in found in biological systems.  Crystal 
structures of enzyme active sites containing substrates and NAD(P)H co-factors show the 
nicotinamide moiety  prefers an endo-orientation (Fig. 6).11  
  
 
 
 
The second piece of evidence derives from theoretical modeling.12  The Houk group 
performed calculations on both exo- and endo-transition states of dihydropyridine 
reduction of a pyridinium cation (Fig. 7). In this simple system, the endo approach was 
favored over the exo by 2.7 kcal/mol.     
                                                
(11) (a) Karplus, P. A.; Daniels, M. J.; Herriott, J. R. Science 1991, 251, 60-66. (b) Karplus, P. A.; Schulz, G. E. J. Mol. Biol. 
1989, 210, 163-180. (c) Pai, E. F.; Karplus, P. A.; Schulz, G. E. Biochemistry 1988, 27, 4465-4474. (d) Abadzapatero, C.; 
Griffith, J. P.; Sussman, J. L.; Rossmann, M. G. J. Mol. Biol. 1987, 198, 445-467. 
(12)  Wu, Y. D.; Lai, D. K. W.; Houk, K. N. J. Am. Chem. Soc. 1995, 117, 4100-4108. 
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Figure 7.  Houk's Theoretical Calculations Support an Endo Transition State
 
 Further analysis of these transition states helps to explain the impact FMOs have 
on stabilizing the endo orientation (Fig. 8).  The Houk group’s theoretical modeling 
supports a favorable π*-HOMO-π* overlap between the hydride donor/hydride/hydride 
acceptor, respectively.13  In particular, the LUMO-LUMO interaction at the C-4 frontier 
orbitals is the largest contribution to this effect (Fig. 8, A, dashed box).  It is calculated 
that the composite LUMO created in this overlap, despite being unfilled, is lower in 
energy than in the non-interacting case. Importantly, this overlap is more significant in 
the endo-transition state due to an energetically favorable bent delivery of the hydride. 
Calculations indicate an obtuse delivery angle is favored over a linear approach by 1.7 
kcal/mol for two reasons. The first is that the hydride HOMO and pyridinium LUMO 
interaction is maximized.  The second reason is that the hydride HOMO interaction with 
the pyridinium HOMO is, at the same time, minimized (Fig. 8, B).  In the linear approach 
                                                
(13) (a) Wu, Y. D.; Lai, D. K. W.; Houk, K. N. J. Am. Chem. Soc. 1995, 117, 4100-4108. (b) Houk, K. N.; Paddonrow, M. N.; 
Rondan, N. G.; Wu, Y. D.; Brown, F. K.; Spellmeyer, D. C.; Metz, J. T.; Li, Y.; Loncharich, R. J. Science 1986, 231, 
1108-1117. (24) Wu, Y. D.; Houk, K. N. J. Am. Chem. Soc. 1987, 109, 2226-2227. 
Figure 8.  Explaining the Endo TS using FMO
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! A and B correlate to the endo transiton state ! C correlates to the exo transiton state
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this HOMO-HOMO destabilizing interaction is increased, disfavoring this transition state 
geometry.  For the exo transition state this LUMO-LUMO stabilizing interaction is absent 
(Fig. 8, compare A to C) and therefore is not as stabilized as the endo-conformation.   
 
Analysis of the Catalyst: Rationalizing the Decreased Reactivity and Selectivity   
 While the effectiveness of catalyst 2 has been discussed, the decreased efficiency 
of catalyst 15 needs to be explained.  We postulate that, in the transition state, 
interactions of the β-substituents on the substrate with the imidazolidinone may decrease 
the reactivity and selectivity for bis-substituted catalysts.  The reason for this is based 
upon relative energies of the iminium intermediates and the forming sp3 center created 
by hydride delivery in the transition state (Fig. 9).  In the event, and if isomerization of 
the olefin occurs (vide infra), then two possible iminium intermediates can form using 
catalyst 15, 1A/1B–or in the case of catalyst 2, 2A/2B.  For catalyst 15, the overall energy 
of both iminium transition states are higher than catalyst 2 due to the possibility for the 
substrate to interact with both the benzyl and the t-butyl group.  As a result, this increased 
energy may favor a competing pathway leading to a decreased yield of reduced product 
(Fig. 5, 82% yield).  Conversely, the transition states for catalyst 2 are overall lower in 
energy due to the minimal catalyst/substrate interaction during sp3 bond formation.  In 
this case, the decrease in energy favors the desired reaction pathway resulting in an 
increased overall yield of reduced product (Fig. 5, 91% yield). 
The observed selectivity difference can also be described in terms of transition 
state energies.  For catalyst 15, the interaction of both geometrical isomers with the 
benzyl and t-butyl moieties may only have a small ∆E between the two transition states 
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1A and 1B, causing the decrease in enantioselectivity (Fig. 5, 76% ee).  Conversely, for 
catalyst 2, the ∆E difference between transition state 2B and 2A may be large, favoring 
the reduction of isomer 2A, resulting in an increased ee (Fig. 5, 93% ee) 
 
 
Absolute Sense of Enantioinduction 
By comparison to a known compound, we assigned our absolute stereochemistry 
as the (R)-enantiomer.  The sense of enantio-induction is consistent with the proposed 
requirements for stereocontrol, namely, iminium ion geometry control and enantiofacial 
discrimination (Fig. 10).  Gaussian modeling of these two iminium intermediates 
indicated a 2.02 kcal/mol energy difference in favor of iminium 16, providing further 
support that imidazolidinone catalysts effectively favor the s-trans geometry.  
 
 
Figure 9.  Rationalizing the Reactivity and Selectivity Differences
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Assessing the Effect of Olefin Geometry 
 Most hydrogenation technologies used in conjunction with tri-substituted olefins 
are dependent on the distribution of geometrical isomers.  For example, subjecting pure 
E-olefin to Buchwald’s enantioselective catalytic copper hydride conditions provides the 
(S)-product in high yield and good ee (eq. 4).14  Conversely, reacting pure Z-olefin to the 
exact conditions provides the (R)-product (eq. 5).  Taken together, a 1:1 mixture of 
geometrical isomers will produce nearly racemic product.  These results indicate 
transition-metal hydrogenation technologies are limited to using pure olefin isomers to 
access highly enantioenriched products.  In this context, we sought to understand how 
olefin geometry would impact organocatalytic hydrogenation.   
 
 
                                                
(14)  Appella, D. H.; Moritani, Y.; Shintani, R.; Ferreira, E. M.; Buchwald, S. L. J. Am. Chem. Soc. 1999, 121, 9473-9474. 
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To assess this effect, pure Z-olefin 18 and pure E-olefin 1 were subjected to the same 
organocatalytic conditions (eq. 6).  To our great delight both reactions produced the same 
(S)-enantiomer of product 3. 
!  Pure E and pure Z-isomers provide the same enantiomer
Ph
Me
O
Me
Ph
O
Me
Ph O
N
N
H
OMe
Me
Me
Me
· TCA
0.2 M CHCl3, –30 °C
1: E–isomer
2: Z–isomer
N
H
O
OEt
O
EtO
Me Me
both give (S)-product
(6)
2 5 3
 
Furthermore, subjecting mixtures of geometrical isomers to EOHR produced a 
trend of higher ee’s as the ratio of E-isomer to Z-isomer increases (Fig. 11).   These 
results show the organocatalytic reduction is more stereoselective and not stereospecific 
like transition-metal mediated reactions.  Interestingly, the product ee is increased after 
“aging” a solution of Z-isomer 18 with catalyst 2•TCA for 1.5 hours, followed by 
addition of dihydropyridine 5, and is further improved by cooling down the solution to     
–50 °C. 
 
Ph OEt
OEt
Ph OEt
OEt
OEt
O
Ph OEt
OEtPh
Et
(S)-p-Tol-BINAP
CuCl
NaOt-Bu
PMHS
toluene
98% yield
91% ee
98% yield
83% ee
E-isomer
Z-isomer
(S)-product
(R)-product
! 1:1 Mixtures of E and Z-isomers provide racemic product
(4)
(5)
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A VT-NMR experiment was utilized to probe this phenomenon.  E-isomer 1 was 
added to a homogeneous solution of catalyst 2•TCA salt in CDCl3 cooled to –30 °C and 
monitored over time (Fig. 12).  Interestingly, a rapid isomerization event produced a 10:1 
mixture of E-isomer 1 to Z-isomer 18 in 5 minutes.  This is significant because as the 
reaction proceeds, the relative concentration of Z-olefin 18 remains steady, while E-olefin 
1 is selectively consumed, producing  (S)-enantiomer 3.  Importantly, as the reaction 
proceeds and 1 is reduced, more 18 is isomerized to 1 in order to maintain this 
equilibrium.  This dynamic kinetic resolution is the basis for the high ee and, to our 
delight, indicates this hydrogenation method can accommodate mixtures of geometrical 
isomers.  It is a powerful complement to many of the current methods that access tri-
substituted alkenes, such as Horner-Wadsworth-Emmons reactions and olefin metathesis, 
because the resulting mixtures of geometrical isomers will only have a small impact on 
product enantioselectivity. 
ratio (E/Z) (S)
100 / 0
80 / 20
50 / 50
20 / 80
0 / 100
93% ee
91% ee
89% ee
86% ee
84% ee
Enantioselective not Enantiospecific
!  Pre-equilibrating the amine catalyst and the Z aldehyde
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Figure 11.  Evaluating the Effects of Olefin Mixtures on Enantioselectivity
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Experimental observations provide insight into the cause of isomerization.  This 
event is most likely caused by the imidazolidinone catalyst as it occurs in the absence of 
acid co-catalyst.  Two plausible mechanisms may be at work (Fig. 13).  One may be a 
Bayliss-Hillman-type addition elimination mediated isomerization.  In the event, 
conjugate addition of catalyst to iminium 16 provides intermediate 19 that undergoes 
sigma bond rotation leading to 20.  Species 20 eliminates the amine to provide Z-isomer 
21.  The second possible mechanism may be attributed to Br∅nsted acid-base chemistry.  
Iminium 16 could be deprotonated to provide diene 22, which undergoes sigma-bond 
rotation to form diene 23.  Finally, diene 23 is re-protonated to furnish Z-isomer 21.  
!  E olefin reacts more rapidly than the Z olefin
O
Me
Me O
O
MeN
H
Me Me
EtO
O
OEt
O
· TCA
CDCl3, –30 °C
1.2 eq. 91% yield
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Figure 12. Results of a VT-NMR Experiment
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5
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Mechanistic work to discriminate between these two modes of isomerization has yet to be 
performed. 
+ HNR2N
Me
!  Bayliss-Hillman type addition/elimination
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Developing a Facile Use of This Methodology 
 Our next goal was to develop this methodology into a single reagent to facilitate a 
greater ease-of-use reaction platform.  This was achieved by milling together the 
Hantzsch dihydropyridine 5 (solid) with catalyst 2•TCA salt (solid) in a 6:1 ratio (Fig. 
14).   The resulting reagent was termed Mixture for Asymmetric Catalytic Hydrogenation  
 
 
 
Figure 14.  Mixture for Asymmetric Catalytic Hydrogenation: MacH-(R)
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and is commercially available as the mnemonic MacH-(R).  Gratifyingly, even after 16 
months of storage at 0 °C, MacH-(R) reduced substrate 1 to provide 3 in good yield and 
good ee (eq. 7).  This stability study indicates the reagent can be stored for long periods 
of time without any noticeable degradation. 
 
    
 
 
 
Related Work 
 Around the time we reported our enantioselective catalytic hydrogenation 
technology, the List Group reported a similar methodology (eq. 8).15  In this work, a 
range 
Me
O
Me
O
N
N
H
OMe
t-Bu Bn
N
H
i-PrMe
CO2MeMeO2C · TCA
10 mol %
1.02 eq.
dioxane, 13 °C, 48 h
RR
5 examples
77– 90% yield
90 – 96% ee
(8)
24 25 27
 
                                                
(15) Yang, J. W.; Fonseca, M. T. H.; Vignola, N.; List, B. Angew. Chem. Int. Ed. 2005, 44, 108-110. 
!  Asymmetric transfer hydrogenation using MacH (after 16 months storage at 0 °C)
Me
O
MacH–(R)
CHCl3, –30 °C
O
Me
93% yield
93% ee
(7)
1 3
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of para-substituted α,β-unsaturated aldehydes 24 are reduced using non-symmetrical 
Hantzsch 25 and the MacMillan 2nd generation imidazolidinone catalyst to provide 
general product 27 in good yields and good ee’s.  Other extensions of this reduction 
platform include tandem catalysis16 and total synthesis.17 
 
Conclusions 
 In summary we have documented the development of a new hydrogenation 
technology applied to the LUMO-lowering activation of α,β-unsaturated aldehydes.  This 
work demonstrates the generality of the organocatalytic approach to LUMO-lowering 
catalysis.  Future extension of this work will focus on broadening both the substrate and 
reaction scope of this new process, as well as its extension into new tandem catalysis 
processes. 
                                                
(16) (a) Huang, Y.; Walji, A. M.; Larsen, C. H.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 15051-15053. (b) Walji, A. 
M.; MacMillan, D. W. C. Synlett 2007, 1477-1489. 
(17) de Figueiredo, R. M.; Berner, R.; Julis, J.; Liu, T.; Tuerp, D.; Christmann, M. J. Org. Chem. 2007, 72, 640-642. 
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Supporting Information 
 
General Information.  Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.1 Non-aqueous reagents were transferred under 
nitrogen via syringe or cannula and purified according to the method of Grubbs.2 Organic 
solutions were concentrated under reduced pressure on a Büchi rotary evaporator.  
Chromatographic purification of products was accomplished using forced-flow 
chromatography on ICN 60 32-64 mesh silica gel and Iatrobeads® according to the 
method of Still.3 Thin-layer chromatography (TLC) was performed on EM Reagents 0.25 
mm silica gel 60-F plates.  Chromatograms were visualized by fluorescence quenching or 
by staining using either potassium permanganate or anisaldehyde stain. 
1H and 13C NMR spectra were recorded on a Varian Mercury 300 Spectrometer, 
and are internally referenced to residual solvent signals.  Data for 1H NMR are reported 
as follows: chemical shift (d ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet), integration, coupling constant (Hz) and assignment.  Data for 13C 
NMR are reported in terms of chemical shift.  IR spectra were recorded on a Perkin 
Elmer Paragon 1000 spectrometer and are reported in terms of frequency of absorption 
(cm–1).  Mass spectra were obtained from the Caltech Mass Spectroscopy Facility by 
electron ionization, chemical ionization, or fast atom/ion bombardment techniques.  Gas 
liquid chromatography (GLC) was performed on Hewlett-Packard 6850 and 6890 Series 
gas chromatographs equipped with a split-mode capillary injection system and flame 
ionization detectors using a Bodman Chiraldex b-DM (30 m × 0.25 mm), a Bodman 
                                                
(1) Perrin, D. D. A., W. L. F. Purification of Laboratory Chemicals; 3rd ed.; Pergamon Press: Of, 1988. 
(2) Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518-1520. 
(3) Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925. 
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Chiraldex Γ-TA (30 m × 0.25 mm), or a Hydrodex-B-TBDAc (50 m × 0.25 mm) column 
as noted.  High-performance liquid chromatography (HPLC) was performed on Hewlett-
Packard 1100 Series chromatographs using a Chiralcel OD-H column (25 cm) and OD-H 
guard (5 cm).  Optical rotations were measured on a Jasco P-1010 polarimeter, and [α]D 
values are reported in 10–1 dg cm2 g–1; concentration (c) is in g/100 mL. 
  
 
Preparation of the starting materials 
The following α,β-unsaturated aldehydes have already been described in the literature: 
(E)-3-phenylbut-2-enal,4 (E)-3-phenylpent-2-enal,5 (E)-methyl 3-formyl-2-
methylacrylate.6 
 
Diethyl-1,4-dihydro-2,6dimethylpyridine-3,5-dicarboxylate:  A modified procedure 
from a reported method.7  In a beaker, a solid suspension of neat ammonium acetate (20.7 
g, 268 mmol, 1.25 eq.), hexamethylenetetramine (30 g, 214 mmol, 1.0 eq.), and ethyl 
acetoacetate (69.6 g, 535 mmol, 2.5 eq.) was heated in a conventional microwave on 
“high” power 2 x 35 seconds, with gentle swirling in between cycles.  After the second 
heating phase and, upon cooling, a solid rapidly forms.  After cooling, the solid was 
triturated with absolute ethanol (4 x 150 mL) and 5% water ethanol solution (2 x 100 mL) 
and dried on high vacuum to provide a light green solid that matched the reported 
characterization data.  
                                                
(4) Gandhi, R. P. W., J. S.; Mukherji, S. M. J. Ind. Chem. Soc. 1957, 34, 509. 
(5) Schreiber, W. L.; Pittet., A. O.; Vock, M. H. J. Agr. Food Chem. 1974, 22, 269. 
(6) Ishida, A.; Mukaiyama, T. Bull. Chem. Soc. Jap. 1978, 51, 2077. 
(7) Eynde, J. J. V.; Mayence, A. Molecules 2003, 8, 381-391. 
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Resolution of 2-tert-butyl-3-methylimidazolidin-4-one:  The imidazolidinone was 
synthesized according to a Seebach method.8 Dissolve 30 g of racemic imidazolidinone 
and 15 g of R-mandelic acid into ~25 mL of reagent grade acetone and GENTLY heat 
until homogenous (do not boil as ee will drop).  The resulting solution was cooled to 
room-temperature and then placed in a freezer for 12 hours to produce a light yellow 
solid.  Afterwards, wash the solid three times with ice-cold acetone (35 mL) and two 
times with room temperature ether (30 mL) to isolate 15 g of a white solid.  Depending 
on the scale, another re-crystallization/wash sequence may be necessary.  The resulting 
white solid (6 g) was free based with 3 N NaOH (100 mL), and the aqueous layer was 
extracted three times with methylene chloride (100 mL).  The organic layer was dried 
over Na2SO4, filtered, and concentrated to produce a clear oil (5.0 g).  A small portion 
(10 mg) was put aside.  The rest of the batch was dissolved in a 2:1 Et2O:pentane solution 
(50 mL).  To this was added dropwise, with swirling, a solution of TCA (5.2 g) dissolved 
in a 2:1 Et2O:pentane solution (20 mL).  Crystallization begins at room temperature and 
is continued at 0 °C for 2–3 hours.  The crystals were filtered off and washed three times 
in ice cold 2:1 Et2O:pentane solution then dried on high vacuum to produce a white solid 
(6.2 g).  The solid should be stored at 4 °C as it seems to oil out after 6 months at room 
temperature. 
 
Determining ee:  The 10 mg aliquot was BOC protected with 1 eq. triethylamine and 1 
eq. di-tert-butyldicarbonate by shaking the components in a vial with ethylacetate for 
about 5–10 minutes, quenching in water, and then injecting a small aliquot of the organic 
phase onto an achiral GC.  
                                                
(8) Fitzi, R.; Seebach, D. Angew. Chem. Int. Ed. Eng. 1986, 25, 345-346. 
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The enantiomeric ratio was determined by GLC using a B-DM Chiraldex (50 m × 0.25 
mm) column (155 °C isotherm, 1 mL/min.);  (R) isomer tr = 19.2 min. and (S) isomer tr = 
20.1 min.  (Here, the S isomer is the major enantiomer because the BOC group changes 
the Cahn-Ingold-Prelog prioritization.) 
 
(E)-3-(3,4-dichlorophenyl)-N-methoxy-N-methylbut-2-enamide:  To a solution of 
sodium metal (1.05 g, 45.9 mmol), dissolved in EtOH (32 mL) and cooled to 0 °C, was 
added diethyl (N-methoxy-N-methylcarbamoylmethyl)-phosphonate (10 g, 41.8 mmol).  
The resulting light yellow solution was stirred for 10 minutes.  To this was added 3,4-
dichloroacetophenone (7.11 g, 37.6 mmol) and the resulting solution stirred at 60 °C for 
approximately 2.5 hours until judged complete by TLC.  The reaction mixture was 
concentrated in vacuo.  The resulting residue was purified by flash chromatography (30% 
EtOAc/hexanes) to provide a clear oil (4.34 g, 42% yield). 
IR (film) 3064, 2965, 2937, 1651, 1623, 1551, 1471, 1441, 1411, 1371, 1323, 1179, 
1138, 1028, 981, 868, 821, 662, 474 cm–1; 1H NMR (300 MHz, CDCl3) ∂ 7.57 (d, 1H, J = 
2.1 Hz, ClC=CH=CH), 7.47 (d, 1H, J = 8.51 Hz, ClC=CH=C), 7.33 (dd, 1H, J = 2.1, 
8.24 Hz, ClC=CH=CH), 6.56 (bs, 1H, CH3C=CH), 3.74 (s, 3H, NOCH3), 3.30 (s, 3H, 
NCH3), 2.50 (d, 3H, J = 1.33 Hz, CH3); 13C NMR (75 MHz, CDCl3) ∂ 171.1, 167.3, 
132.9, 132.6, 130.4, 128.3, 125.6, 117.3, 61.7, 60.4, 21.1, 17.8; HRMS (EI+) exact mass 
calculated for [M]+ (C10H16OCl2) requires m/z 273.0323, found m/z 273.0317. 
 
(E)-3-(3,4-dichlorophenyl)but-2-enal:  To a solution of (E)-3-(3,4-dichlorophenyl)-N-
methoxy-N-methylbut-2-enamide (800 mg, 2.92 mmol) in CH2Cl2 (15 mL), cooled to –78 
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°C in a dry ice/acetone bath, was added DIBALH (3.07 mmol, 0.547 mL).  After 3.5 
hours, THF was added and the reaction mixture was warmed to room temperature.  The 
viscous solution was poured into 100 mL of a saturated solution of potassium sodium 
tartrate and stirred for 15 minutes.  The organic layer was separated and the aqueous layer 
was extracted with 100 mL of CH2Cl2 (3×).  The organic layers were dried over Na2SO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
(5% EtOAc/hexanes) and triturated with pentanes to afford the title compound as a 
colorless oil (160 mg, 25% yield). 
IR (film) 3285, 3089, 2963, 2886, 1653, 1616, 1548, 1474, 1444, 1389, 1324, 1279, 
1242, 1148, 1137, 1071, 1028, 954, 898, 865, 828, 698, 536 cm–1; 1H NMR (300 MHz, 
CDCl3) ∂ 11.9 (d, 1H, J = 7.71 Hz CHO), 7.65 (d, 1H, J = 2.13 Hz, ClC=CH=CH), 7.52 
(d, 1H, J = 8.51 Hz, ClC=CH=C), 7.40 (dd, 1H, J = 2.13, 8.24 Hz, ClC=CH=CH), 6.38 
(dd, 1H, J = 1.06, 7.74 Hz CHCHO), 2.57 (d, 3H, J = 1.06, CH3); 13C NMR (75 MHz, 
CDCl3) ∂ 190.8, 154.5, 140.5, 134.2, 130.8, 128.2, 128.0, 125.4, 65.9, 16.3; HRMS (EI+) 
exact mass calculated for [M]+ (C10H8OCl2) requires m/z 213.9952, found m/z 213.9950. 
 
(E)-3-cyclohexylbut-2-en-1-ol:  To a 0 °C solution of (E)-ethyl 3-cyclohexylbut-2-
enoate9 (1 g, 5.09 mmol) in dry Et2O (10 mL) was added a solution of lithium aluminum 
hydride (5.10 mL, 5.10 mmol, 1 M in Et2O).  After 5 minutes, the reaction mixture was 
neutralized by dropwise addition of THF solution followed by addition of a saturated 
solution of potassium sodium tartrate.  The reaction mixture was stirred for 25 minutes, 
then diluted with Et2O.  The organic layer was separated and washed with water, dried 
                                                
(9) Appella, D. H. Y., M.; Shantini, R.; Ferreira, E. M.; Buchwald, S. M. J. Am. Chem. Soc. 1999, 121, 9473. 
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over Na2SO4, and concentrated in vacuo to afford (E)-3-cyclohexylbut-2-en-1-ol as a 
colorless oil which was used directly in the following reaction. 
 
 (E)-3-cyclohexylbut-2-enal:  To a solution of (E)-3-cyclohexylbut-2-enol (700 mg, 4.54 
mmol) in dichloromethane (11 mL), cooled to 0 °C, was added Dess-Martin periodinane 
(2.11 g, 4.99 mmol).  The resulting suspension was warmed to 23 °C and stirred for 
approximately 30 minutes until the reaction was judged to be complete by TLC.  The 
reaction mixture was poured into 50 mL of saturated aqueous NaHCO3 containing 
Na2S2O3 (1 g).  This mixture was stirred vigorously until both layers became clear.  The 
aqueous layer was extracted with 50 mL ofCH2Cl2 (2×) and the combined organic layers 
were dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by 
flash chromatography (25% EtOAc/hexanes) to afford the title compound as a colorless 
oil (350 mg, 51% yield) that was a 5.2:1 mixture of E:Z isomers.  Major isomer:  IR 
(film) 2929, 2854, 1729, 1674, 1640, 1450, 1383, 1198, 1164, 894, 850, 522 cm–1; 1H 
NMR (300 MHz, CDCl3) ∂ 10.5 (d, 1H, J = 7.9 Hz CHO), 5.90 (dq, 1H, J = 1.1, 7.9 Hz, 
C=CH), 2.18 (d, 3H, J = 1.3 Hz, CH3), 2.09 − 2.02 (m, 1H, CH2CHCH2), 1.87 − 1.70 (m, 
5H), 1.40 (m, 5H); 13C NMR (75 MHz, CDCl3) ∂ 191.9, 168.8, 125.8, 48.4, 31.4, 31.2, 
26.3, 26.1, 26.0, 16.1; HRMS (EI+) exact mass calculated for [M]+ (C10H16O) requires m/z 
152.1201, found m/z 152.1205. 
 
(E)-ethyl 3-cyclohexylpent-2-enoate:  To 90 mL of EtOH, cooled to 0 °C in an ice bath, 
was added sodium metal (1.64 g, 71.3 mmol).  Once the metal had completely dissolved, 
triethyl phosphonoacetate (15.9 g, 14.1 mL, 71.3 mmol) was added via syringe.  The 
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resulting solution was warmed to room temperature and stirred for 10 minutes.  
Cyclohexyl ethyl ketone (9.44 g, 9.20 mL, 67.3 mmol) was added and the solution stirred 
for 15 hours at room temperature.  The reaction was quenched in 100 mL ice water 
slurry.  The aqueous layer was extracted with 200 mL of Et2O (3×).  The combined 
organic layers were washed with 400 mL of brine, dried over Na2SO4, filtered, and 
concentrated in vacuo.  The product was purified by flash chromatography (1% 
Et2O/pentane) to provide a clear oil (2.5 g, 18% yield) that was a 3:1 mixture of E:Z 
isomers.  Major isomer:  IR (film) 2977, 2929, 2854, 2360, 2341, 1716, 1638, 1448, 
1203, 1147, 1042, 862, 750 cm–1; 1H NMR (300 MHz, CDCl3) ∂ 5.58 (s, 1H, C=CH), 
4.15 (q, 2H, J = 4.1 Hz, OCH2CH3), 2.58 (q, 2H, J = 7.4 Hz, CH2CH3), 1.81 − 1.62 (m, 
5H,), 1.35 − 1.11 (m, 9H), 1.06 (t, 3H, J = 2.2 Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) 
∂ 171.3, 113.4, 59.6, 46.8, 32.3, 31.2, 26.9, 26.8, 26.6, 26.3, 25.3, 14.5, 13.8; HRMS 
(EI+) exact mass calculated for [M]+ (C13H22O2) requires m/z 210.1620, found m/z 
210.1628. 
 
(E)-3-cyclohexylpent-2-enol:  To a solution of (E)-ethyl 3-cyclohexylpent-2-enoate (2.3 
g, 10.9 mmol) in Et2O (22 mL), was added lithium aluminum hydride (1.0 M in Et2O, 
10.9 mL, 10.9 mmol) dropwise.  After 5 minutes, the reaction mixture was slowly 
quenched with 1 mL of MeOH and poured into 100 mL of a saturated solution of 
potassium sodium tartrate.  The aqueous layer was extracted with 100 mL of Et2O (3×).  
The combined organics were dried over Na2SO4, filtered, and concentrated.  The product 
was purified by flash chromatography (10% EtOAc/hexanes) to provide a clear oil (1.59 
g, 87% yield) that was a 3:1 mixture of E:Z isomers.  Major isomer:  IR (film) 3421, 
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2929, 2854, 1732, 1684, 1635, 1449, 1235, 1164, 864, 749 cm–1; 1H NMR (300 MHz, 
CDCl3) ∂ 5.33 (t, 1H, J = 6.7 Hz, CHCH2OH), 4.17 (d, 2H, J = 6.9 Hz, CH2OH), 2.07 (q, 
2H, J = 7.4 Hz, CH2CH3), 1.99 – 1.63 (m, 6H), 1.48 – 1.08 (m, 6H), 0.97 (t, 3H, J = 7.4 
Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) ∂ 151.1, 121.2, 59.4, 44.8, 32.6, 31.6, 26.9, 
26.7, 26.4, 23.1, 14.7; HRMS (EI+) exact mass calculated for [M]+ (C11H20O) requires m/z 
168.1514, found m/z 168.1520. 
 
(E)-3-cyclohexylpent-2-enal:  To a solution of (E)-3-cyclohexylpent-2-enol (1.50 g, 8.91 
mmol) in dichloromethane (45 mL), cooled to 0 °C, was added Dess-Martin periodinane 
(9.7 g, 22.9 mmol).  The resulting suspension was warmed to room temperaure and 
stirred for approximately 2 hours until the reaction was judged to be complete by TLC.  
The reaction was poured into 100 mL of saturated aqueous NaHCO3 containing Na2S2O3 
(3 g).  This mixture was stirred vigorously until both layers became clear.  The aqueous 
layer was extracted with CH2Cl2 (2×) and the combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo. The residue was purified by flash 
chromatography (5% Et2O/pentane) to afford the title compound (1 g, 68% yield) as a 
colorless oil that was a 3:1 mixture of E:Z isomers.  Major isomer:  IR (film) 2927, 2746, 
1668, 1622, 1450, 1189, 1124, 860 cm–1; 1H NMR (300 MHz, CDCl3) ∂ 10.04 (d, 1H, J = 
8.24 Hz, CHO), 5.83 (d, 1H, J = 8.24 Hz, C=CH), 2.61 (q, 2H, J = 7.4 Hz, CH2CH3), 
2.07 (tt, 1H, J = 2.6, 11.0 Hz, CH2CHCH2), 1.88 − 1.71 (m, 5H), 1.41 − 1.15 (m, 8H); 
13C NMR (75 MHz, CDCl3) ∂ 191.8, 175.2, 124.9, 46.2, 31.9, 26.5, 26.3, 26.0, 25.9, 24.2, 
15.4; HRMS (EI+) exact mass calculated for [M]+ (C11H18O) requires m/z 166.1358, 
found m/z 166.1355. 
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(E)-ethyl-4-[tris-(1-methylethyl)silyloxy]-3-methylbut-2-enoate: To a suspension of 
sodium hydride (60% dispersion in mineral oil, 1.58 g, 62.6 mmol) in dry toluene (500 
mL) at 0 °C was added, dropwise, triethyl phosphonoacetate (12.4 mL, 62.6 mmol) under 
an atmosphere of argon.  After 30 minutes, 1-[tris-(1-methylethyl)silyloxy]-pentanone 
(12 g, 52.2 mmol) was diluted into toluene (25 mL) and added to the reaction mixture, 
which was then allowed to warm to room temperature over a period of 2 hours.  The 
resulting mixture was washed with water, dried over MgSO4 and concentrated in vacuo.  
The residue was purified by flash chromatography (3% Et2O/pentane) to afford (E)-ethyl 
4-[tris-(1-methylethyl)silyloxy]-3-methylbut-2-enoate as a colorless oil (10.5 g, 67% 
yield).  Major isomer:  IR (film) 2945, 2868, 1716, 1663, 1223, 1154, 1114 cm–1; 1H 
NMR (300 MHz, CDCl3) ∂ 6.07 (bs, 1H, CH), 4.21 (s, 2H, CH2OTIPS), 4.17 (q, 2H, J = 
6.9 Hz, CH3CH2O), 2.06 (s, 3H, CCH3), 1.29 (t, 3H, J = 7.8 Hz, CH3CH2O), 1.09 (m, 
21H, TIPSO); 13C NMR (75 MHz, CDCl3) ∂ 167.0, 157.0, 113.2, 67.2, 59.4, 17.9, 15.3, 
14.3, 11.9; HRMS (EI+) exact mass calculated for [M]+ (C16H32O3Si) requires m/z 
300.2121, found m/z 300.2125. 
 
(E)-3-[tris-(1-methylethyl)silyloxy]but-2-en-1-ol:  To a 0 °C solution of (E)-ethyl 4-
[tris-(1-methylethyl)silyloxy]-3-methylbut-2-enoate (5 g, 17.6 mmol) in dry Et2O was 
added a solution of lithium aluminum hydride (17.6 mL, 17.6 mmol, 1 M in Et2O).  After 
30 minutes, the reaction mixture was neutralized by dropwise addition of THF followed 
by addition of a saturated solution of potassium sodium tartrate.  The reaction mixture 
was stirred overnight and then diluted with Et2O.  The organic layer was separated and 
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washed with water, dried over MgSO4, and concentrated in vacuo to afford (E)-3-[tris-(1-
methylethyl)silyloxy]but-2-en-1-ol as a colorless oil which was used directly in the next 
reaction. 
 
(E)-3-[tris-(1-methylethyl)silyloxymethyl]but-2-enal:  To a room-temperature solution 
of (E)-3-[tris-(1-methylethyl)silyloxy]but-2-en-1-ol (crude from the previous step, 
assumed 17.6 mmol) in dichloromethane (100 mL) was added Dess-Martin periodinane 
(9.7 g, 22.9 mmol).  The resulting suspension was stirred for 60 minutes, until the 
reaction was judged to be complete by TLC.  The reaction mixture was diluted with Et2O 
and a saturated aqueous solution of NaHCO3 containing Na2S2O3 was added.  This 
mixture was stirred vigorously until both layers became clear.  The aqueous layer was 
extracted with 100 mL of CH2Cl2 (2×) and the combined organic layers were dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (5% Et2O/pentane) to afford the title compound as a colorless oil (3.69 
g, 82% yield).  IR (film) 2944, 2867, 1681, 1464, 1384, 1123 cm–1; 1H NMR (300 MHz, 
CDCl3) ∂ 10.09 (d, 1H, J = 8.3 Hz, CHO), 6.28 (dd, 1H, J = 1.5, 8.4 Hz, CH), 4.28 (d, 
2H, J = 0.9 Hz, CH2OTIPS), 2.09 (d, 3H, J = 0.6 Hz, CH3C), 1.1 – 1.0 (m, 21H, TIPSO); 
13C NMR (75 MHz, CDCl3) ∂ 191.2, 161.6, 124.1, 67.0, 18.0, 14.1, 11.9; HRMS (EI+) 
exact mass calculated for [M]+ (C14H28O2Si) requires m/z 256.1859, found m/z 256.1862. 
 
 
General Procedure for the enantioselective hydrogenation of enal:  A colorless 
solution of (E)-3-phenylbut-2-enal (140 mg, 1 mmol) dissolved in 5 mL of chloroform 
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(0.2 M) was cooled to –30 °C in a dry ice/acetone bath.  To this solution was added the 
trichloroacetic acid salt of (R)-2-tert-butyl-3-methylimidazolidin-4-one (64 mg, 0.2 
mmol) and Hantzsch ester (304 mg, 1.2 mmol).  The resulting yellow suspension was 
stirred at –30 °C until the reaction was determined to be complete by TLC, by which time 
the mixture was a light yellow homogeneous solution.   
Workup procedure A:  The reaction mixture was then diluted with Et2O and passed 
though a short pad of silica gel.  The resulting solution was concentrated in vacuo and 
purified by flash chromatography (solvent noted) to provide the title compounds. 
Workup procedure B:  The cold reaction mixture was poured into a 10% HCl solution 
and diluted with Et2O.  The organic layer was washed 4 times with 10% HCl solution and 
once with a saturated aqueous solution of NaHCO3.  The resulting solution was dried 
over MgSO4 and concentrated in vacuo.  The residue was purified by flash 
chromatography (solvent noted) to provide the title compounds. 
 
(S)-3-phenylbutanal:  Prepared according to the general procedure from (E)-3-
phenylbut-2-enal (140 mg, 1 mmol) for 23 hours, using workup procedure A to provide 
the title compound as a colorless oil (127 mg, 91% yield, 93% ee) after purification by 
flash chromatography on Iatrobeads® (15 – 20% Et2O/pentane).  The physical data were 
identical in all respects to those previously reported.10 The enantiomeric ratio was 
determined by GLC using a Bodman Chiraldex β-DM (30 m × 0.25 mm) column (90 °C 
isotherm, 1 mL/min.);  (R) isomer tr = 38.6 min. and (S) isomer tr = 39.5 min. 
! 
["]
D
22  = 
+32.9° (c = 1.00, EtOH). 
                                                
(10) Bull, S. D. D., S. G.; Nicholson, R. L.; Sanganee, H. J.; Smith, A. D. Org. Biomol. Chem. 2003, 1, 2886. 
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(S)-3-phenylpentanal: Prepared according to the general procedure from (E)-3-
phenylpent-2-enal (160 mg, 1 mmol) for 16 hours, using workup procedure A to provide 
the title compound as a colorless oil (119 mg, 74% yield, 94% ee) after purification by 
flash chromatography on Iatrobeads® (10% Et2O/pentane).  The physical data were 
identical in all respects to those previously reported.11 The enantiomeric ratio was 
determined by GLC using a Bodman Chiraldex β-DM (30 m × 0.25 mm) column (95 °C 
isotherm, 1 mL/min.);  (R) isomer tr = 42.8 min. and (S) isomer tr = 43.9 min. 
! 
["]
D
22  = 
+20.1° (c = 1.00, EtOH). 
 
(S)-3-(3,4-dichlorophenyl)butanal: Prepared according to the general procedure from 
(E)-3-(3,4-dichlorophenyl)but-2-enal (150 mg, 0.691 mmol) for 19 hours, using workup 
procedure A to provide the title compound as a colorless oil (133 mg, 89% yield, 92% ee) 
after purification by flash chromatography on silica gel (50% CH2Cl2/pentane). The 
enantiomeric ratio was determined by GLC using a Bodman Chiraldex Γ-TA (30 m × 
0.25 mm) column (120 °C isotherm, 1 mL/min.); (S) isomer tr = 42.7 min. and (R) isomer 
tr = 44.8 min. IR (film) 2966, 2931, 2825, 2725, 1725, 1564, 1470, 1403, 1277, 1135, 
1030, 882, 823, 709, 678, 596 cm–1; 1H NMR (300 MHz, CDCl3) d 9.74 (t, 1H, J = 1.09 
Hz CHO), 7.40 (d, 1H, J = 8.21 Hz, ClC=CHCH), 7.34 (d, 1H, J = 2.35 Hz, ClCCHC), 
7.09 (dd, 1H, J = 2.35, 8.21 Hz ClCCHCH), 3.37 (qdd, 1H, J = 7.04, 7.04, 7.04 Hz 
CH3CHCH2), 2.74 (ddd, 2H, 1.47, 7.04, 17.30 Hz CH2CHO), 1.32 (d, 3H, J = 7.04 Hz, 
CH3); 13C NMR (75 MHz, CDCl3) ∂ 200.7, 145.9, 132.6, 130.6, 130.4, 128.9, 126.4, 
                                                
(11) Berlan, J.; Bersace., Y.; Pourcelot, G.; Cresson, P. Tetrahedron 1986, 42, 4757. (Reported a rotation of +2.1° for a 
product that was 15% ee.) 
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51.5, 33.4, 21.9; HRMS (EI+) exact mass calculated for [M]+ (C10H10OCl2) requires m/z 
216.0109, found m/z 216.0103; 
! 
["]
D
22  = +27.6° (c = 1.59, CHCl3). 
 
(S)-3-cyclohexylbutanal: Prepared according to the general procedure from (E)-3-
cyclohexylbut-2-enal (154 mg, 1 mmol) for 22 hours, using workup procedure A to 
provide the title compound as a colorless oil (45.1 mg, 91% yield, 96% ee) after 
purification by flash chromatography on silica gel (10% Et2O/hexane).  The physical data 
were identical in all respects to those previously reported.12 The enantiomeric ratio was 
determined by GLC using a Bodman Chiraldex β-DM (30 m × 0.25 mm) column (80 °C 
isotherm, 1 mL/min.);  (R) isomer tr = 70.6 min. and (S) isomer tr = 71.3 min. 
! 
["]
D
22  = 
+8.3° (c = 1.00, EtOH).  
 
(S)-3-cyclohexylpentanal: Prepared according to the general procedure from (E)-3-
cyclohexylpent-2-enal (250 mg, 1.50 mmol) for 24 hours, using workup procedure A to 
provide the title compound as a colorless oil (240.8 mg, 95% yield, 91%ee) after 
purification by flash chromatography on silica gel (10% Et2O/pentane). The enantiomeric 
ratio was determined by GLC using a Hydrodex-B-TBDAc (50 m × 0.25 mm) column 
(90 °C isotherm, 1 mL/min.);  (R) isomer tr = 35.2 min. and (S) isomer tr = 37.9 min.  IR 
(film) 2927, 2854, 1732, 1708, 1449, 1412, 1381, 1286, 1164, 954, 892 cm–1; 1H NMR 
(300 MHz, CDCl3) ∂ 9.79 (t, 1H, J = 2.4.3 Hz, CHO), 2.44,  (ddd, 1H, J = 2.1, 5.8, 16.4 
Hz, CH), 2.28 (ddd, 1H, J = 2.7, 7.2, 16.2 Hz, CH), 1.82 – 1.61 (m, 5H), 1.47 – 0.99 (m, 
12H); 13C NMR (75 MHz, CDCl3) δ 203.9, 45.7, 40.3, 39.9, 30.4, 29.2, 26.74, 26.69, 
                                                
(12) Tanaka, K.; Fu, G. C. J. Org. Chem. 2001, 66, 8177. (Reported a rotation of +7.4° for a product that was  74% ee.) 
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26.67, 24.3, 11.8; HRMS (EI+) exact mass calculated for [M]+ (C11H20O) requires m/z 
168.1514, found m/z 168.1522; 
! 
["]
D
22  = +6.2° (c = 1.03, CHCl3).                                                                                        
 
(S)-methyl 2-methyl-4-oxobutanoate:  Prepared according to the general procedure 
from (E)-methyl 3-formyl-2-methylacrylate (100 mg, 0.781 mmol) for 26 hours to 
provide the title compound (83% conversion, 91% ee).  Conversion was determined via 
1H NMR by comparison with an internal standard (BnOMe).  The physical data were 
identical in all respects to those previously reported.13 The enantiomeric ratio was 
determined by GLC using a Bodman Chiraldex Γ-TA (30 m × 0.25 mm) column (100 °C 
isotherm, 1 mL/min.);  (S) isomer tr = 6.7 min. and (R) isomer tr = 7.7 min. 
! 
["]
D
22  = +1.4° 
(c = 1.15, CHCl3).   
 
(S)-3-[tris-(1-methylethyl)silyloxymethyl]butanal: Prepared according to the general 
procedure from (E)-3-[tris-(1-methylethyl)silyloxymethyl]but-2-enal (245 mg, 1 mmol) 
for 72 hours, using  workup procedure A to provide the title compound as a colorless oil 
(190 mg, 74% yield, 87% ee) after purification by flash chromatography on Iatrobeads® 
(10% Et2O/pentane).  The enantiomeric ratio was determined by HPLC (the aldehyde 
was reduced and protected using BzCl) on Chiralcel® OD-H (0.46 mm × 25 cm) Isocratic 
5% EtOH/Hexanes, 1 mL/min., 25 °C);  (S) isomer tr = 19.2 min. and (R) isomer tr = 22.2 
min.  IR (film) 2944, 2867, 2716, 1728, 1464, 1385, 1101 cm–1; 1H NMR (300 MHz, 
CDCl3) ∂ 9.80 (t, 1H J = 2.4 Hz, CHO), 3.66 (dd, 1H, J = 5.1, 9.9Hz, TIPSOCH), 3.47 
(dd, 1H, J = 6.9, 9.6 Hz, TIPSOCH), 2.58 (m, 1H, CHCHO), 2.28 (m, 2H, MeCHCH), 
                                                
(13) Kollar, L.; Consiglio, K.; Pino, P. J. Organomet. Chem. 1987, 330, 305. (Reported a rotation of +0.58° for a product that 
was 10% ee.) 
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1.06 (m, 21H, TIPSO), 0.97 (d, J = 6.9 Hz, CH3); 13C NMR (75 MHz, CDCl3) ∂ 202.7, 
68.0, 48.2, 31.6, 17.9, 16.7, 11.9; HRMS (EI+) exact mass calculated for [M–H]+ 
(C14H29O2Si) requires m/z 257.1930 found m/z 257.1937; 
! 
["]
D
22  = –2.7° (c = 1.07, 
CHCl3).              
 
(S)-3,4,4-trimethylpentanal:  Prepared according to the general procedure, at room 
temperature, from (E)-3,4,4-trimethylpent-2-enal (70 mg, 0.56 mmol) for 30 minutes to 
provide the title compound (95% conversion, 97% ee).  Conversion was determined using 
1H NMR by comparison with an internal standard (BnOMe).  The physical data were 
identical in all respects to those previously reported.14 The enantiomeric ratio was 
determined by GLC using a Bodman Chiraldex β-DM (30 m × 0.25 mm) column (60 °C 
isotherm, 1 mL/min.);  (R) isomer tr = 19.29 min. and (S) isomer tr = 20.32 min. 
! 
["]
D
22  = + 
29.3° (c = 1.00, CHCl3). 
 
 
 
 
                                                
(14) Berlan, J.; Besace, Y.; Pourcelot, G.; Cresson, P. Tetrahedron 1986, 42, 4757. (Reported a rotation of +3.4° for a product 
that was 16% ee.) 
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Chapter 3 
 
Design and Development of an Organocatalytic Reduction of Enones 
 
Introduction 
 We sought to extend our hydrogenation technologies1 towards α,β-unsaturated 
cyclic enones, an important class of structurally related molecules.  Access to carbocycles 
containing stereogenicity is an ongoing focus of asymmetric catalysis due to their broad 
utility in the preparation of natural isolates and medicinal agents.  Considerable effort has 
focused on the conjugate reduction of β-substutited enones using transition metal 
complexes as catalysts.2 Recently, chiral ligands have been developed and applied 
towards catalytic enantioselective conjugate enone reduction.  The first account was 
reported in 2000 by the Buchwald group3 (eq. 1) and has been complimented by similar 
work.4 
 
 
 
  
  
                                                
(1) Ouellet, S. G.; Tuttle, J. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 32-33. 
(2) (a) Kienan, E. G., N. Comprehensive Organic Synthesis; Perfamin Press: Oxford, 1991. (b) Mori, A.; Fujita, A.; Kajiro, H.; 
Nishihara, Y.; Hiyama, T. Tetrahedron 1999, 55, 4573-4582. (c) Mahoney, W. S.; Stryker, J. M. J. Am. Chem. Soc. 1989, 111, 
8818-8823. (d) Jurkauskas, V.; Sadighi, J. P.; Buchwald, S. L. Org. Lett. 2003, 5, 2417-2420. (e) Lipshutz, B. H.; Keith, J.; 
Papa, P.; Vivian, R. Tetrahedron Lett. 1998, 39, 4627-4630. 
(3) Moritani, Y.; Appella, D. H.; Jurkauskas, V.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 6797-6798. 
(4) Lipshutz, B. H.; Servesko, J. M.; Petersen, T. B.; Papa, P. P.; Lover, A. A. Org. Lett. 2004, 6, 1273-1275. 
5 mol% CuCl
O
R
n( )
O
R
11 examples
42–91% yield
87–98% ee
5 mol% NaOt-Bu
5 mol% (S)-p-Tol-BINAP
1.5 eq. PMHS
n( )toluene
(eq. 1)
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In the realm of organocatalytic iminium activation, cyclic ketones remain a challenging 
class of substrates.  First, these compounds are less reactive compared to their aldehyde 
counterparts (Fig. 1). This characteristic is attributed to the subtle replacement of an 
aldehyde hydrogen with a methylene unit.  The resulting increase in the steric component 
at that position leads to slower iminium formation.   
 
 
 
 
 
 
 
 
 
Second, a catalyst has to effectively distinguish the subtle, but significant, steric 
differences between methane and methylene groups in order to achieve enantioselectivity 
(Fig. 2).  If conformational interchange is a facile process, then enantioselectivity will 
erode due to poor facial selectivity in the hydride addition step.    
 
 
 
 
 
N
Figure 2.  Challenges for Stereocontrol
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Figure 1.  Reactivity Differences Between Unsaturated Aldehydes and Ketones
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Development of an Organocatalytic Enone Hydrogenation Reaction 
Initial forays into developing this methodology were hindered by these challenges 
(Fig. 3). Indeed, imidazolidinone catalyst 1 and 2nd-generation catalyst 2 failed to 
catalyze the reduction of 3-methylcyclopentenone, obviating the need for a different 
catalyst structure that is more appropriate for this type of substrate.      
 
 
 
 
 
Inspiration for a more effective catalyst came from within our group.5  In 2002, Alan 
Northrup developed imidazolidinone catalyst 3 to activate α,β-unsaturated ketones 
towards Diels-Alder cycloadditions (eq. 2).  The basis for this enhanced reactivity is 
attributed to the ability of the furan to accommodate the methylene protons by, one, 
rotating out of the chemical space occupied by the hydrogens and, two, engaging in a 
                                                
(5) Northrup, A. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 2458-2460. 
N
N
H
OMe
O
Me
O
Et
OMe OMe
88% yield, 96% ee
>200:1 endo:exo
20 mol %
EtOH, –30 °C
· HClO4
+
! A priviledged enone catalyst
O
Et
(eq. 2)
3
catalyst  TFA
N
H
Me Me
OEt
O
EtO
O O
Me
N
N
H
OMe
Me
Me
Me
N
N
H
OMe
Me
Me
Me
1: 0% conversion 2: 0% conversion
O
Me
0.2 M CHCl3, RT
Figure 3.  Typical Organocatalysts Failed to Catalyze a Reaction
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CH-π stabilizing interaction.6 In the first reaction with catalyst 3, we were gratified to 
discover the model system was activated towards hydride reduction and provided the 
desired product in good ee albeit low yield (eq. 3).  This is the first demonstration of a 
conjugate nucleophilic addition reaction to an α,β-unsaturated ketone utilizing 
imidazolidinone 3 as a catalyst. 
 
 
 
 
Having found an effective catalyst, the next step was to improve product 
conversion while maintaining good levels of enantioselectivity.  Exploring a range of 
solvents indicated Et2O improved conversion and maintained good levels of ee (Table 1,  
 
 
 
 
 
 
 
 
 
 
                                                
(6) Northrup, A. B., Ph. D. Thesis, California Institute of Technology, 2005. 
catalyst 3 • TFA
N
H
Me Me
OEt
O
EtO
O O
Me
O
Me
0.2 M CHCl3, RT
19% conversion
91% ee
20 mol %
(eq. 3)
!  Preliminary results for the enone hydrogenation reaction development
solvent co-catalyst % conversiona % eeb
CHCl3 TFA 19 91
Toluene TFA 56 91
Et2O TCA 77 93
Et2O TCA 77 96
MeOH TFA 63 33
Et2O TFA 63 90
Et2O 16 78HCl
Et2O 77 96TCA
[C]
0.2 M
0.2 M
1.0 M
0.2 M
0.2 M
0.2 M
0.5 M
N
H
Me Me
OEt
O
EtO
O O
Me
O
Me
solvent, RT
20 mol% catalyst 3 · HX
0.2 M
Table 1.  Optimizating the Enone Hydrogenation
entry
1
3
6
8
2
4
5
7
aConversion determined by GC analysis comparison to an internal standard.
bEnantiomeric excess determined by chiral GC analysis
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entries 1-4).  A co-catalyst survey indicated weaker acids improved product conversion 
as opposed to stronger variants presumably due to more efficient proton shuttling (Table 
1, entries 5-7).  Concentration had little effect on the transformation as the high 
conversion and ee was maintained across a range of molarities (Table 1, entries 7-9).   
 
Substrate Scope 
 With these optimal conditions in hand, a range of enones that are amenable to this 
new process was examined (Table 2).  Analysis of alkyl groups representing a spectrum 
of steric demand indicate enones containing methyl (Table 2, entry 1) and benzyl 
substituents (Table 4, entry 2) were reduced in high yield and with good enantiocontrol.  
Sterically congested centers, that are typically difficult to reduce using organometallic 
catalysts, readily react under enantioselective organocatalytic hydride conditions (EOHR) 
(Table 2, entries 3-4).  We were pleased to discover that protected alcohol equivalents 
(Table 2, entry 5) are tolerated under these conditions.  Variation of the electronic nature 
of the enone substutuent has an effect on the observed enantioinduction.  Iminium- 
stabilizing substituents decrease the enantiomeric excess (Table 2, entry 6).  Conversely, 
a high level of selectivity is maintained in the reduction of enones that do not readily 
participate in iminium formation (Table 2, entry 7).  Gratifyingly, the catalyst 
differentiates between enones of comparable electronics but different steric demand 
(Table 2, entry 8).   
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entry % yield % eea
1
3
5
7
time (h)
N
H
MeMe
EtO2C CO2Et
2
O
R
O
R
6
77b 95
85 96
91 90c
76 91c
89 74
76 90c
82 93c
26
8
24
24
8.5
24
24
1.0 M, Et2O, 23 °C
TFA
20 mol%
Table 2.  Substrate Scope: Cyclopentenones
aEnantiomeric excess determined by GLC analysis. bYield determined by GLC. cReaction 
run at 0 °C.
1.2 eq.
c-hex
R
Bn
4
8
93 969t-bu
Me
CH2OBn
Ph
CO2Me
COMe
catalyst 3
 
Importantly, functional groups sensitive to metal-mediated hydrogenation, such as 
ketones and benzyl protecting groups, withstand these mild conditions. 
    Assessing the effect of larger rings on EOHR was explored (Table 3).  In the six-
membered-ring series both alkyl (Table 3, entry 1) and cycloalkyl substituents (Table 3, 
entry 2) were reduced in good yield and selectivity.  Moreover, EOHR successfully 
reduced substrates that contain sterically demanding functionality proximal to the 
reaction center (Table 5, entry 3).  Further increasing the ring size to cycloheptenone 
(Table 3, entry 4) provided the product in moderate yield and enantioselectivity.  
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Absolute Sense of Enantioinduction  
Comparing the GC retention time of reduced product 3-methylcyclopentanone to 
a commercially available, enantiopure sample proves the (R)-enantiomer is produced 
(Fig. 3).  This indicates the catalyst forms an iminium intermediate that has the benzyl 
group shielding the Re-face of the substrate and favoring the Si-face for hydride delivery.  
This orientation is entirely consistent with that found for the ketone Diels-Alder 
chemistry where MM3 calculations indicate this type of iminium is favored by 11.3 
KJ/mol.7 
 
 
 
                                                
(7) Northrup, A. B. Ph. D. Thesis California Institute of Technology, 2005. 
entry % yield % eea
1
3
time (h)
N
H
MeMe
EtO2C CO2Et
2
75 88
65 97
80 90
43
48
43
1.0 M, Et2O, 23 °C
catalsyt 3 TFA
20 mol%
Table 3.   Substrate Scope: Larger Rings
aEnantiomeric excess determined by GLC analysis.
1.2 eq.
n-Bu
R
c-Hex
4
O
R
O
R
48 63 82
O
MeMe
Me
O
n-Bu
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Challenges Associated with this Chemistry 
 While developing the substrate scope, we discovered certain limitations to this 
methodology (Fig. 5).  In the cyclopentane series, the phenyl ring bearing substrate 4 was 
reduced with low enantioselectivity (Fig. 5, 74% ee).  Additionally, larger rings (Fig. 5, 
5-7) are reduced very slowly (typically 48 h) and the cycloheptenone substrate 8 exhibits 
a low yield and poor enantioselectivity (Fig. 5, 63% yield, 82% ee).   
N
N
!  The absolute stereochemistry is consistent with the benzyl group oriented over the alkene
O
absolute
O
Me
Ph
Me
O Me
stereochemistry
Me
Figure 4.  Absolute Sense of Enantioinduction
!  Product stereochemistry matches that of an (R)-configured commercially available sample
75% yield
88% ee
43 h
63% yield
82% ee
48 h
80% yield
90% ee
43 h
65% yield
97% ee
48 h
!  Larger rings suffer from long reaction times
O
O
O
n -Bu
c-Hex
n-Bu
!  The phenyl derivative is reduced with low enantioselectivity
O
Ph
89% yield
74% ee
O
MeMe
Me
Figure 5. Challenges Associated with the Reduction Chemistry
4
5 6
7 8
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Attempts to overcome the low enantioselectivity exhibited by 3-
phenylcyclopentenone 4 by varying solvent, temperature, catalyst, and co-catalyst did not 
improve the initial results.  Our next efforts focused on varying the hydride component 
(Table 4).  Decreasing the steric component on the 2,6-positions slightly increased the 
enantioselectivity but led to an undesired decrease in conversion (Table 4, Entries 1-3).  
Alternatively, substituting the ethoxy group with an isopropoxy group gave a good yield 
and a slightly improved ee (Table 4, entry 5).  Unexpectedly, increasing the bulk of the 
ester dramatically improved the enantioselectivity while maintaining good levels of 
conversion (Table 4, entry 6). 
N
H
X X
OR
O
RO
O O
Ph
O
Ph
1.0 M Et2O, RT
20 mol% catalyst 3 TCA
X time (h) % conversiona % eeb
3
3
3
6
96
93
78
86
74
73
78
91
Me
H
Me
Me
CO2i-Pr
CO2t-Bu
CO2R
CO2Et
CO2Et
Table 4.  Analyzing Hantzsch Derivatives for Efficacy
24 57 86i-PrCO2Me
4 76 82EtCO2Et
5
6c
entry
4
1
3
2
aConversion determined by GC analysis comparison to an internal standard.
bEnantiomeric excess determined by chiral GC analysis.
cReaction run at 0 °C.  
Having solved the problem of enantioselectivity for the phenyl substrate, we 
sought to improve the reaction rates of the larger rings.  To achieve this goal, Hantzsch 
ester 9 was utilized for reducing these less-reactive species (Table 5).  Remarkably, in 
almost every instance, the reaction rate was nearly doubled, while high levels of 
enantioselectivities and yields were maintained (Table 5 entries 1-2, 4).  Gratifyingly, the 
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cycloheptenone substrate now exhibited improvements in yield and ee from the initial 
result (Table 5, entry 4).  Isophorone exhibited only slightly improved levels of reactivity, 
presumably owing to the influence the bulky gem-dimethyl group has on the reacting 
center (Table 5, entry 4).   
 
 
 
 
 
 
 
 
 
 
 
 
The increased reduction rate exhibited by Hantzsch 9 is not limited to larger rings.  
Indeed, subjecting 5-membered rings to these conditions provided the reduced products 
with shorter reaction times (Table 6).  As shown in table 6, in many cases reduction rates 
were nearly doubled (Table 6 entries 1-2) or better (Table 6, entries 3-4). This remarkable 
difference in reactivity prompted us to assess the effect this reductant would have on α,β-
unsaturated aldehydes. 
 
O
O
O
O
n -Bu
c-Hex
Me
n-Bu
Me
Me
82% yield
90% ee
25 h
71% yield
88% ee
24 h
70% yield
92% ee
9 h
66% yield
98% ee
40 h
75% yield
88% ee
43 h
80% yield
90% ee
43h
65% yield
97% ee
48 h
63% yield
82% ee
48 h
0.5 M Et2O, 0 °C
20 mol% catalyst 3 TCA
N
H
Me Me
OR2
O
R2O
OO
R1
O
R1
product R2 = ethyl R2 = t-butyl, 9
n(  ) n(  )
entry
1
2
3
4
Table 5.  Comparison of Ethyl and t-Butyl Hantzsch Reduction Reactions with Larger Rings
  
50 
 
 
 
 
 
 
 
 
 
 
 
 
 
Utilizing t-Butyl Hantzsch Dihydropyridine in the Reduction of Geranial   
During the course of our enal studies, one important substrate class posed a 
significant problem.  In particular, β,β-methyl, ethyl substituted olefins, such as geranial 
10, were reduced in very low ee using dihydropyridine 12 (Fig. 6).  Remarkably, 
Hantzsch ester 9 continued its trend of reaction improvement, providing citronellal 11 at 
a faster rate, with an improved yield, and a dramatically increased ee under the same 
conditions (compare ethyl derivative 12: 17h, 79% yield, 38% ee to t-butyl derivative 9: 
7h, 88% yield, 80% ee).  
 
 
77% yield
91% ee
13 h
78% yield
90% ee
11 h
83% yield
93% ee
1 h
78% yield
93% ee
1 h
76% yield
91% ee
24 h
91% yield
90% ee
24h
76% yield
90% ee
24 h
63% yield
93% ee
24 h
product R2 = ethyl R2 = t-butyl, 9
0.5 M Et2O, 0 °C
20 mol% catalyst 3 TCA
N
H
Me Me
OR2
O
R2O
OO
R1
O
R1
O
O CH2OBn
Bn
O
O
CO2Me
COMe
Table 6.  Comparison of Ethyl and t-Butyl Hantzsch Reductions of Cyclopentenones
1
2
3
4
entry
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Insight into this effect is gleaned by analyzing a simple rate diagram (Fig. 7).  In 
the case of dihydripyridine 12, the rate of reduction is slower than the rate of 
isomerization.  As a result, more E-isomer 13 is isomerized to Z-isomer 15 that is 
subsequently reduced to undesired enantiomer 16, causing a decrease in 
enantioselectivity.  Conversely, the rate of reduction is faster than isomerization in the 
case of dihydropyridine 9.  Less of the Z-isomer 15 is produced during the reaction and 
more of the E-isomer 13 is reduced to give desired product 14 with an increase in 
enantioselectivity.  
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Figure 7.  Explaining the Increase in Enantioselectivity Demonstrated by the t-Butyl Hantzsch
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While this explanation accounts for the contrast in enantioselectivities between the two 
Hantzsch derivatives, it does not provide insight into why the t-butyl analog is more 
reactive. 
 
Explanation of the Reactivity Differences 
 The first observation to probe these rate differences was a qualitative analysis of 
the reaction conditions (Fig. 8).  In CHCl3, reductions that utilize ethyl Hantzsch 12 are 
heterogeneous.  Conversely, in the same solvent, t-butyl Hantzsch 9 reductions are 
homogeneous.  These solubility differences may contribute to the rate discrepancies.  In 
the homogeneous case, a larger effective concentration of reductant would explain why 
the t-butyl derivative is more reactive.  In the heterogeneous case, a lower concentration 
of reductant decreases the reaction rate, allows more isomerization to occur (vide supra), 
leading to the erosion of enantioselectivity. 
N
H
Me Me
O
OMe
O
O Me
N
H
Me Me
O
OMe
O
O Me
Me
Me
Me
Me
Heterogeneous reactions Homogeneous reactions
H–
ethyl derivative
H–
t-butyl derivative
<
!  Hypothesis:  The t-butyl reactions have a larger effective concentraion of reductant
!  The Hantzcsh derivatives exhibit different degrees of solubility
Figure 8.  Explaining the Hantzsch Ester Rate Differences
12 9
 
A GC time course experiment was used to test this hypothesis.  In the event, two 
reactions were set up using geometrically pure geranial 10, under standard reduction 
conditions.  Both were set up at 0.035 M, the concentration where both reactions are 
homogeneous (Fig. 9).  The time course indicated both transformations reached their 
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endpoints after six hours and produced citronellal in comparable yields.  Furthermore, a 
plot of various time points against product conversion indicated both reactions exhibited 
similar initial rates of reaction.  Interestingly, the higher dilution eroded the ee in the case 
of dihydropyridine 9 and exhibited a slight improvement for dihydropyridine 12, as 
compared to the optimized conditions shown in Figure 6 (85% ee versus 60% ee).  These 
results support our hypothesis that the increased solubility of Hantzsch 9 is a principal 
contributor to the different reaction rates.   
 
 
 
 
Structural Differences that May Further Contribute to Reactivity Differences 
While solubility plays a clear role in reactivity differences between the two 
dihydropyridines, it may not be the only explanation for rate enhancement.  Indeed, 
structural differences may also have an effect.  To examine this possibility, x-ray analysis 
was performed on each derivative (Fig. 10).  Intriguingly, these analogs exhibit 
Figure 9.  Comparing Homogeneous Reactions of Both Hantzsch Ester Derivatives
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differences in their ground state conformations:  A non-intuitive observation, considering 
the seemingly benign effect ester substitution could have on their ring structures.  Initial 
observations indicated the estimated proton-carbon bond lengths (Ha/Hb, Fig. 10) on 
ethylderivative 12 are equivalent, while those on t-butyl derivative 9 are non-equivalent. 
Figure 10.  X-Ray Crystallography Analysis of Both Hantzsch Derivatives
H
NMe Me
O
EtO
OEt
O
H H
H
NMe Me
O
EtO
OEt
O
Ha Hb
H
NMe Me
O
t-BuO
Ot-Bu
O
H H
H
NMe Me
O
t-BuO
Ot-Bu
O
Ha Hb
C–Ha = C–Hb = 0.987 A°
C–Ha = 0.976 A
C–Hb = 1.015 A
°
°
■  Proton postions are estimated based on dihedral angles
12
9
 
 
A closer examination indicates differences in the dihydropyridine ring geometries 
(Fig. 11).  It was found ethyl Hantzsch 12 exists as a planar structure, explaining why 
carbon-proton bond distances are equivalent.  Interestingly, t-butyl Hantzsch 9 adopts a 
pseudo-boat conformation, causing one proton to orient in an axial position and the other 
in an equatorial position, thereby accounting for the observed difference in carbon proton 
bond distances.   
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 These fascinating structural differences may also contribute to reactivity 
differences between the two analogues.  One important feature of dihydropyridine 
reactivity is its ability to pucker during the reduction event.  For instance, in NADPH 
mediated enzymatic reductions, the nicotinamide hydride source adopts a puckered boat 
conformation and delivers a pro-S hydride to the electrophile.  Indeed, it is the degree of 
puckering that has a large impact on dihydropyridine reactivity (Fig. 12).  Specifically, 
angles θA and θb are metrics for the hydride-donating ability of the dihydropyridine.8   
Larger angles, especially for θA, decrease the activation energy required for the hydride 
transfer. 
 
 
                                                
(8) (a) Wu, Y. D.; Lai, D. K. W.; Houk, K. N. J. Am. Chem. Soc. 1995, 117, 4100-4108. (b) Almarsson, O.; Bruice, T. C. J. 
Am. Chem. Soc. 1993, 115, 2125-2138. (c) Almarsson, O.; Karaman, R.; Bruice, T. C. J. Am. Chem. Soc. 1992, 114, 8702-
8704. 
planar structure
■  The t-butyl Hantzsch analog prefers a pseudo-boat structure in the ground state
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!  Theoretical calculations show the activation energy of hydride transfer of the puckered                                          
     conformation is lower than the planar conformation
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Figure 12.  Effect of Puckering on Hydride Transfer
 
The effect of these angle differences on reactivity may be explained by orbital 
analysis.  Increased puckering improves p-orbital overlap, creating an intermediate 
having more aromatic character, resulting in a transition state structure resembling the 
more stable pyridinium product (Fig. 13).  Moreover, this puckering allows the nitrogen 
lone pair to delocalize into the π-system, creating a more electron rich axial hydrogen 
that, as a result, is a more reactive hydride.      
 
 
 
 
 
 
 
 
 
 
 
!  Molecular orbital analysis of the puckered conformation
!  The actual angles of the t-butyl Hantzsch may be significant
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Figure 13.  Assessing the Puckering Effect on Dihydropyridine Reactivity
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For this chemistry, while we postulate both Hantzsch derivatives will adopt a 
puckered boat conformation in their transition states, the larger puckering angles (Fig. 
13, ØA and Øb,) exhibited by the t-butyl Hantzsch 9 may contribute to the observed 
increase in reactivity.  It is this degree of puckering that may not be energetically 
accessible by the ethyl Hantzsch 12, making it less reactive (Fig. 13, see table). 
 
Dynamic Kinetic Resolution 
 Due to the intriguing electronic effects as noted with 3-phenylcyclopenten-2-one, 
it was reasoned that a complementary approach to the β-aryl stereogenicity could be 
achieved by a dynamic kinetic resolution (Fig. 14).  In order to test this hypothesis a  
 
 
 
 
 
 
 
 
racemic sample of 4-phenycyclopenten-2-one was subjected to EOHR conditions.  We 
were delighted to isolate enantioenriched (R)-3-phenylcyclopentanone in near 
quantitative conversion with moderate enantioselectivity (eq. 4).  Furthermore, 3,4-
dimethylcyclopenten-2-one was tested for DKR and a clear preference for meso- 
!  Utilizing dynamic kinetic resolution (DKR) may provide the desired product
Figure 14.  An Alternative Approach to Cyclic Enone Stereogenicity
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selectivity was found.  Interestingly, the minor trans isomers were also enantioenriched 
(eq. 5).   
 
 Subjecting racemic acyclic substrate 17 to these reduction conditions produced 
saturated product with some enantioenrichment and good yield (eq. 6).  Though 
unoptimized, these results are encouraging due to the possibility of developing a broadly 
applicable method for the generation of cyclic benzylic and alkyl stereogenicity in the 
realm of DKR. 
 
Recent Developments 
Soon after this methodology was published, the List Group reported an 
asymmetric reduction of α,β-unsaturated ketones using asymmetric counterion directed 
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catalysis (ACDC) technology in conjunction with a Hantzsch hydride source (eq. 7).9   
Significantly, this paper reports the reduction of two acyclic α,β-unsaturated ketones that 
have, so far, not been reactive to our hydrogenation conditions. 
Bu2O, 60 °C, 48 h
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Conclusion 
 A new organocatalytic enantioselective catalytic hydrogenation method of α,β-
unsaturated enones has been developed using iminium activation technology.  
Optimization efforts led to the discovery of a more reactive hydride source and 
preliminary investigations provide insight to the reasons why the t-butyl Hantzsch 
dihydropyridine derivative is a more reactive hydride donor compared to the ethyl 
derivative.  Furthermore, early efforts outlining the entry into a general dynamic kinetic 
resolution of both ketone and aldehyde substrates have been reported.   Future directions 
include extending this chemistry into tandem catalysis and further developing the DKR 
into a broadly useful methodology. 
                                                
(9) Martin, N. J. A.; List, B. J. Am. Chem. Soc. 2006, 128, 13368-13369. 
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Supporting Information 
  
General Information.  Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.1  Non-aqueous reagents were transferred under 
nitrogen via syringe or cannula and purified according to the method of Grubbs.2  
Organic solutions were concentrated under reduced pressure on a Büchi rotary 
evaporator.  Chromatographic purification of products was accomplished using forced-
flow chromatography on ICN 60 32-64 mesh silica gel and Iatrobeads® according to the 
method of Still.3  Thin-layer chromatography (TLC) was performed on EM Reagents 
0.25 mm silica gel 60-F plates.  Chromatograms were visualized by fluorescence 
quenching or by staining using either potassium permanganate or anisaldehyde stain. 
1H and 13C NMR spectra were recorded on a Varian Mercury 300 Spectrometer, 
and are internally referenced to residual solvent signals.  Data for 1H NMR are reported 
as follows: chemical shift (d ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet), integration, coupling constant (Hz), and assignment.  Data for 13C 
NMR are reported in terms of chemical shift.  IR spectra were recorded on a Perkin 
Elmer Paragon 1000 spectrometer and are reported in terms of frequency of absorption 
(cm–1).  Mass spectra were obtained from the Caltech Mass Spectrometry Facility by 
electron ionization, chemical ionization, or fast atom/ion bombardment techniques.  Gas 
liquid chromatography (GLC) was performed on Hewlett-Packard 6850 and 6890 Series 
gas chromatographs equipped with a split-mode capillary injection system and flame 
                                                
(1) Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 1988. 
(2) Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518. 
(3)  Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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ionization detectors using a Bodman Chiraldex b-DM (30 m × 0.25 mm), a Bodman 
Chiraldex Γ-TA (30 m × 0.25 mm), or a Hydrodex-B-TBDAc (50 m × 0.25 mm) column 
as noted.  Optical rotations were measured on a Jasco P-1010 polarimeter, and [α]D 
values are reported in 10–1 dg cm2 g–1; concentration (c) is in g/100 mL. 
  
Preparation of the starting materials 
These α,β-unsaturated cyclic enones are commercially available from Aldrich: 3-methyl-
2-cyclopenten-1-one and isophorone (3,5,5-trimethylcyclohex-2-enone).  The following 
α,β-unsaturated cyclic enones have already been described in the literature: 3-
hexylcyclopent-2-enone, 3-cyclohexylcyclopent-2-enone,4 3-tert-butylcyclopent-2-
enone,5 3-phenylcyclopent-2-enone,6 3-benzylcyclopent-2-enone,7 3-
(benzyloxymethyl)cyclopent-2-enone,8 methyl 3-oxocyclopent-1-enecarboxylate, 3-
acetylcyclopent-2-enone,9  3-butylcyclohex-2-enone,10 3-cyclohexylcyclohex-2-one.11 
 
Column-free preparation of di-tert-butyl 2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate:  A suspension of  hexamethylenetetramine (67 g, 474 mmol) and 
ammonium acetate (73 g, 948 mmol) in neat tert-butyl acetoacetate (150 g, 948 mmol) 
was reacted in a 1 L beaker using a conventional microwave on “high” power,  with 
thorough stirring for 30 seconds after each heating period, as follows: 2 x 45 seconds, 3 x 
30 seconds.  The light green solution was next heated for another 30 seconds and was 
followed by VIGOROUS bubbling.  The solution was stirred with the spatula vigorously 
for ~5 minutes.  The resulting amorphous orange solid was heated for another 15 seconds 
                                                
(4) Collins, S.; Hong, Y.; Mataoka, M.; Nguyen, T. J. Org. Chem. 1990, 55, 3395. 
(5) Ponaras, A. A.; Zaim, O.; Pazo, Y.; Ohannesian, L. J. Org. Chem. 1988, 53, 1110. and Garbisch, E. W., Jr.; Sprecher, R. F. 
J. Am. Chem. Soc. 1969, 91, 6785. 
(6) Jurkauskas, V.; Sadigni, J. P.; Buchwald, S. L. Org. Lett. 2003, 5, 2417. 
(7) Moritani, Y.; Appella, D. H.; Jurkauskas, V.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 6797. 
(8) Dauben, W. G.; Warshawsky, A. M. J. Org. Chem. 1990, 55, 3075. 
(9) Yu, J.-Q.; Corey, E. J. J. Am. Chem. Soc. 2003, 125, 3232. And Catino, A. J.; Forslund, R. E.; Doyle, M. P. J. Am. Chem. 
Soc. 2004, 126, 13622. 
(10) Mudryk, B.; Cohen, T. J. Am. Chem. Soc. 1993, 115, 3854. 
(11) Snider, B. B.; Rodini, D. J.; van Straten, J. J. Am. Chem. Soc. 1980, 102, 5872. 
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and stirred for 5 minutes.  The orange solid was allowed to harden and cool to room 
temperature, after which it was dissolved in dichloromethane (500 mL) with the aid of a 
spatula.  To this red solution was added sodium sulfate (20 g) and the mixture was stirred 
for 20 minutes.  The dissolving/drying process should take less than 1 hour to minimize 
pyridine formation.  The solution was vacuum filtered using a glass fritted Buchner filter 
funnel and then concentrated to an orange solid.  After ensuring complete removal of 
dichloromethane via high vacuum, the solid was transferred to a glass fritted Buchner 
filter funnel in pentane and thoroughly triturated, in order, with 10% NaOH (3 x 200 
mL), water (2 x 200 mL), 5% HCl (4 x 200 mL), water (2 x 200 mL), and pentane (4 x 
200 mL).  The resulting light yellow crude solid is dissolved in EtOH (ratio 140 g: 500 
mL EtOH) by gently heating with a heat gun.  Here the EtOH should not boil.  The 
resulting solution was allowed to cool to room temperature and then placed at 4 °C for 2 
hours.  The resulting solid was filtered off and triturated 3 x 150 mL ice cold EtOH.  
SAVE THE FILTRATE. The solid was next triturated 4 x 200 mL pentane.  The 
resulting solid was dried on high vacuum for 16 hours to provide 42 g of a light yellow 
solid (30% yield) 
 
It is possible to recrystallize the EtOH filtrate by re-cooling to 4 °C overnight and 
repeating the steps above.   Due to the presence of pyridine in the second crop of crystals 
a second recrystallization sequence was repeated as above.  
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General procedure for the preparation of the starting materials: 
 
OEt
O
O
Bn
1. BnMgCl
2. HCl
 
 
3-benzylcyclopent-2-enone: To a –78 °C solution of benzyl magnesium chloride (14.3 
mL, 28.5 mmol, 1.2 eq., 2 M solution in THF) in ether (50 mL) was slowly added 3-
ethoxycyclopent-2-enone (2.84 mL, 23.8 mmol, 1 eq.).  The reaction mixture was 
warmed up to –30 °C over 1 hour followed by addition of a 1 M solution of HCl until the 
pH was adjusted to 1 as indicated by litmus paper.  The solution was warmed up to room 
temperature and the layers were separated.  The aqueous phase was extracted with 40 mL 
of Et2O (3×) and the combined organic layers were washed with 100 mL of brine (1×), 
dried over anhydrous MgSO4, and concentrated in vacuo.  The residual oil was purified 
by flash chromatography (25% EtOAc/hexanes) to afford the title compound as a 
colorless oil (3.1 g, 76% yield). 
 
(Z)-1-butylcyclohept-2-enol:  To a clear solution of 2-cyclohepten-1-one (5 g, 45.5 
mmol) in ether (50 mL), cooled to 0 °C, was added n-BuLi (2.0 M in hexanes, 25 mL, 
50.0 mmol) dropwise to produce an opaque yellow solution.  The reaction was stirred for 
2 hours at 0 °C and then warmed to room temperature. After 1 hour, the reaction was 
complete as determined by TLC, and quenched in 50 mL NH4Cl.  The organic layer was 
separated and the aqueous layer was extracted with 50 mL of Et2O (3×). The combined 
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organic layers were dried over Na2SO4, filtered and concentrated in vacuo.  The resulting 
residue was purified by flash chromatography (10% Et2O/pentane) to afford the title 
compound as a light yellow oil (2 g, 26% yield).  IR (film) 3377, 3015, 2930, 2860, 1456, 
1378, 1335, 1223, 1121, 1103, 1043, 997 cm–1; 1H NMR (300 MHz, CDCl3) ∂ 5.69 (dt, 
1H, J = 11.9, 5.6 Hz, CCH=CH), 5.59 (d, 1H, J = 11.9 Hz, CCH=CH), 2.17 – 2.09 (m, 
2H), 1.84 – 1.45 (m, 9H), 1.38 – 1.27 (m, 4H), 0.93 – 0.88 (m, 3H); 13C NMR (75 MHz, 
CDCl3) ∂ 139.1, 130.0, 76.1, 41.1, 38.5, 27.6, 27.5, 25.6, 24.1, 23.2, 14.1; HRMS (EI+) 
exact mass calculated for [M]+ (C11H20O) requires m/z 168.1514, found m/z 168.1516. 
 
(Z)-3-butylcyclohept-2-enone:  To a solution of (Z)-1-butylcyclohept-2-enol (2 g, 11.9 
mmol) dissolved in dichloromethane (60 mL) was added pyridine chlorochromate on 
basic alumina (20 wt.%, 25.7 g, 23.8 mmol).  The resulting reddish solution was stirred at 
room temperature for 2 hours until determined to be complete by TLC.  The mixture was 
diluted in 100 mL Et2O and stirred for 1 hour after which it was poured over filter paper 
that was subsequently washed with the Et2O.  The filtrate was partially concentrated (30 
mL) and passed through a Florisil column with Et2O (100 mL).  The resulting colorless 
solution was concentrated and purified by flash chromatography (5% Et2O/Pentane) to 
provide a colorless oil (920 mg, 47 % yield).  IR (film) 2933, 2864, 1662, 1458, 1421, 
1375, 1344, 1322, 1267, 1201, 1124, 1103, 1048, 937, 875, 855 cm–1; 1H NMR (300 
MHz, CDCl3) ∂ 5.89 (s, 1H, COCH), 2.58 – 2.53 (m, 2H, C=OH2, 2.41– 2.38 (m, 2H, 
HC=CCH2), 2.18 (t, 2H, J = 6.91 Hz, HC=CCH2(CH2)2CH3), 1.80 – 1.74 (m, 2H, 
COCH2CH2), 1.50 – 1.40 (m, 2H, HC=CCH2CH2), 1.38 – 1.25 (m, 2H, 
HC=C(CH2)2CH2CH3), 0.90 (t, 3H, J = 7.18 Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) ∂ 
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204.4, 162.4, 128.2, 42.1, 40.8, 32.5, 29.7, 25.1, 22.4, 21.2, 13.9; HRMS (EI+) exact mass 
calculated for [M]+ (C11H18O) requires m/z 166.1358, found m/z 166.1359. 
 
 
General Procedures for the enantioselective hydrogenation of cyclic enones:   
 
Procedure A:  To a room temperature solution of 3-substituted-cyclopent-2-enone (1 
mmol) dissolved in 1 mL of Et2O (1 M) was added trichloroacetic acid (33 mg, 0.2 
mmol, 0.2 eq.), (2S,5S)-5-benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one (54 
mg, 0.2 mmol, 0.2 eq.), and ethyl Hantzsch ester (304 mg, 1.2 mmol, 1.2 eq.).  The 
resulting yellow suspension was stirred at room temperature until the reaction was judged 
to be complete by TLC.  The reaction mixture was passed though a short pad of silica gel 
and eluted with Et2O.  The resulting solution was concentrated in vacuo and purified by 
flash chromatography (solvent noted) to provide the title compound. 
 
Procedure B:  To a solution of 3-substituted-cyclopent-2-enone (1 mmol) dissolved in 0.5 
mL of Et2O (0.5 M), cooled to 4 °C using an ice bath, was added trichloroacetic acid (33 
mg, 0.2 mmol, 0.2 eq.), (2S,5S)-5-benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-
4-one (54 mg, 0.2 mmol, 0.2 eq.), and t-Butyl Hantzsch ester (340 mg, 1.1 mmol, 1.1 
eq.).  The resulting yellow suspension was stirred at 4 °C until the reaction was judged to 
be complete by TLC.  The reaction mixture was passed through a short pad of silica gel 
and eluted with Et2O.  The resulting solution was concentrated in vacuo and purified by 
flash chromatography (solvent noted) to provide a crude mixture of the title compound 
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and pyridine by-product.  The pyridine was removed by washing with 5 mL 6 M HCl 
(3×), 5 mL H2O (1×) and 5 mL sat. NaHCO3 (1×) to provide the title compound. 
     
(R)-3-methylcyclopentanone: Prepared according to the general procedure A from 3-
methylcyclopent-2-enone (20 mg, 0.204 mmol) for 26 hours to provide the title 
compound (77% conversion, 95% ee).  Conversion was determined via GLC analysis by 
comparison with an internal standard (BnOMe).  The physical data were identical in all 
respects to those of the commercially available (R)-3-methylcyclopentanone.  The 
enantiomeric ratio was determined by GLC using a Bodman Chiraldex Γ-TA (30 m × 
0.25 mm) column (100 °C isotherm, 1 mL/min.);  (S) isomer tr = 25.1 min. and (R) 
isomer tr = 25.8 min. 
General procedure B provided the title compound (72% conversion, 95% ee) after 8.5 
hours. 
 
(R)-3-cyclohexylcyclopentanone: Prepared according to the general procedure A from 
3-cyclohexylcyclopent-2-enone (164 mg, 1 mmol) for 23 hours to provide the title 
compound as a yellow oil (152 mg, 93% yield, 96% ee) after purification by flash 
chromatography on Iatrobeads® (15 – 20% Et2O/pentane).  The physical data were 
identical in all respects to those previously reported.12 The enantiomeric ratio was 
determined by GLC using a Hydrodex-B-TBDAc (50 m × 0.25 mm) column (105 °C 
isotherm, 1 mL/min.); (S) isomer tr = 127.7 min. and (R) isomer tr = 127.9 min. 
! 
["]
D
22  = 
+8.6 ° (c = 1.00, CHCl3). 
                                                
(12) Jones, P.; Reddy, C. K.; Knochel, P. Tetrahedron 1998, 54, 1471. (Racemic product, no optical rotation.)   
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General procedure B provided the title compound (82% yield, 93% ee) after 11 hours. 
 
(R)-3-tert-butylcyclopentanone: Prepared according to the general procedure A from 3-
tert-butylcyclopent-2-enone (138 mg, 1 mmol) for 8 hours to provide the title compound 
as a colorless oil (126 mg, 85% yield, 96% ee) after purification by flash chromatography 
on Iatrobeads® (20% Et2O/pentane).  The physical data were identical in all respects to 
those previously reported.13  The enantiomeric ratio was determined by GLC using a 
Bodman Chiraldex Γ-TA (30 m × 0.25 mm) column (90 °C isotherm, 1 mL/min.);  (S) 
isomer tr = 14.4 min. and (R) isomer tr = 15.0 min. 
! 
["]
D
22  = +150.3 ° (c = 1.00, CHCl3). 
General procedure B provided the title compound (81% conversion, 96% ee) after 5.5 
hours. 
 
(R)-3-benzylcyclopentanone: Prepared according to the general procedure A from 3-
benzylcyclopent-2-enone (172 mg, 1 mmol) for 24 hours at 0 °C. After the reaction 
mixture was passed though a short pad of silica gel, the resulting mixture was poured into 
5 mL of a 10% HCl solution and diluted with 5 mL of Et2O.  The layers were separated, 
then the organic layer was washed with 5 mL of a 10% HCl solution (4×) and with 5 mL 
of water (1×).  The resulting solution was dried over MgSO4 and concentrated in vacuo to 
provide the title compound as a colorless oil (158 mg, 91% yield, 90% ee) after 
purification by flash chromatography on Iatrobeads® (2% Et2O/benzene).  The physical 
data were identical in all respects to those previously reported.14  The enantiomeric ratio 
                                                
(13) Ahlbrecht, H.; Weber, P. Synthesis 1992, 1019. (Racemic product, no optical rotation.) 
(14) Yanagisawa, A.; Habaue, S.; Yasue, K.; Yamamoto, H. J. Am. Chem. Soc. 1994, 116, 6130. and Moritani, Y.; Appella, D. 
H.; Jurkauskas, V.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 6797.  (Reported an optical rotation of –96 ° for the 
(S)-isomer that is 96% e.)  
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was determined by GLC using a Hydrodex-B-TBDAc (50 m × 0.25 mm) column (145 °C 
isotherm, 1 mL/min.); (S) isomer tr = 91.5 min. and (R) isomer tr = 90.1 min. 
! 
["]
D
22  = 
+83.9 ° (c = 1.00, CHCl3). 
General procedure B provided the title compound (78% yield, 90% ee) after 11 hours. 
 
(R)-3-(benzyloxymethyl)cyclopentanone: Prepared according to the general procedure 
A from 3-(benzyloxymethyl)cyclopent-2-enone (202 mg, 1 mmol) for 24 h at 0 °C.  After 
the reaction mixture was passed though a short pad of silica gel, the resulting solution 
was poured into 5 mL of a 10% HCl solution and diluted with 5 mL of Et2O.  The layers 
were separated, then the organic layer was washed with 5 mL of a 10% HCl solution (4×) 
and with 5 mL of water (1×).  The resulting solution was dried over MgSO4 and 
concentrated in vacuo to provide the title compound as a colorless oil (155 mg, 76% 
yield, 91% ee) after purification by flash chromatography on silica gel (15% 
Et2O/pentane).  The enantiomeric ratio was determined by GLC using a Hydrodex-B-
TBDAc (50 m × 0.25 mm) column (150 °C isotherm, 1 mL/min.);  (S) isomer tr = 151.2 
min. and (R) isomer tr = 153.2 min. IR (film) 3030, 2860, 1740, 1404, 1100 cm–1; 1H 
NMR (300 MHz, CDCl3) ∂ 7.42 – 7.28 (m, 5H, ArH5), 4.55 (s, 2H, CH2Ph), 3.51 (d, 2H, 
J = 6.3 Hz, CHCH2O), 2.61 – 2.49 (m, 1H), 2.44 – 2.25 (m, 2H), 2.23 – 2.01 (m, 3H), 
1.84 – 1.71 (m, 1H); 13C NMR (75 MHz, CDCl3) ∂ 219.2, 138.1, 128.3, 127.4, 126.8, 
73.2, 73.0, 41.9, 37.8, 36.7, 26.0; HRMS (EI+) exact mass calculated for [M]+ (C13H16O2) 
requires m/z 204.1150, found m/z 204.1144; 
! 
["]
D
22  = +31.2 ° (c = 1.0, CHCl3). 
General procedure B provided the title compound (77% yield, 91% ee) after 13 hours. 
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(R)-3-phenylcyclopentanone: Prepared according to the general procedure A from 3-
phenylcyclopent-2-enone (158 mg, 1 mmol) for 8.5 hours to provide the title compound 
as a light yellow oil (140 mg, 89% yield, 74% ee) after purification by flash 
chromatography on Iatrobeads® (0 - 2% Et2O/benzene).  The physical data were identical 
in all respects to those previously reported.15  The enantiomeric ratio was determined by 
GLC using a Hydrodex-B-TBDAc (50 m × 0.25 mm) column (145 °C isotherm, 1 
mL/min.);  (S) isomer tr = 56.3 min. and (R) isomer tr = 61.3 min. 
! 
["]
D
22  = +60.2 ° (c = 
1.00, CHCl3). 
General procedure B provided the title compound (73% yield, 91% ee) after 9 hours. 
 
(R)-methyl 3-oxocyclopentanecarboxylate: Prepared according to the general procedure 
A from methyl 3-oxocyclopent-1-enecarboxylate (140 mg, 1 mmol) for 24 hours at 0 °C 
to provide the title compound as a colorless oil (108 mg, 76% yield, 90% ee) after 
purification by flash chromatography on silica gel (40% Et2O/pentane).  The physical 
data were identical in all respects to those previously reported.16  The enantiomeric ratio 
was determined by GLC using a Hydrodex-B-TBDAc (50 m × 0.25 mm) column (130 °C 
isotherm, 1 mL/min.);  (S) isomer tr = 41.9 min. and (R) isomer tr = 43.5 min. 
! 
["]
D
22  = 
+28.0 ° (c = 1.00, CHCl3). 
General procedure B provided the title compound (78% yield, 93% ee) after 1 hour. 
 
                                                
(15) Gadwood, R. C.; Mallick, I. M.; DeWinter, A. J. J. Org. Chem. 1987, 52, 774.  Gomez-Bengoa, E.; Heron, N. M.; Didiuk, 
M. T.; Luchaco, C. A.; Hoveyda, A. H. J. Am. Chem. Soc. 1998, 120, 7649. and Hashimoto, S.-I.; Watanabe, N.; Ikegami, 
S.  Synlett. 1994, 353.  
(16) Ranu, B. C.; Dutta, J. Guchhait, S. K. Org. Lett. 2001, 3, 2603.  The absolute stereochemistry was assigned by analogy. 
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(R)-3-acetylcyclopentanone: Prepared according to the general procedure A from 3-
acetylcyclopent-2-enone (124 mg, 1 mmol) for 24 hours at 0 °C to provide the title 
compound as a colorless oil (103 mg, 82% yield, 93% ee) after purification by flash 
chromatography on silica gel (50% Et2O/benzene).  The physical data were identical in 
all respects to those previously reported.17  The enantiomeric ratio was determined by 
GLC using a Hydrodex-B-TBDAc (50 m × 0.25 mm) column (145 °C isotherm, 1 
mL/min.);  (S) isomer tr = 52.0 min. and (R) isomer tr = 53.3 min.  
! 
["]
D
22  = +56.3 ° (c = 
1.0, CHCl3). 
General procedure B provided the title compound (83% yield, 93% ee) after 1 hour. 
 
(R)-3-butylcyclohexanone:  Prepared according to the general procedure A from 3-
butylcyclohexen-2-one (168 mg, 1.09 mmol) in 0.2 M Et2O for 43 hours at room 
temperature to provide the title compound as a colorless oil (128.3 mg, 75% yield, 88% 
ee) after purification by flash chromatography on silica gel (5% Et2O/pentane).  The 
physical data were identical in all respects to those previously reported.18  The 
enantiomeric ratio was determined by GLC using a Hydrodex-B-TBDAc (50 m × 0.25 
mm) column (150 °C isotherm, 1 mL/min.);  (S) isomer tr = 37.0 min. and (R) isomer tr = 
36.0 min. 
! 
["]
D
22  = +15.5 ° (c = 1.00, CHCl3). 
 General procedure B provided the title compound (82% yield, 90% ee) after 25 hours. 
 
 
                                                
(17) Monte, W. T.; Baizer, M. M.; Little, R. D. J. Org. Chem. 1983, 48, 803. (Racemic product, no optical rotation.) 
(18) Jones, P.; Reddy, C. K.; Knowche, P. Tetrahedron 1998, 54, 1471.  and Moritani, Y.; Appella, D. H.; Jurkauskas, V.; 
Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 6797. (Reported a rotation of –17 ° for the (S)-enantiomer that is 87% ee.)  
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(R)-3-cyclohexylcyclohexanone: Prepared according to the general procedure A from 3-
cyclohexylcyclohexen-2-one (178 mg, 1.09 mmol) in 0.2 M Et2O for 43 hours at room 
temperature to provide the title compound as a colorless oil (157 mg, 80% yield, 90% ee) 
after purification by flash chromatography on silica gel (5% Et2O/pentane).  The 
enantiomeric ratio was determined by GLC using a Hydrodex-B-TBDAc (50 m × 0.25 
mm) column (110 °C isotherm, 1 mL/min.);  (S) isomer tr = 73.5 min. and (R) isomer tr = 
65.2 min. IR (film) 2924, 2853, 1715, 1449, 14223, 1346, 1317, 1263, 1225, 1101, 1056, 
982, 892, 866 cm–1; 1H NMR (300 MHz, CDCl3) ∂ 2.44 – 2.21 (m, 3H), 2.16 – 2.04 (m, 
2H), 1.93 – 1.85 (m, 1H), 1.80 – 1.54 (m, 8H), 1.47 – 1.33 (m, 1H), 1.32 – 1.11 (m, 3H), 
1.08 – 0.92 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 212.9, 45.6, 44.7, 42.7, 41.6, 30.0, 
29.9, 28.4, 26.6, 26.59, 25.54, 25.6; HRMS (EI+) exact mass calculated for [M]+ 
(C12H20O) requires m/z 180.1514, found m/z 180.1508; 
! 
["]
D
22  = +11.9 ° (c = 1.05, CHCl3). 
General procedure B provided the title compound (71% yield, 88% ee) after 24 hours. 
 
(R)-3,3,5-trimethylcyclohexanone:  Prepared according to the general procedure A from 
isophorone (138 mg, 1.09 mmol) in 0.2 M Et2O for 48 hours at room temperature to 
provide the title compound as a colorless oil (100 mg, 65% yield, 97% ee) after 
purification by flash chromatography on silica gel (5% Et2O/pentane).  The physical data 
were identical in all respects to those previously reported.19  The enantiomeric ratio was 
determined by GLC using a Hydrodex-B-TBDAc (50 m × 0.25 mm) column (110 °C 
isotherm, 1 mL/min.);  (S) isomer tr = 11.8 min. and (R) isomer tr = 12.4 min. 
! 
["]
D
22  = –
18.7 °(c = 1.03, CHCl3). 
                                                
(19) Allinger, N. L.; Riew, C. K. J. Org. Chem. 1975, 40, 1316.  (Reported a rotation of +20.3 ° for the (S)-enantiomer that is 
75% ee.)  
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 General procedure B provided the title compound (66% yield, 98% ee) after 40 hours. 
 
(R)-3-butylcycloheptanone: Prepared according to the general procedure A from 3-
butylcyclohept-2-enone (166.3 mg, 1 mmol) for 48 hours at room temperature to provide 
the title compound as a light yellow oil (106 mg, 63% yield, 82% ee) after purification by 
flash chromatography on silica gel (5% Et2O/pentane).  The physical data were identical 
in all respects to those previously reported.20  The enantiomeric ratio was determined by 
GLC using a Hydrodex-B-TBDAc (50 m × 0.25 mm) column (105 °C isotherm, 1 
mL/min.);  (S) isomer tr = 100.6 min. and (R) isomer tr = 102.7 min. 
! 
["]
D
22  = +40.3 ° (c = 
1.05, CHCl3). 
General procedure B provided the title compound (70% yield, 92% ee) after 9 hours. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
(20) Strangeland, E. L.; Sammakia, T. Tetrahedron 1997, 53, 16503.  (Reported a rotation of +31.4 ° for a product that is 92% 
ee.) 
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Note: The crystallographic data have been deposited in the Cambridge Database (CCDC) and has been 
placed on hold pending further instructions from me.  The deposition number is 295385.  Ideally the 
CCDC would like the publication to contain a footnote of the type: "Crystallographic data have been 
deposited at the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK and copies can be obtained on 
request, free of charge, by quoting the publication citation and the deposition number 295385." 
  
75 
Table 1.  Crystal data and structure refinement for JBT02 (CCDC 295385). 
Empirical formula  C13H19NO4 
Formula weight  253.29 
Crystallization Solvent  Not given 
Crystal Habit  Block 
Crystal size 0.34 x 0.22 x 0.15 mm3 
Crystal color  Pale yellow  
 Data Collection  
Type of diffractometer  Bruker SMART 1000 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for 5978 reflections used 
in lattice determination  2.73 to 33.41° 
Unit cell dimensions a = 24.3323(16) Å 
 b = 6.8424(5) Å β= 92.078(2)° 
 c = 7.4651(5) Å 
Volume 1242.06(15) Å3 
Z 4 
Crystal system  Monoclinic 
Space group  C2/m 
Density (calculated) 1.355 Mg/m3 
F(000) 544 
Data collection program Bruker SMART v5.630 
θ range for data collection 1.67 to 33.82° 
Completeness to θ = 33.82° 91.8 %  
Index ranges -35 ≤ h ≤ 34, -10 ≤ k ≤ 10, -11 ≤ l ≤ 11 
Data collection scan type  ω scans at 5 φ settings 
Data reduction program  Bruker SAINT v6.45A 
Reflections collected 12600 
Independent reflections 2457 [Rint= 0.0584] 
Absorption coefficient 0.100 mm-1 
Absorption correction None 
Max. and min. transmission 0.9851 and 0.9667 
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Table 1 (cont.) 
 Structure solution and Refinement  
Structure solution program  Bruker XS v6.12 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Difference Fourier map 
Structure refinement program  Bruker XL v6.12 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 2457 / 0 / 152 
Treatment of hydrogen atoms  Unrestrained 
Goodness-of-fit on F2 2.363 
Final R indices [I>2σ(I),  1961 reflections] R1 = 0.0465, wR2 = 0.0870 
R indices (all data) R1 = 0.0595, wR2 = 0.0892 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.000 
Average shift/error  0.000 
Largest diff. peak and hole 0.505 and -0.402 e.Å-3 
 Special Refinement Details  
This structure has been previously reported 21 and appears in the CSD as deposition EXCMHP. 
The structure presented here is not substantially different than the previously reported structure. However, I 
believe the structure is more correctly described in the monoclinic system with space group C2/m. The data 
collected here is substantially more complete than the previously reported structure and warrants inclusion 
as such in any future publication. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
 
                                                
21 Lenstra, A.T.H., Molecular-Structure of 3,5-Diethoxycarbonyl-2,6-Dimethyl-1,4-Dihydropyridine - X-ray Study. Bulletin des Societes 
Chimiques Belges, 1979. 88(3): p. 133-141. 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for JBT02 (CCDC 295385).  U(eq) is defined as the trace of the 
orthogonalized Uij tensor.  
________________________________________________________________________________  
 x y z Ueq 
________________________________________________________________________________   
O(1) 3765(1) 0 -810(1) 17(1) 
O(2) 3980(1) 0 2152(1) 24(1) 
O(3) 1150(1) 0 -1489(1) 18(1) 
O(4) 1866(1) 0 -3306(1) 18(1) 
N 2253(1) 0 2957(1) 15(1) 
C(1) 2816(1) 0 2782(2) 13(1) 
C(2) 3029(1) 0 1129(2) 13(1) 
C(3) 2663(1) 0 -566(2) 13(1) 
C(4) 2054(1) 0 -175(2) 12(1) 
C(5) 1874(1) 0 1529(2) 13(1) 
C(6) 3129(1) 0 4556(2) 19(1) 
C(7) 3625(1) 0 947(2) 15(1) 
C(8) 1695(1) 0 -1787(2) 13(1) 
C(9) 1292(1) 0 2129(2) 18(1) 
C(10) 4354(1) 0 -1059(2) 19(1) 
C(11) 4461(1) 0 -3032(2) 22(1) 
C(12) 786(1) 0 -3072(2) 19(1) 
C(13) 209(1) 0 -2416(2) 25(1) 
________________________________________________________________________________ 
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Table 3.   Bond lengths [Å] and angles [°] for  JBT02 (CCDC 295385). 
_______________________________________________________________________________
O(1)-C(7)  1.3673(15) 
O(1)-C(10)  1.4498(17) 
O(2)-C(7)  1.2241(15) 
O(3)-C(8)  1.3546(16) 
O(3)-C(12)  1.4506(15) 
O(4)-C(8)  1.2218(15) 
N-C(1)  1.3811(18) 
N-C(5)  1.3849(16) 
N-H(1)  0.862(16) 
C(1)-C(2)  1.3557(17) 
C(1)-C(6)  1.5021(17) 
C(2)-C(7)  1.4606(19) 
C(2)-C(3)  1.5221(16) 
C(3)-C(4)  1.5183(18) 
C(3)-H(3A)  0.987(10) 
C(4)-C(5)  1.3612(17) 
C(4)-C(8)  1.4611(16) 
C(5)-C(9)  1.501(2) 
C(6)-H(6A)  0.952(13) 
C(6)-H(6B)  0.94(2) 
C(9)-H(9A)  0.965(12) 
C(9)-H(9B)  0.959(18) 
C(10)-C(11)  1.505(2) 
C(10)-H(10A)  0.994(11) 
C(11)-H(11A)  0.965(12) 
C(11)-H(11B)  0.958(17) 
C(12)-C(13)  1.502(2) 
C(12)-H(12A)  0.975(11) 
C(13)-H(13A)  0.982(12) 
C(13)-H(13B)  0.981(18) 
 
C(7)-O(1)-C(10) 113.89(10) 
C(8)-O(3)-C(12) 116.07(10) 
C(1)-N-C(5) 124.32(11) 
C(1)-N-H(1) 119.5(10) 
C(5)-N-H(1) 116.2(10) 
C(2)-C(1)-N 119.94(10) 
C(2)-C(1)-C(6) 127.18(12) 
N-C(1)-C(6) 112.88(11) 
C(1)-C(2)-C(7) 119.87(11) 
C(1)-C(2)-C(3) 121.66(12) 
C(7)-C(2)-C(3) 118.47(11) 
C(4)-C(3)-C(2) 112.73(10) 
C(4)-C(3)-H(3A) 109.6(6) 
C(2)-C(3)-H(3A) 108.5(6) 
C(5)-C(4)-C(8) 124.46(12) 
C(5)-C(4)-C(3) 121.99(10) 
C(8)-C(4)-C(3) 113.55(10) 
C(4)-C(5)-N 119.36(12) 
C(4)-C(5)-C(9) 128.26(11) 
N-C(5)-C(9) 112.38(11) 
C(1)-C(6)-H(6A) 110.9(7) 
C(1)-C(6)-H(6B) 109.1(11) 
H(6A)-C(6)-H(6B) 110.7(9) 
O(2)-C(7)-O(1) 120.72(12) 
O(2)-C(7)-C(2) 127.40(12) 
O(1)-C(7)-C(2) 111.87(10) 
O(4)-C(8)-O(3) 121.38(11) 
O(4)-C(8)-C(4) 123.44(12) 
O(3)-C(8)-C(4) 115.18(10) 
C(5)-C(9)-H(9A) 113.2(8) 
C(5)-C(9)-H(9B) 110.9(11) 
H(9A)-C(9)-H(9B) 108.3(9) 
O(1)-C(10)-C(11) 109.46(11) 
O(1)-C(10)-H(10A) 107.4(6) 
C(11)-C(10)-H(10A) 112.3(6) 
C(10)-C(11)-H(11A) 111.4(7) 
C(10)-C(11)-H(11B) 110.6(9) 
H(11A)-C(11)-H(11B) 106.9(9) 
O(3)-C(12)-C(13) 106.49(11) 
O(3)-C(12)-H(12A) 108.2(6) 
C(13)-C(12)-H(12A) 112.1(7) 
C(12)-C(13)-H(13A) 110.1(8) 
C(12)-C(13)-H(13B) 109.4(11) 
H(13A)-C(13)-H(13B) 110.1(9)
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_______________________________________________________________________________ 
 
Table 4.   Anisotropic displacement parameters  (Å2x 104 ) for JBT02 (CCDC 
295385).  The anisotropic displacement factor exponent takes the form: -2π 2 [ h2 
a*2U 11  + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 107(5)  257(5) 130(4)  0 16(3)  0 
O(2) 161(6)  400(6) 154(4)  0 -27(4)  0 
O(3) 120(5)  322(6) 96(4)  0 -14(3)  0 
O(4) 173(5)  252(5) 101(4)  0 17(3)  0 
N 156(6)  207(6) 76(4)  0 20(4)  0 
C(1) 144(7)  132(6) 119(5)  0 -12(5)  0 
C(2) 127(7)  145(6) 119(5)  0 -2(5)  0 
C(3) 146(7)  162(7) 88(5)  0 9(4)  0 
C(4) 126(7)  117(6) 105(5)  0 1(4)  0 
C(5) 156(7)  121(6) 119(5)  0 0(4)  0 
C(6) 166(8)  279(8) 110(5)  0 -8(5)  0 
C(7) 166(7)  165(6) 126(5)  0 19(5)  0 
C(8) 138(7)  138(6) 120(5)  0 12(4)  0 
C(9) 150(7)  270(8) 117(5)  0 8(5)  0 
C(10) 124(7)  274(8) 173(6)  0 8(5)  0 
C(11) 163(8)  317(9) 188(6)  0 33(6)  0 
C(12) 147(7)  312(8) 103(5)  0 -20(5)  0 
C(13) 158(8)  455(10) 146(6)  0 -20(5)  0 
______________________________________________________________________________ 
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Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters 
(Å2x 10 3) for JBT02 (CCDC 295385). 
________________________________________________________________________________  
 x  y  z  Uiso 
________________________________________________________________________________  
H(1) 2121(6) 0 4010(20) 18(4) 
H(3A) 2750(4) 1166(15) -1280(13) 16(3) 
H(6A) 3367(6) 1101(18) 4655(15) 39(4) 
H(6B) 2879(8) 0 5480(20) 42(5) 
H(9A) 1080(5) 1100(18) 1681(16) 38(3) 
H(9B) 1282(7) 0 3410(20) 39(5) 
H(10A) 4509(4) 1173(17) -438(13) 22(3) 
H(11A) 4312(5) 1152(18) -3614(15) 33(3) 
H(11B) 4849(7) 0 -3220(20) 24(4) 
H(12A) 863(4) 1164(17) -3772(14) 25(3) 
H(13A) 151(5) 1154(18) -1665(17) 40(4) 
H(13B) -53(7) 0 -3450(20) 37(5) 
________________________________________________________________________________ 
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Table 6.  Hydrogen bonds for JBT02 (CCDC 295385)  [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
N-H(1)...O(4)#1 0.862(16) 2.117(16) 2.9767(14) 175.0(14) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x,y,z+1       
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Table 1.  Crystal data and structure refinement for JBT01 (CCDC 294051). 
Empirical formula  C17H27NO4 
Formula weight  309.40 
Crystallization Solvent  Not given 
Crystal Habit  Block 
Crystal size 0.37 x 0.28 x 0.18 mm3 
Crystal color  Pale yellow  
 Data Collection  
Type of diffractometer  Bruker SMART 1000 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for 9125 reflections used 
in lattice determination  2.71 to 34.25° 
Unit cell dimensions a = 7.9678(4) Å 
 b = 20.8362(11) Å β= 106.0340(10)° 
 c = 11.2805(6) Å 
Volume 1799.92(16) Å3 
Z 4 
Crystal system  Monoclinic 
Space group  P21/n 
Density (calculated) 1.142 Mg/m3 
F(000) 672 
Data collection program Bruker SMART v5.630 
θ range for data collection 1.95 to 35.06° 
Completeness to θ = 35.06° 89.7 %  
Index ranges -12 ≤ h ≤ 12, -31 ≤ k ≤ 33, -14 ≤ l ≤ 17 
Data collection scan type  ω scans at 7 φ settings 
Data reduction program  Bruker SAINT v6.45A 
Reflections collected 30215 
Independent reflections 7143 [Rint= 0.0670] 
Absorption coefficient 0.080 mm-1 
Absorption correction None 
Max. and min. transmission 0.9857 and 0.9708 
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Table 1 (cont.) 
 Structure solution and Refinement  
Structure solution program  Bruker XS v6.12 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Difference Fourier map 
Structure refinement program  Bruker XL v6.12 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 7143 / 0 / 307 
Treatment of hydrogen atoms  Unrestrained 
Goodness-of-fit on F2 1.445 
Final R indices [I>2σ(I),  4432 reflections] R1 = 0.0483, wR2 = 0.0751 
R indices (all data) R1 = 0.0851, wR2 = 0.0784 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.000 
Average shift/error  0.000 
Largest diff. peak and hole 0.386 and -0.310 e.Å-3 
 Special Refinement Details  
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for JBT01 (CCDC 294051).  U(eq) is defined as the trace of the 
orthogonalized Uij tensor.  
________________________________________________________________________________  
 x y z Ueq 
________________________________________________________________________________   
O(1) 3978(1) 3496(1) 8437(1) 23(1) 
O(2) 1041(1) 3515(1) 7653(1) 21(1) 
O(3) -2143(1) 1573(1) 7851(1) 20(1) 
O(4) -746(1) 622(1) 8363(1) 24(1) 
N(1) 3546(1) 1815(1) 10321(1) 21(1) 
C(1) 3723(1) 2408(1) 9824(1) 18(1) 
C(2) 2336(1) 2662(1) 8970(1) 17(1) 
C(3) 568(1) 2338(1) 8696(1) 19(1) 
C(4) 746(1) 1626(1) 8972(1) 16(1) 
C(5) 2182(1) 1395(1) 9805(1) 18(1) 
C(6) 5527(1) 2688(1) 10314(1) 25(1) 
C(7) 2369(1) 3260(1) 8301(1) 18(1) 
C(8) -735(1) 1204(1) 8382(1) 17(1) 
C(9) 2558(1) 719(1) 10255(1) 22(1) 
C(10) 4280(1) 4096(1) 7823(1) 22(1) 
C(11) 3630(2) 4026(1) 6433(1) 31(1) 
C(12) 6262(1) 4148(1) 8239(1) 36(1) 
C(13) 3440(2) 4658(1) 8301(1) 31(1) 
C(14) -3826(1) 1293(1) 7148(1) 21(1) 
C(15) -3594(2) 937(1) 6032(1) 33(1) 
C(16) -4936(1) 1891(1) 6751(1) 32(1) 
C(17) -4567(2) 879(1) 7987(1) 34(1) 
________________________________________________________________________________ 
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Table 3.   Bond lengths [Å] and angles [°] for  JBT01 (CCDC 294051). 
_______________________________________________________________________________
O(1)-C(7)  1.3414(10) 
O(1)-C(10)  1.4814(11) 
O(2)-C(7)  1.2280(10) 
O(3)-C(8)  1.3547(10) 
O(3)-C(14)  1.4762(10) 
O(4)-C(8)  1.2147(10) 
N(1)-C(1)  1.3794(12) 
N(1)-C(5)  1.3929(11) 
N(1)-H(1)  0.878(11) 
C(1)-C(2)  1.3567(12) 
C(1)-C(6)  1.5086(13) 
C(2)-C(7)  1.4623(13) 
C(2)-C(3)  1.5144(12) 
C(3)-C(4)  1.5152(13) 
C(3)-H(3A)  0.976(10) 
C(3)-H(3B)  1.015(11) 
C(4)-C(5)  1.3528(12) 
C(4)-C(8)  1.4739(12) 
C(5)-C(9)  1.4987(13) 
C(6)-H(6A)  0.966(13) 
C(6)-H(6B)  0.981(12) 
C(6)-H(6C)  0.984(11) 
C(9)-H(9A)  0.986(11) 
C(9)-H(9B)  0.979(12) 
C(9)-H(9C)  0.973(12) 
C(10)-C(11)  1.5160(15) 
C(10)-C(13)  1.5197(15) 
C(10)-C(12)  1.5216(14) 
C(11)-H(11A)  1.010(12) 
C(11)-H(11B)  0.994(12) 
C(11)-H(11C)  0.992(12) 
C(12)-H(12A)  0.995(13) 
C(12)-H(12B)  0.961(12) 
C(12)-H(12C)  1.014(11) 
C(13)-H(13A)  0.986(12) 
C(13)-H(13B)  0.998(11) 
C(13)-H(13C)  0.992(13) 
C(14)-C(17)  1.5154(15) 
C(14)-C(15)  1.5159(15) 
C(14)-C(16)  1.5219(14) 
C(15)-H(15A)  0.967(14) 
C(15)-H(15B)  0.982(12) 
C(15)-H(15C)  0.992(12) 
C(16)-H(16A)  0.977(13) 
C(16)-H(16B)  0.985(11) 
C(16)-H(16C)  0.992(12) 
C(17)-H(17A)  0.979(11) 
C(17)-H(17B)  0.966(12) 
C(17)-H(17C)  1.009(14) 
 
C(7)-O(1)-C(10) 121.92(7) 
C(8)-O(3)-C(14) 122.11(7) 
C(1)-N(1)-C(5) 123.32(8) 
C(1)-N(1)-H(1) 118.7(7) 
C(5)-N(1)-H(1) 117.7(7) 
C(2)-C(1)-N(1) 118.87(8) 
C(2)-C(1)-C(6) 128.08(9) 
N(1)-C(1)-C(6) 113.04(8) 
C(1)-C(2)-C(7) 124.85(8) 
C(1)-C(2)-C(3) 120.05(8) 
C(7)-C(2)-C(3) 115.03(8) 
C(2)-C(3)-C(4) 111.44(7) 
C(2)-C(3)-H(3A) 109.3(5) 
C(4)-C(3)-H(3A) 109.5(5) 
C(2)-C(3)-H(3B) 111.1(6) 
C(4)-C(3)-H(3B) 110.0(6) 
H(3A)-C(3)-H(3B) 105.4(8) 
C(5)-C(4)-C(8) 121.31(8) 
C(5)-C(4)-C(3) 120.31(8) 
C(8)-C(4)-C(3) 118.22(7) 
C(4)-C(5)-N(1) 118.61(8) 
C(4)-C(5)-C(9) 128.41(8) 
N(1)-C(5)-C(9) 112.96(8) 
C(1)-C(6)-H(6A) 111.3(7) 
C(1)-C(6)-H(6B) 110.1(6) 
H(6A)-C(6)-H(6B) 108.3(9) 
C(1)-C(6)-H(6C) 111.1(6) 
H(6A)-C(6)-H(6C) 106.9(9) 
H(6B)-C(6)-H(6C) 109.0(9) 
O(2)-C(7)-O(1) 123.33(8) 
O(2)-C(7)-C(2) 122.70(8) 
O(1)-C(7)-C(2) 113.95(8) 
O(4)-C(8)-O(3) 123.94(8) 
O(4)-C(8)-C(4) 127.16(8) 
O(3)-C(8)-C(4) 108.90(7) 
C(5)-C(9)-H(9A) 112.2(6) 
C(5)-C(9)-H(9B) 109.2(6) 
H(9A)-C(9)-H(9B) 110.5(9) 
C(5)-C(9)-H(9C) 110.0(7) 
H(9A)-C(9)-H(9C) 109.8(9) 
H(9B)-C(9)-H(9C) 104.9(9) 
O(1)-C(10)-C(11) 110.39(8) 
O(1)-C(10)-C(13) 109.86(8) 
C(11)-C(10)-C(13) 112.57(9) 
O(1)-C(10)-C(12) 101.79(8) 
C(11)-C(10)-C(12) 110.82(10) 
C(13)-C(10)-C(12) 110.89(9) 
C(10)-C(11)-H(11A) 110.1(7) 
C(10)-C(11)-H(11B) 110.2(7) 
H(11A)-C(11)-H(11B) 107.6(9) 
C(10)-C(11)-H(11C) 110.6(7) 
H(11A)-C(11)-H(11C) 109.5(9) 
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H(11B)-C(11)-H(11C) 108.8(9) 
C(10)-C(12)-H(12A) 111.2(7) 
C(10)-C(12)-H(12B) 108.0(6) 
H(12A)-C(12)-H(12B) 110.5(10) 
C(10)-C(12)-H(12C) 109.9(6) 
H(12A)-C(12)-H(12C) 107.6(9) 
H(12B)-C(12)-H(12C) 109.5(9) 
C(10)-C(13)-H(13A) 111.4(7) 
C(10)-C(13)-H(13B) 107.2(6) 
H(13A)-C(13)-H(13B) 109.4(9) 
C(10)-C(13)-H(13C) 110.7(7) 
H(13A)-C(13)-H(13C) 109.8(10) 
H(13B)-C(13)-H(13C) 108.4(9) 
O(3)-C(14)-C(17) 110.02(8) 
O(3)-C(14)-C(15) 109.80(8) 
C(17)-C(14)-C(15) 113.45(10) 
O(3)-C(14)-C(16) 101.68(8) 
C(17)-C(14)-C(16) 110.75(9) 
C(15)-C(14)-C(16) 110.51(9) 
C(14)-C(15)-H(15A) 110.7(8) 
C(14)-C(15)-H(15B) 108.5(7) 
H(15A)-C(15)-H(15B) 108.6(11) 
C(14)-C(15)-H(15C) 112.3(7) 
H(15A)-C(15)-H(15C) 108.5(10) 
H(15B)-C(15)-H(15C) 108.3(10) 
C(14)-C(16)-H(16A) 109.6(7) 
C(14)-C(16)-H(16B) 108.5(7) 
H(16A)-C(16)-H(16B) 110.2(9) 
C(14)-C(16)-H(16C) 109.5(6) 
H(16A)-C(16)-H(16C) 108.8(10) 
H(16B)-C(16)-H(16C) 110.3(9) 
C(14)-C(17)-H(17A) 111.5(7) 
C(14)-C(17)-H(17B) 107.3(7) 
H(17A)-C(17)-H(17B) 110.3(9) 
C(14)-C(17)-H(17C) 110.2(7) 
H(17A)-C(17)-H(17C) 106.6(10) 
H(17B)-C(17)-H(17C) 111.1(10)
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_______________________________________________________________________________ 
 
Table 4.   Anisotropic displacement parameters  (Å2x 104 ) for JBT01 (CCDC 
294051).  The anisotropic displacement factor exponent takes the form: -2π 2 [ h2 
a*2U 11  + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 179(3)  211(3) 277(4)  90(3) 10(3)  -39(3) 
O(2) 204(3)  189(3) 202(4)  16(3) -22(3)  -17(3) 
O(3) 125(3)  190(3) 246(4)  13(3) -5(3)  -17(2) 
O(4) 224(3)  162(3) 295(4)  -9(3) 7(3)  -8(3) 
N(1) 175(4)  208(4) 204(5)  63(3) -38(3)  -29(3) 
C(1) 184(4)  192(5) 158(5)  0(4) 17(4)  -41(3) 
C(2) 166(4)  161(4) 158(5)  -12(4) 9(4)  -30(3) 
C(3) 158(4)  183(5) 206(5)  19(4) -3(4)  -15(4) 
C(4) 150(4)  163(4) 175(5)  7(4) 36(4)  -15(3) 
C(5) 160(4)  187(5) 177(5)  8(4) 41(4)  -24(3) 
C(6) 197(5)  254(6) 230(6)  62(5) -42(4)  -65(4) 
C(7) 200(5)  167(4) 146(5)  -34(4) 17(4)  -33(3) 
C(8) 147(4)  193(5) 164(5)  4(4) 31(4)  8(3) 
C(9) 188(5)  196(5) 267(6)  51(4) 31(4)  -2(4) 
C(10) 226(5)  181(5) 247(5)  73(4) 40(4)  -43(4) 
C(11) 360(6)  327(6) 261(6)  42(5) 102(5)  -60(5) 
C(12) 247(6)  343(7) 465(8)  153(6) 48(6)  -77(5) 
C(13) 352(7)  222(5) 369(7)  -17(5) 103(6)  -72(5) 
C(14) 127(4)  244(5) 226(5)  4(4) -16(4)  -31(3) 
C(15) 320(6)  364(7) 246(6)  -44(5) -18(5)  23(5) 
C(16) 191(5)  360(6) 357(7)  24(6) -21(5)  42(5) 
C(17) 206(5)  410(7) 393(7)  75(6) 48(5)  -96(5) 
______________________________________________________________________________ 
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Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters 
(Å2x 10 3) for JBT01 (CCDC 294051). 
________________________________________________________________________________  
 x  y  z  Uiso 
________________________________________________________________________________  
H(1) 4382(14) 1679(5) 10952(11) 32(3) 
H(3A) -54(12) 2402(4) 7829(10) 19(3) 
H(3B) -192(13) 2545(5) 9177(10) 31(3) 
H(6A) 6173(15) 2669(5) 9706(12) 45(4) 
H(6B) 6182(14) 2450(5) 11046(11) 35(3) 
H(6C) 5470(13) 3143(6) 10535(10) 32(3) 
H(9A) 1486(13) 482(5) 10255(10) 29(3) 
H(9B) 3369(14) 725(5) 11084(11) 38(3) 
H(9C) 3178(15) 493(6) 9750(11) 44(3) 
H(11A) 4132(14) 3625(6) 6161(11) 45(3) 
H(11B) 4016(14) 4397(6) 6023(10) 41(3) 
H(11C) 2337(16) 4003(5) 6163(12) 46(3) 
H(12A) 6702(15) 4167(5) 9154(13) 46(4) 
H(12B) 6591(14) 4528(6) 7876(10) 40(3) 
H(12C) 6803(14) 3758(5) 7953(11) 40(3) 
H(13A) 2155(15) 4630(5) 8029(11) 41(3) 
H(13B) 3824(13) 5057(5) 7963(10) 35(3) 
H(13C) 3845(15) 4678(6) 9215(13) 49(4) 
H(15A) -3061(17) 1211(6) 5548(13) 59(4) 
H(15B) -4750(16) 806(6) 5518(11) 48(4) 
H(15C) -2864(15) 547(6) 6264(11) 45(3) 
H(16A) -5107(15) 2107(6) 7478(12) 49(4) 
H(16B) -6070(15) 1760(5) 6195(11) 41(3) 
H(16C) -4329(14) 2189(5) 6321(11) 39(3) 
H(17A) -3882(14) 487(6) 8230(11) 39(3) 
H(17B) -5754(16) 774(5) 7538(11) 44(3) 
H(17C) -4529(16) 1118(6) 8772(14) 56(4) 
________________________________________________________________________________ 
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Table 6.  Hydrogen bonds for JBT01 (CCDC 294051)  [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
N(1)-H(1)...O(2)#1 0.878(11) 2.047(11) 2.9088(10) 166.9(10) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x+1/2,-y+1/2,z+1/2       
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Chapter 4 
Progress Toward the Total Synthesis of (+)-Minfiensine 
 
Isolation, Structure, and Biological Activity 
Members of the Strychnos family of natural products were first isolated in 1989 
from the plant Strychnos minfiensis by Massiot et al.1 and are comprised of indole and 
tryptophan units, presumably via cyclization of corynanthene intermediates (Fig. 1).2   
Despite recent heightened interest in related akuammiline alkaloids exhibiting interesting 
biological activity as isolates and as traditional medicines,3 little is known about their 
pharmacology.  The potential for new therapies and understanding their subsequent 
modes of action makes these molecules attractive targets for total synthesis. 
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2
Figure 1.  Structurally Related Members of the Strychnos Alkaloid Family
Minfiensine
1  
Minfiensine 1 is a pentacyclic pyrroloindoline alkaloid bearing a quaternary 
carbon stereocenter and a fully differentiated aminal motif at the fused ring juncture.  The 
only synthesis of this natural product was reported by the Overman group in 2005.4  Their 
                                                
(1) Massiot, G.; Thepenier, P.; Jacquier, M. J.; Lemenolivier, L.; Delaude, C. Heterocycles 1989, 29, 1435-1438. 
(2) (a) Scott, A. I. Acc. Chem. Res. 1970, 3, 151-157. (b) Scott, A. I.; Cherry, P. C.; Quereshi, A. A. J. Am. Chem. Soc. 1969, 91, 
4932. 
(3) Ramirez, A. G.-R., S. Curr. Med. Chem. 2003, 10, 1891-1915. 
(4) (a) Dounay, A. B.; Overman, L. E.; Wrobleski, A. D. J.  Am. Chem. Soc. 2005, 127, 10186-10187. (b) Dounay, A. B.; 
Overman, L. E.; Wrobleski, A. D.  J.  Am. Chem. Soc. 2006, 128, 2154-2154. 
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strategy utilized a series of intramolecular Heck reactions5 to set the pentacycle, followed 
by oxidation state manipulations to assemble the target molecule (Fig. 2).     
 
 
 
  
 
The key step in their sequence relies on an asymmetric Heck/iminium ion cyclization (eq. 
1).  In this reaction, triflate 4 undergoes Heck cyclization to form the quaternary carbon 
stereocenter in 5.  Protonation of the enamine followed by 1,2-addition to the resulting 
iminium by the pendant amine furnishes tetracycle 6 in good yield and high ee.  In this 
transformation, the quaternary center is set with high levels of enantioselectivity, paving 
the way for substrate-controlled assembly of the remaining pyrroloindoline core.  
 
                                                
(5)  (a) Douglas, C. J.; Overman, L. E. PNAS 2004, 101, 5363-5367. (b) Lebsack, A. D.; Link, J. T.; Overman, L. E.; Stearns, 
B. A.  J.  Am. Chem. Soc. 2002, 124, 9008-9009. (c) Overman, L. E.; Watson, D. A. J. Org. Chem. 2006, 71, 2600-2608. (d) 
Dounay, A. B.; Humphreys, P. G.; Overman, L. E.; Wrobleski, A. D.  J.  Am. Chem. Soc. 2008, ASAP articles. 
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!  Asymmetric Heck Iminium Ion Cyclization
!  Intramolecular Heck Cyclization
!  Oxidation State Manipulation
Figure 2.  Overman's Synthetic Strategy
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Overman et al. then assembled intermediate 7 that was next elaborated into vinyl 
iodide 8  (Fig. 3).  The final ring was created by a second intramolecular Heck 
cyclization, followed by deprotection of the alcohol, oxidation to the ketone and 
subsequent alkylation to provide late-stage intermediate 9.  Five additional 
transformations installed the required oxidation states of (+)-minfiensine 1 in 23 steps 
and 3.2% overall yield.  Recently, the Overman group reported an improved endgame 
that reduced the overall number of linear steps to 15.5d 
 
 Synthetic Strategy 
Our approach to (+)-minfiensine 1 focuses on the pyrroloindoline core of the 
natural product.  In 2004, our group reported a powerful and rapid means for entry into 
these tricyclic cores utilizing iminium-activation organocatalysis (eq. 2).6 In this 
methodology, substituted tryptamine derivative 10 is reacted with α,β-unsaturated 
aldehyde 11 under iminium activation conditions using imidazolidinone 12 to furnish 
pyrroloindoline 13.  This organocatalytic cyclization was successful in using a variety of 
                                                
(6)  (a) Austin, J. F.; Kim, S. G.; Sinz, C. J.; Xiao, W. J.; MacMillan, D. W. C. PNAS  2004, 101, 5482-5487. (b) Austin, J. F.; 
MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 1172-1173. 
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Figure 3.  Completion of Overman's Synthesis
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indole derivatives to access a broad range of elaborated pyrroloindoline cores bearing 
quaternary carbon stereocenters in excellent ee, good dr, and good yields.  Furthermore, 
an assortment of β-substituted aldehydes was successfully utilized in this chemistry.   
 
This methodology takes advantage of the latent indolinium created after Friedel-Crafts 
addition of the indole to an iminium-activated α,β-unsaturated aldehyde 14 (Fig. 4). In 
the proposed catalytic cycle, imidazolidinone 12 condenses with enal 11 to provide 
activated intermediate 14.  Indole nucleophile 15 adds in a conjugate fashion to produce 
indolinum 16 that cyclizes to pyrroloindoline 17 via intramolecular attack of the pendant 
amine.  Finally, hydrolysis releases catalyst 12 back into the cycle and unveils aldehyde 
18. 
 
 
 
 
 
 
 
 
!  The pyrroloindoline forming strategy creates quaternary carbon stereocenters in excellent ee's
89-97% ee
68-90% yield
•TFA
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This strategy has been utilized in the rapid synthesis of two complex natural products, 
(–)-flustramine B7 and pseudophrynamine A8 (Fig. 5).   
Figure 5.  Organocatalytic Cyclization Is a Powerful Entry into Natural Products
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Dr. Sung-Gon Kim and Dr. Wen-Jing Xiao Dr. Shojiro Miyazaki and Dr. Sung-Gon Kim 
While this methodology is broadly useful for a range of substituted indoles, one 
major obstacle exists.  Currently, 2,3-dialkyl substituted indoles are unreactive in these 
reactions, presumably due to the increased non-bonding interactions that hinder approach 
of the electrophile to the π-system.   Indeed, both natural products assembled using this 
                                                
(7)  Austin, J. F.; Kim, S. G.; Sinz, C. J.; Xiao, W. J.; MacMillan, D. W. C. PNAS 2004, 101, 5482-5487. 
(8) Unpublished results. 
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Figure 4.  Organocatalytic Pyrroloindoline Construction Relies on Interception of a Reactive Intermediate
X–
• HX
N
N
H
Ind
OMe
tBu
• HX
12
11
14
15
16
1718
  
102 
technology contain hydrogens at the aminal center of the pyrroloindoline core.  
Conversely, minfiensine bears an alkyl substituent at this position, presenting a potential 
problem for the key cyclization event. 
In order to address this reactivity problem, an alternative driving force was 
proposed.  We felt the release of trans-annular ring strain (up to 12.6 kcal/mol for nine-
membered lactams9) characteristic of medium size rings would provide an opportunity to 
utilize the organocatalytic cascade cyclization (Fig. 6). 
  
 
 
 
In order to test this hypothesis, a model system was synthesized via a known route 
reported by the Ban Group (eq. 3).10  This remarkable photo-Fries rearrangement begins 
with free-radical cleavage of the amide bond shown in structure 21 followed by 
tautomerization to the more stable intermediate 22.  Radical carbon-carbon bond 
formation provides intermediate 23 that is in equilibrium with hemi-aminal 24.  
Protonation provides indolinium 25, which undergoes fragmentation via 26 to furnish 
indole caprylolactam 20 in 70% isolated yield.   This method is one of the few effective 
ways to access nine-membered lactams in good yields. 
 
 
 
                                                
(9) Rousseau, G. Tetrahedron 1995, 51, 2777-2849. 
(10) (a) Ban, Y.; Yoshida, K.; Goto, J.; Oishi, T. J. Am. Chem. Soc. 1981, 103, 6990-6992. (14) Ban, Y.; Yoshida, K.; Goto, J.; 
Oishi, T.; Takeda, E. Tetrahedron 1983, 39, 3657-3668. 
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N
H
NH
+ ~12 kcal /mol
  
103 
h!
5% MeOH/Et2O
N
H
NH
O
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 With this molecule in hand, we proceeded with the organocatalytic cyclization.  
To our great delight, subjecting indole caprylolactam 20 into standard pyrroloindoline 
forming conditions with acrolein provided the desired tetracyclic alcohol 28 after a 
reductive workup (eq. 4). 
N
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N
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Me
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NH
O
N
H
N
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O
!  Initial result
O
20 mol% catalyst 12 • 2,4–DNBA
10% i-PrOH/CH2Cl2
–60 °C, 36 h
then NaBH4
32% yield, 32% ee
3 eq.
!  Four of the five rings are assembled from the tricyclic starting material
(4)
1
20 27 28
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Remarkably, four of the five rings found in the natural product are assembled 
from the fused indole caprylolactam 20 in 32% yield and 32% ee, thereby establishing 
this approach as a viable route for rapid entry into the [6,5,5,6]-tetracyclic framework of  
(+)-minfiensine.  The proposed catalytic cycle provides a picture of this cyclization event 
(Fig. 7).  Catalyst 12 condenses with acrolein to form iminium 29.  Friedel-Crafts 
addition of indole 20 provides indolinium intermediate 30 that is trapped by the amide 
nitrogen to provide pyrroloindoline 31.  Hydrolysis of the resulting enamine 31 delivers 
the aldehyde that is subsequently reduced to furnish the desired product 28.   
 
 
 
 
 
 
 
 
 
 
A series of experiments were performed to understand and improve this cyclization.  The 
first problem was the formation of the bis-alkylated pyrroloindoline, isolated in 49% 
yield, as the major product in this first reaction.  Protecting the indole nitrogen to provide 
32 prevented this event and, under slightly modified conditions, tetracyclic product 33 
was obtained in improved yield and ee (eq. 5).  
Figure 7.  Assembling the Tetracyclic Ring System
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 Next, the role of the amide group was assessed.  Transformation of the amide to 
its corresponding secondary amine was possible under reducing conditions.  Subjecting 
compound 34 to the cascade conditions resulted only in alkylation of the secondary 
amine to produce 35 in preference to the desired conjugate addition/cyclization product.  
Importantly, the carbonyl acts to attenuate the nucleophilicity of the amine, favoring the 
intramolecular cyclization over the intermolecular alkylation (eq. 6). 
 
 
Retrosynthetic Analysis 
Having identified the structural features required in this cyclization reaction, a 
retrosynthesis of minfiensine was formulated (Fig. 8).  The final carbon-carbon bond 
needed to access the final ring could be furnished by SOMO catalysis. Elaborated 
caprylolactam 37 should furnish SOMO substrate 36 under organocatalytic cyclization 
N
NH
O
N
N
OH
O
!  Protecting the indole group prevents acrolein addition and increases yield
Bn Bn
O
62% yield, 56% ee
20 mol% catalyst 12 • TCA
10% MeOH/CH2Cl2
–60 °C, 36 h
then NaBH4
3 eq.
(5)
32 27 33
!  The carbonyl modulates the amine reactivity
N
N
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main component
trace desired product
N
NH
Bn
O
3 eq.
(6)
20 mol% catalyst 12 • TCA
10% MeOH/CH2Cl2
–60 °C, 36 h
then NaBH4
34 27 35
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conditions. Caprylolactam 37 could be obtained via ring-closing metathesis of 
intermediate 38 that can be assembled from commercially available tryptamine 39.  
 
 
SOMO catalysis is a new mode of organocatalytic activation reported by our 
group in 2007.11  A portion of the catalytic cycle, shown in eq. 7, outlines the mechanistic 
underpinnings of this powerful methodology.  Enamine 40 undergoes a single electron 
oxidation event to generate radical cation 41.  This versatile intermediate species has 
been demonstrated to react enantioselectively with a variety of SOMO-nucleophiles, (i.e., 
allylsilane) to provide iminium 42.  The net transformation yields enantioenriched α-
alkyl aldehydes in good yield and ee.   
                                                
(11) Beeson, T. D.; Mastracchio, A.; Hong, J. B.; Ashton, K.; MacMillan, D. W. C. Science 2007, 316, 582-585. 
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It was envisioned that this technology could be applied to this synthesis by installing the 
requisite functionality found in structure 36 (Fig. 9).  After enamine formation to provide 
intermediate 43, a single-electron oxidant, typically ceric ammonium nitrate (CAN) or 
iron(III) phenanthroline, will induce formation of radical cation 44.  Trapping by the 
allylsilane creates the final carbon-carbon bond in 45 and, after hydrolysis, provides late-
stage pentacycle 46 that should be readily advanced to the target molecule.   
 
Unsuccessful Approaches to the Elaborated Caprylolactam 
Elaboration of tryptamine into compound 38 proceeded uneventfully.  The challenges 
arose beginning at the ring-closing metathesis step (Fig. 10).  Subjecting diene 38 to 
!  SOMO catalysis:  Generating a radical cation via the single electron oxidation of an enamine
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RCM failed to provide the desired caprylolactam.  Instead, either isomerized material 47 
or dimer 48 was isolated as major components.  Attempts to optimize this reaction by 
varying metathesis catalysts, temperatures, solvents, and concentrations never created the 
desired fused indole caprylolactam.  Efforts to re-subject dimer 48 to a variety of 
metathesis conditions did not produce desired lactam, as this dimer was remarkably 
resistant to further transformation.  Finally, attempts to prevent olefin isomerization by 
utilizing benzoquinone and 2,6-dichlorobenzoquinone to intercept the intermediate 
ruthenium hydride only favored dimer production.12  
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Figure 10.  Attempts to Access the Nine-Membered Lactam Using Ring-Closing Metathesis
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Realizing the inadequacies of substrate 38 in RCM, we chose to pursue an 
alternative strategy.  Many useful methods that access medium-size rings proceed by 
synthesis of a more accessible macrocycle followed by ring contraction to provide the 
                                                
(12) Hong, S. H.; Sanders, D. P.; Lee, C. W.; Grubbs, R. H. J. Am. Chem. Soc. 2005, 127, 17160-17161. 
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desired medium ring.  One very effective approach utilizes an intramolecular Staudinger 
cyclization to access nine-membered lactams (Fig. 11).13  In the event, protected 
diphenylphosphine intermediate 49 is unmasked and, subsequently, attacks the azide to 
furnish zwitterionic macrocycle 50.  Extrusion of nitrogen gas to produce 51 brings the 
amine in close proximity to the thioester, facilitating a reaction to create lactam 
phosphonium intermediate 52 that hydrolyzes to furnish the desired lactam 53 in 80% 
isolated yield. 
 
 Cyclization precursor 54 was synthesized as a 6:1 mixture of geometrical isomers 
and subjected to van Maarseveen’s conditions (eq. 8). Within 15 minutes, isomerization 
of the (Z)-alkene to the more stable (E)-alkene was observed, instead of the desired 
deprotection/cyclization event.  Due to the preference for this deleterious pathway over 
macrocyclization, this route was not explored any further.  
                                                
(13) Olivier, D.; Meester, W. J. N.; Bieraugel, H.; Schoemaker, H. E.; Hiemstra, H.; van Maarseveen, J. H. Angew. Chem. Int. 
Ed. 2003, 42, 4373-4375. 
Figure 11.  Van Maarseveen's Intramolecular Staudinger Ligation
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The van Maarseveen Group also reported a related macrocyclization/ring-
contraction to access nine-membered lactams (Fig. 12).14  In this strategy, a phenol-based 
linker is used in intermediate 56.  After BOC deprotection with TFA, basic conditions 
induce cyclization to the desired lactam 58 in 70% yield.   
 
Application of this method required the synthesis of intermediate 59 (eq. 9).  In this case, 
the allylsilane was omitted due to a propensity for protodesilylation under strongly acidic 
conditions. All attempts to access the 13-membered ring resulted in either dimerization or 
isomerization of the primary alkene.  This substrate 59 proved to be just as poor an RCM 
substrate as 38.   
 
 
 
                                                
(14) Bieraugel, H.; Jansen, T. P.; Schoemaker, H. E.; Hiemstra, H.; van Maarseveen, J. H. Org. Lett. 2002, 4, 2673-2674. 
Figure 12.  A Related Strategy to Access the Lactam
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Having attempted these ring-contraction strategies without success, we re-focused 
our attention to functionalizing the original model system (Fig. 13). After orthoganol 
protection of the nitrogens, α-selenenylation was accomplished using LDA and PhSeCl 
to provide 63.  Further attempts to introduce other functionality on 63 at the selenide- 
bearing carbon were met with regioselectivity issues presumably induced by torsional 
strain.  In the event, lithiation occurred predominantly at the benzylic position shown in 
64.  This undesired reaction could not be circumvented.   
 
Modifying the Strategy 
An alternate strategy was to simplify cyclization precursor 55 to α,β-unsaturated 
caprylolactam 65 (Fig. 14).  Removing the silane appendage replaces the sterically 
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Figure 13.  Issues with Lithiating Substituted Caprylolactams
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demanding type III alkene with a sterically less-demanding type II alkene 66.15  We 
hoped this combination of more reactive olefins would facilitate closure of the strained 
ring.  
 
 
 
 
 
Treating tryptamine 39 with phthalic anhydride, followed by re-crystallization provided 
pure phthalimide-protected compound 67 (eq. 10).  Following a Danishefsky procedure,16 
the allyl group was installed and subsequent benzyl protection provided compound 68 in 
44% yield over two chemical steps.  During the protection step, it was crucial to closely 
monitor the reaction for the exact end point, due to deleterious alkene bond 
isomerization.  Furthermore, neutral pH 7 buffer solution was required for all subsequent 
aqueous workups in order to prevent this undesired event.   
 
                                                
(15) Chatterjee, A. K.; Choi, T. L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 11360 11370. 
(16) Chatterjee, A. K.; Choi, T. L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 1999, 121, 11964-11975. 
Figure 14.  Simplifying the Nine-Membered Lactam Intermediate
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Due to the sensitivity of the alkene 68 towards isomerization, mild phthalimide 
deprotection conditions were sought. Methyl hydrazine was utilized to unmask the amine, 
as it was successful in Nicolaou’s calicheamicin synthesis.17  Subjecting the crude amine 
to acylation conditions provided amide 69 in 78% yield over two steps (eq. 11).  This 
expedient route provided this RCM substrate in multi-gram quantities.   
 
 
 
 
As an initial foray into constructing the caprylolactam, amide 69 was subjected to 
standard RCM conditions (eq. 12).  Disappointingly, only dimer 70 was formed in 
quantitative yield.  This result is best explained in terms of amide bond cis/trans 
isomerization.  The barrier to this rotation event is typically high  (15–20 kcal/mol) 
favoring the more stable trans configuration.18  In this case, the trans geometry orients 
the acrylamide olefin distal to the intermediate ruthenium carbene, preventing a 
successful cross metathesis. 
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!  The unprotected amide dimerizes
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(17) Smith, A. L.; Hwang, C. K.; Pitsinos, E.; Scarlato, G. R.; Nicolaou, K. C. J. Am. Chem. Soc. 1992, 114, 3134-3136. 
(18) Kemnitz, C. R.; Loewen, M. J. J. Am. Chem. Soc. 2007, 129, 2521-2528. 
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In order to overcome this barrier, a BOC group was introduced under standard conditions 
to provide bisalkene 71 (eq. 13).  
 
Gratifyingly, subjecting this compound to the previous conditions provided indole 
caprylolactam 72 in 56% yield, and confirms the ability of imide 71 to overcome the 
energy barrier of C-N bond rotation to position the acrylamide alkene in close proximity 
to the ruthenium carbene (eq. 14). 
 
Having solved the cyclization step, we sought to unveil cascade cyclization 
precursor 65 via BOC deprotection of lactam 72.  Utilizing standard TFA conditions 
resulted in extensive decomposition of the starting material (Table 1, entry 1).  
Employing alternative acids led to quantitative hydrolysis of the lactam moiety (Table 1, 
entry 2). The substrate was then subjected to basic conditions.  Unfortunately, neither 
K2CO3 nor Cs2CO3 successfully removed the BOC group (Table 1, entries 3,4).   
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Due to the sensitivity of this substrate to Brønsted acid and basic conditions, 
substrate 72 was subjected to Lewis acid conditions.19  Fortuitously, a catalytic amount of 
Yb(OTf)3 cleanly provided deprotected material 65 in 90% yield (eq. 15).   
!  Successful BOC deprotection conditions
60 mol% Yb(OTf)3
N
NH
O
Bn
N
N
O
Bn
BOC
THF
90% yield
(15)
72 65  
In proceeding with the synthesis, caprylolactam 65 was subjected to 
organocatalytic cyclization conditions.  Gratifyingly, this unsaturated analogue of the 
model system provided desired tetracycle 73 in 65% yield and 32% ee, a promising first 
result (eq. 16).   
                                                
(19) Calimsiz, S.; Lipton, M. A. J. Org. Chem. 2005, 70, 6218-6221. 
Table 1.  Subjecting the Caprylolactam to a Variety of Deprotection Conditions
conditions
N
NH
O
Bn
N
N
O
Bn
BOC
conditions result
2 eq. TFA/CH2Cl2
2 eq. TsOH•H2O
K2CO3/DME 70 °C
Cs2CO3/imidazole/THF 70 °C
complex mixture
amide bond hydrolysis product
starting material persisted
complex mixture
entry
1
2
3
4
72 65
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!  Organocatalytic cascade cyclization was successful on the unsaturated system
O
20 mol% catalyst 12 • 2,4–DNBA
10% H2O/CH2Cl2
–78 °C, 24 h
then NaBH4
65% yield, 32% ee
3 eq.
Bn Bn
(16)
65 7327
 
More importantly, the presence of the alkene was tolerated and, subsequently, provided a 
functional handle to introduce the allylsilane.  Before optimizing the cascade sequence, a 
study was performed on tetracycle 73 to gain insight to the stability of electron-rich 
heterocycles under SOMO conditions (Fig. 15).  Alcohol 73 was oxidized to aldehyde 74 
using Dess-Martin periodinane in 81% yield.  Subjecting aldehyde 74 to SOMO 
conditions resulted in rapid degradation to, presumably, polymeric species.   Ceric 
ammonium nitrate (CAN) preferentially oxidizes electon-rich heterocycles over 
enamines.  
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Figure 15.  Testing the Stability of Electron-Rich Heterecyles Under SOMO Conditions
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In order to overcome this issue, we postulated that decreasing the electron density 
of the aniline heterocycle would render CAN-mediated degradation less favorable.  
Indeed, in some cases, free indoles have been stable to CAN oxidation under SOMO 
conditions.  To pursue this goal, an alternative protecting group that could be easily 
removed, was introduced via intermediate 68 (eq. 17).   
N
NPhth
KH, 18-C-6
(17)
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62% yield
68 75
O O
 
Dioxolane species 75 provides a functional group that can be cleaved under mild 
conditions that will leave the olefin moiety unchanged.  This material was advanced to 
the indole caprylolactam by the original sequence.  Intriguingly, subjecting dioxolane 76 
to cascade conditions produced desired tetracycle 77 in 70% yield as a racemic mixture 
(eq. l8).  This result demonstrates that seemingly innocuous changes on the indole 
starting material have a large impact on the outcome of this organocatalytic 
pyrroloindoline-forming reaction.  Fortunately, the sensitive nature of this methodology 
allows slight changes in reaction conditions to aid optimization. 
N
NH
O
N
N
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O
!  Organocatalytic cascade reaction on the dioxolane produce racemic product in good yield
O
20 mol% catalyst 12 • TFA
15% H2O/CH2Cl2 –78 °C
then NaBH4
3 eq.
O O O O
70% yield
racemic
(18)
76 27 77  
  
118 
The first step to improving this reaction was to utilize an alternative 
imidzolidinone catalyst (Fig. 16).  The increased enantiofacial coverage by substituting 
the phenyl group, MM3-1, with an indole moiety, MM3-2, should improve the 
enantioselectivity of the Friedel-Crafts addition.  Furthermore, the indole moiety of 
MM3-2 has a greater electrostatic surface potential than the phenyl group in MM3-1 
(compare 32.6 kcal/mol versus 27.1 kcal/mol).  We believe this attribute will re-enforce 
the iminium geometry of the reactive intermediate by enabling a cation-π interaction to 
further increase the ee of this cyclization.  
 
Initial experiments utilizing the indole catalyst at –78 °C led to nearly racemic 
product formation (3% ee), as was observed in the case of the related benzyl catalyst 12.  
Interestingly, as the reaction temperature was warmed to room temperature, the ee was 
improved from 3% to 40% (Fig. 17).  The improved enantioselectivity by indole catalyst 
78 was not observed using benzyl catalyst 12, as racemic material was obtained after 
repeating this reaction under the same conditions.  These results are atypical for iminium 
catalyzed pyrroloindoline chemistry, where an inverse correlation between reaction 
temperature and enantioselectivity is generally observed.   
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Figure 16.  MM3 Structures of Two Imidazolidinone Catalysts
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An Eyring plot analysis of these data indicates two inflection points over the 
range of temperatures examined in Figure 17 (Fig. 18). This indicates that two different 
reaction mechanisms are taking place, one below and one above –50 °C.  While the exact 
mechanisms remain unknown, it may be that an increased concentration of water at 
warmer temperatures may benefit a higher ee by introducing more acid co-catalyst (vide 
infra) into the reaction or by preventing reversibility of the acrolein addition, as is known 
for similar substrates, by forming a hemi-acetal.  Another explanation may be the 
caprylolactam cis/trans orientation may be effected by additional acid in solution and 
influence the approach of the activated iminium intermediate.20 
 
 
 
                                                
(20) Borgen, G. Mag. Res. Chem. 1991, 29, 805. 
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Figure 18.  Eyring Plot Analysis of the OC Reaction  
 
 
 
 
 
 
 
 
After having determined that 0 °C was the optimal temperature, co-catalysts were 
surveyed for efficacy (Table 2).  While no obvious trends were discovered (Table 1, 
entries 1-4), AcOH (entry 4) gave the highest levels of conversion and ee.   
 
While this key step was being optimized, tetracycle 77 was utilized in subsequent 
reactions.  It was envisioned that Kumada cross-coupling conditions could install the 
N
NH
O
N
N
OH
OO
20 mol% catalyst 78 • co-catalyst
15% H2O/CH2Cl2 0 °C
then NaBH4
3 eq.
O O O O
cocatalyst % yield % ee
AcOH 83 60
time (h)
24
89 54 24DNBA
HCl 82 57 24
77 43 24TFA
pKa
–0.23
–8.0
1.43
3.77
entry
1
2
3
4
Table 2.  Evaluating Co-Catalysts
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allylsilane needed for the SOMO cyclization.  Attempts to access the vinyl bromide 
coupling intermediate were met with regiochemical issues (eq. 19).  In the event, after 
protection of alcohol 77 as the silyl ether 79, halogenation only provided the brominated 
4-position of the aniline ring 80.  The use of alternative bromine sources led to the same 
electrophilic aromatic substitution product.  
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N
OTBS
O
N
N
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O
O O O O
1) Br2/Et3N
89% yield
O O
TBSCl, DMAP
Et3N, CH2Cl2
!  Halogenation/Dehydrohalogenation brominated the aniline ring
Br
(19)
77 79 80  
 The need for a chemoselective reaction was met by utilizing a dihydroxylation 
sequence (eq. 20).  The resulting diol 81 should lend itself to further manipulation into a 
bis-triflate intermediate that should undergo manipulation into vinyltriflate 82. 
OsO4/NMO
N
N
OTBS
O
O O
!  Dihydroxylation worked well
N
N
OTBS
O
O O
N
N
OTBS
O
O O
CH3CN
70% yield OTfOH OH
(20)
79 81 82  
 
Future Directions 
Diol 81 will be transformed into the bis-triflate that should undergo regioselective 
elimination of the β-amide triflate to provide intermediate 82.  This intermediate will be 
subjected to Kumada conditions utilizing the commercially available Grignard of the 
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desired trimethylsilane.  If the methyl stereocenter is not set via substrate-controlled 
diastereoselective addition, asymmetric conditions will be pursued.  Bis-deprotection of 
the resulting silyl ether produces allylsilane 83.  Subsequent oxidation and then SOMO 
catalysis will create the final C-C bond to furnish the final ring in 84.  Finally, installation 
of the alkene, imidate formation of the amide, and subsequent NaBH4 reduction should 
provide (+)-minfiensine 1 (Fig. 19). 
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1) [O]Comins' reagent
OH OTf
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Me
1) LDA, PhSeCl
2) H2O2
2) Meerwein's salt
3) NaBH4
Figure 19.  Plans to Complete the Synthesis
81 82 83
84 85 1  
 
Conclusion 
 In summary, an efficient entry into the ring framework of (+)-minfiensine has 
been described.  We have further established iminium catalysis as a valuable mode of 
activation to access complex architectures found in natural products.  This rapid access to 
the pyrroloindoline core, followed by a SOMO mediated alkylation event, should rapidly 
assemble the tetracyclic core bearing functionality that can be manipulated to the desired 
natural product. 
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Supporting Information 
  
General Information.  Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.1  Non-aqueous reagents were transferred under 
nitrogen via syringe or cannula and purified according to the method of Grubbs.2  
Organic solutions were concentrated under reduced pressure on a Büchi rotary 
evaporator.  Chromatographic purification of products was accomplished using forced-
flow chromatography on ICN 60 32-64 mesh silica gel and Iatrobeads® according to the 
method of Still.3  Thin-layer chromatography (TLC) was performed on EM Reagents 0.25 
mm silica gel 60-F plates.  Chromatograms were visualized by fluorescence quenching or 
by staining using either potassium permanganate or anisaldehyde stain. 
1H and 13C NMR spectra were recorded on a Varian Mercury 300 Spectrometer, 
and are internally referenced to residual solvent signals.  Data for 1H NMR are reported 
as follows: chemical shift (d ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet), integration, coupling constant (Hz), and assignment.  Data for 13C 
NMR are reported in terms of chemical shift.  IR spectra were recorded on a Perkin 
Elmer Paragon 1000 spectrometer and are reported in terms of frequency of absorption 
(cm–1).  Mass spectra were obtained from the Caltech Mass Spectrometry Facility and the 
Princeton Mass Spectrometry Facility by electron ionization, chemical ionization, or fast 
atom/ion bombardment techniques.  Gas liquid chromatography (GLC) was performed on 
Hewlett-Packard 6850 and 6890 Series gas chromatographs equipped with a split-mode 
capillary injection system and flame ionization detectors using a Bodman Chiraldex b-
                                                
(1) Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 1988. 
(2) Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518. 
(3)  Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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DM (30 m × 0.25 mm), a Bodman Chiraldex Γ-TA (30 m × 0.25 mm), or a Hydrodex-B-
TBDAc (50 m × 0.25 mm) column, as noted.  Optical rotations were measured on a Jasco 
P-1010 polarimeter, and [α]D values are reported in 10–1 dg cm2 g–1; concentration (c) is 
in g/100 mL.  Supercritical fluid chromatography was performed on a Berger Minigram 
equipped with a diode array UV detector (λ = 214–258 nm) using a chiral column (25 
cm) and guard column (5 cm) as noted for each compound. 
 
 
 
 
 
 
 
 
 
 
 
Methyl-4-(chlorocarbonyl)butanoate.  Dihydro-3H-pyran-2,6-dione (49 g, 429 mmol) 
was suspended in a solution of dry MeOH (17.4 mL, 429 mmol) in CHCl3 (390 mL) and 
refluxed for 5 hours.  The resulting solution was cooled to room temperature and SOCl2 
(62.6 mL, 858 mmol) was added dropwise via addition funnel over 3 hours.  After 
complete addition, excess SOCl2 was removed via rotary evaporation and the crude 
material was distilled at 67 °C, 2.5 mm Hg to provide the desired product as a clear oil 
(76.1 g, 76% yield).  Spectroscopic data were identical to that reported by Oda et al.4  
 
 
 
                                                
(4)Oda, H.; Kobayashi, T.; Kosugi, M.; Migita, T. Tetrahedron 1995, 51, 695-702. 
N
H
NH
O
21
OO O
Cl OMe
O O
1) MeOH/CHCl3
2) SOCl2
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5-Oxononanedioic acid.  To a clear solution of methyl-4-(chlorocarbonyl)butanoate (130 
g, 790 mmol) in benzene (790 mL) cooled to 0 °C was added freshly distilled 
triethylamine (80 g, 110 mL, 790 mmol) dropwise in order to keep the reaction 
temperature below 25 °C.  The resulting cloudy white solution stirred at 0 °C for 5 
minutes and then carefully warmed to 35 °C over 15 minutes.  The resulting light yellow 
oil was stirred at room temperature for 30 minutes and then passed through a filter to 
remove the triethylamine HCl salts.  This solid was washed with benzene (3 × 200 mL) 
and the resulting elute was concentrated to an orange oil.  To this oil was added 2M KOH 
(680 mL) and the resulting suspension was refluxed for 5 hours.  The homogeneous 
solution was acidified with concentrated HCl (138 mL) and the aqueous solution was 
concentrated to a solid.  These salts were extracted with hot acetone (5 × 100 mL) and the 
solution was dried over Na2SO4, filtered, and concentrated.  After dissolving the resulting 
material in hot H2O, the product recrystallized overnight at 0 °C.  The first batch was 
harvested and the mother liquor was concentrated.  The resulting residue was re-
crystallized as before.  The product was isolated as an amorphous solid (48% average 
yields).  The spectroscopic data were identical to that reported by the Ban Group.5 
 
 
 
 
                                                
(5) Ban, Y.; Yoshida, K.; Goto, J.; Oishi, T.; Takeda, E. Tetrahedron 1983, 39, 3657-3668. 
OH
O O
1) Et3N/toluene
2) 2M KOH
Cl OMe
O O
HO
O
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3-(6,7,8,9-tetrahydro-6-oxopyrido[1,2-a]indol-10-yl)propanoic acid.  To a clear 
solution of 5-oxononanedioic acid (21.8 g, 108 mmol) in EtOH (220 mL) was added 
phenyl hydrazine (11.7 g, 10.7 mL, 108 mmol).  The resulting light yellow solution was 
stirred at room temperature for 30 minutes and then concentrated to produce an orange 
solid.  To this solid was added 10% H2SO4 (700 mL) and the suspension was refluxed for 
1 hour.  Upon cooling a brown solid precipitated and was subsequently filtered.  The 
solid was recrystallized from ethanol to afford the product as a white solid (14.4 g, 52% 
yield).  The spectroscopic data were identical to that reported by the Ban Group.5 
 
 
 
 
 
3-(6,7,8,9-tetrahydro-6-oxopyrido[1,2-a]indol-10-yl)propanoyl chloride.  To a 
suspension of 3-(6,7,8,9-tetrahydro-6-oxopyrido[1,2-a]indol-10-yl)propanoic acid (15.2 
g, 75.2 mmol) in benzene (20 mL) was added oxalyl chloride (11.45 mL, 129 mmol).  
The resulting cloudy orange solution was heated to 60 °C for 30 minutes.  The resulting 
homogeneous solution was concentrated to an orange solid and used crude in the next 
step.  The IR data were identical to that reported by the Ban Group.5 
1) phenyl hydrazine
    EtOH
2) 10% H2SO4OH
O O
HO
O
N
OH
O
O
 oxalyl chloride
N
Cl
O
O
N
OH
O
O
benzene 60 °C
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10-(3-azido-3-oxopropyl)-8,9-dihydropyrido[1,2-a]indol-6(7H)-one.  To a clear 
solution of sodium azide (4.36 g, 67.2 mmol) in H2O (11 ml) cooled to 0 °C was added a 
light yellow solution of 3-(6,7,8,9-tetrahydro-6-oxopyrido[1,2-a]indol-10-yl)propanoyl 
chloride in dry acetone (140 ml) dropwise via addition funnel.  The resulting cloudy 
yellow solution was stirred at 0 °C for 10 minutes and room temperature for 30 minutes 
after which it was diluted with H2O (230 mL).  The solution sat for 30 minutes to ensure 
complete precipitation of solid.  The product was collected by filtration and dried on high 
vacuum to afford a white solid (13 g, 82% yield) that was used as is in the next step.  The 
IR data were identical to that reported by the Ban Group.5 
 
 
 
 
 
Benzyl-2-(6,7,8,9-tetrahydro-6-oxopyrido[1,2-a]indol-10-yl)ethylcarbamate.  A 
suspension of 10-(3-azido-3-oxopropyl)-8,9-dihydropyrido[1,2-a]indol-6(7H)-one was 
refluxed for 1.5 hours and vigorously evolved nitrogen gas.  After cooling to room 
temperature, freshly distilled benzyl alcohol (5.51 g, 5.30 mL, 51 mmol) was added and 
the resulting solution was refluxed for 2.5 hours.  The reaction was cooled to room 
N
N3
O
O
N
Cl
O
O
NaN3
N
NHCBZ
O
N
N3
O
O
2) BnOH
1) benzene, ref.
  
128 
temperature and concentrated to a crude solid.  Recrystallization from EtOAc afforded 
the product as a white solid (12.6 g, 82% yield).  The spectroscopic data were identical to 
that reported by the Ban Group.5 
 
 
 
 
 
10-(2-aminoethyl)-8,9-dihydropyrido[1,2a]indol-6(7H)-one HCl salt.  To a suspension 
of benzyl-2-(6,7,8,9-tetrahydro-6-oxopyrido[1,2-a]indol-10-yl)ethylcarbamate (20.6 g, 
56.8 mmol) in MeOH (290 mL) and H2O (34 mL) was added AcOH (70 mL) and then 
10% Pd/C (2.67 g).  The suspension was stirred under 1 atm of H2 gas.  After 2.5 hours 
the reaction was judged complete by TLC analysis and passed through a plug of celite 
with the aid of MeOH and then concentrated to an amorphous solid.  After dissolving this 
material into 100 mL of EtOH, HCl (14 mL) was added as a solution in EtOH (50 mL).  
The precipitate was filtered and washed with EtOH (150 mL) to provide the desired 
compound as a white solid (12.4 g, 83% yield).  The spectroscopic data were identical to 
that reported by the Ban Group.5 
 
 
 
 
 
N
NH2• HCl
O
N
NHCBZ
O
H2
10% Pd/C
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2,3,6,7-tetrahydroazonino[5,4-b]indol-4(1H,5H,8H)-one (21).  The intermediate 10-(2-
aminoethyl)-8,9-dihydropyrido[1,2a]indol-6(7H)-one HCl salt was basified in 10% 
NaOH (20 mL), then extracted with CH2Cl2 (3 × 20 mL), dried over Na2SO4, filtered, and 
concentrated to an amorphous clear solid.  This material was dissolved with MeOH (15 
mL) and then added to a dry 1 L photo-immersion reactor under Ar.  The solution was 
diluted with 890 mL dry Et2O and irradiated with 300 W Hg Lamp.  The reaction was 
judged complete after 25 hours by TLC analysis and concentrated to an oily solid.  
Purification on silica gel using EtOAc/Acetone (3:2) provided the desired product as a 
white foamy solid (2.27 g, 69% yield).  The spectroscopic data were identical to that 
reported by the Ban Group.5 
 
 
 
 
 
Dihydro-9a,4a-(iminoethano)-9H-carbazole derivative (29).  To a solution of 2,3,6,7-
tetrahydroazonino[5,4-b]indol-4(1H,5H,8H)-one (30 mg, 0.131 mmol) in 10% i-
PrOH/CH2Cl2 (1.1 mL) cooled to –60 °C was added the 2,4-dinitrobenzoic acid salt of 
(2R,5R)-2-tert-butyl-5-benzyl-3-methylimidazolidin-4-one (12 mg, 0.062 mmol) and then 
N
H
NH
O
N
H
N
OH
OO
20 mol% catalyst 12 • 2,4–DNBA
10% i-PrOH/CH2Cl2
–60 °C, 36 h
then NaBH4
N
H
NH
O
N
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O
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acrolein (11 mg, 0.197 mmol).  The resulting solution was stirred for 32 hours until the 
reaction was judged complete by TLC analysis.  To this light yellow solution was added 
EtOH (1:1 v/v, 1.1 mL). The resulting solution was then transferred to an ice bath.  
Treatment with NaBH4 (25 mg, 0.655 mmol) for 30 minutes induced vigorous bubbling 
and the light yellow solution turned clear.  Quenching the excess NaBH4 was performed 
by dropwise addition of 5% HCl (0.1 mL).  The layers were separated and the aqueous 
phase was extracted with CH2Cl2 (3 × 1 mL), dried over Na2SO4, filtered, and 
concentrated.  The crude material was purified on a Gilsen-215 Liquid Handler by 
preparatory high-pressure liquid chromatography to afford the desired product as a foamy 
white solid (12 mg, 32% yield, 32% ee).  Enantiomeric excess was determined by SFC 
analysis using an ADH column in a 5-50% gradient of MeOH (major tr = 5.83 min., 
minor tr = 7.43 min.) IR (film) 3302, 2944, 1624, 1607, 1466m 1408, 1322, 1263, 1182, 
1058, 995, 937, 744 cm–1; 1H NMR (500 MHz, CDCl3) ∂ 7.08 – 7.03 (m, 2H, 2 × ArH), 
6.77 (t, 1H, J = 7.8 Hz, ArH), 6.58 (d, 1H, J = 7.8 Hz, ArH), 4.56 (bs, 1H, NH), 4.10, 
(ddd, 1H, J = 7.3, 4.3, 1.4 Hz, NCHH), 3.6 (t, 2H, J = 5.8 Hz, CH2OH), 2.94 – 2.88 (m, 
1H, NCHH), 2.5 (dd, 1H, J = 7.3 Hz, CHC=O), 2.43 – 2.36 (m, 1H, CHC=O), 2.15 – 
1.95 (m, 4H, CHHCH2CH2C=O, NCH2CHH) 1.88 – 1.70 (m, 5H, CH2CHHCH2OH, 
NCH2CHH, CHHCH2CH2C=O), 1.53 – 1.47 (m, 1H, CHHCH2CH2OH; 13C NMR (75 
MHz, CDCl3) ∂ 168.1, 147.9, 132.0, 128.3, 123.6, 119.2, 108.9, 87.6, 63.0, 59.3, 44.1, 
37.2, 31.4, 29.9, 29.7, 28.0, 16.9; HRMS (EI+) exact mass calculated for [M]+ 
(C17H23N2O2) requires m/z 286.1681, found m/z 286.1682.  
! 
["]
D
22  = –21.4 ° (c = 10.3, CHCl3). 
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2-(2-(1H-indol-3-yl)ethyl)isoindoline-1,3-dione (69).  A suspension of tryptamine (10 g, 
62.4 mmol) and phthalic anhydride (10.15 g, 68.6 mmol) in toluene (390 mL) was 
refluxed for 16 hours until the reaction was judged complete by TLC analysis.  The 
resulting red solution was concentrated to a pink solid.  This crude material was triturated 
with 3:1 hexanes/CH2Cl2 (6 × 100 mL) to afford a light pink solid that was used as is in 
the next step.   The spectroscopic data were identical to that reported by the Hsung 
Group.6 
 
 
 
 
 
 
 
                                                
(6)  Luo, S. J.; Zificsak, C. A.; Hsung, R. P. Org Lett 2003, 5, 4709-4712. 
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2-(2-(2-allyl-1H-indol-3-yl)ethyl)isoindoline-1,3-dione.  To a red solution of 2-(3-(1H-
indol-3-yl)propyl)isoindoline-1,3-dione (15 g, 51.7 mmol) in dry toluene (170 mL), under 
Ar, in the dark, and cooled to –78 °C, was added dry triethylamine (8.6 mL, 62 mmol) 
then t-butyl hypochlorite (7.53 mL, 62 mmol) dropwise.  The resulting solution was 
stirred at –78 °C for 30 minutes and then, in order, was added allyl tri-n-butyl stannane 
(32 mL, 103.4 mmol) and boron trifluoride etherate (13 mL, 103.4 mmol).  This solution 
was allowed to slowly warm to room temperature over 12 hours until the reaction was 
judged complete by TLC analysis.  A saturated solution of K2CO3 (250 mL) was added 
and the reaction stirred at room temperature for 30 minutes.  The layers were separated 
and the aqueous phase was extracted with EtOAc (3 × 200 mL), dried over Na2SO4, 
filtered, and concentrated.   The crude material was purified by SiO2 chromatography 
(20–40% EtOAc/Hexanes) to provide a light yellow solid.  Excess tin impurities were 
removed by suspending the solid in hexanes and stirring with diethylazodicarboxylate 
(0.5 eq.) for 1 hour followed by filtration and hexane washes (3 × 150 mL).  The product 
was isolated as a light yellow solid (14 g, 82% yield). IR (film) 3394, 1768, 1702, 1462, 
1437, 1395, 1358, 1339, 1243, 1187, 1171, 1121, 1099, 1088, 1021, 912, 735, 715 cm–1; 
1H NMR  (500 MHz, CDCl3) ∂ 7.88 (bs, 1H, ind. NH), 7.85 – 7.84 (m, 2H, ArH), 7.73 – 
7.70 (m, 3H, ArH), 7.30 – 7.28 (m, 1H, ArH), 7.14 (t, 1H, J = 7.06 Hz, ArH), 7.10 (t, 1H, 
N
H
NPhth
N
NPhth
SnBu3
THF
H
 Et3N, t-BuOCl
BF3 · Et2O
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J = 7.16 Hz, ArH), 6.01 – 5.93 (m, 1H, CH2CH=CH2), 5.21 (dd, 1H, J = 18.7, 1.62 Hz, 
CH=CH trans), 5.16 (dd, 1H J = 10.0, 1.44 Hz CH=CH cis), 3.92 (t, 2H, J = 7.90 Hz, 
CH2NPhth), 3.58 (d, 2H, CH2CH=CH2), 3.10 (t, 2H, J = 7.91 Hz CH2CH2NPhth); 13C 
NMR (75 MHz, CDCl3) ∂ 168.4, 135.3, 134.8, 133.8, 133.3, 132.2, 128.5, 121.4, 119.5, 
118.3, 117.3, 110.4, 108.1; HRMS (EI+) exact mass calculated for [M]+ (C21H18N2O2) 
requires m/z 330.1368, found m/z 330.1370. 
 
 
 
 
 
 
2-(2-(1-(2-(1,3-dioxolan-2-yl)ethyl)-2-allyl-1H-indol-3-yl)ethyl)isoindoline-1,3-dione 
(79)  A suspension of KH (30% dispersion in mineral oil, 3.42 g, 25.6 mmol) was added 
to a flame-dried 250 mL round bottom flask and purged with argon. To this was added 
anhydrous THF (40 mL) and the resulting suspension was cooled to –78 °C using a dry 
ice/acetone bath.  In another flame-dried 100 mL RBF, under argon, was placed the 
starting indole (6.54 g, 19.7 mmol) and recrystallized, dried 18-crown-6 (7.8 g, 29.6 
mmol).  These solids were dissolved in 25 mL dry THF and added in a rapid drop-wise 
fashion to the KH suspension, stirred at –78 °C for 1 hour and then warmed to 0 °C for 
40 minutes to ensure complete hydrogen gas evolution.  After cooling to –78 °C, the 
dioxolane reagent (3.3 mL, 27.6 mmol) was added immediately after passing it through a 
small plug of silica gel and the resulting solution was allowed to slowly warm to room 
N
H
NPhth
N
NPhth
KH, 18-C-6
O
O
Br
THF
O O
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temperature over 6 hours.  After stirring for an additional hour at room temperature, the 
reaction was judged complete by TLC analysis.  The reaction was quenched with 200 mL 
pH 7 buffer solution and the aqueous layer was extracted 3 times with EtOAc (150 mL), 
dried over Na2SO4, filtered, and concentrated to a red oil.  The product was applied to a 
silica gel column in toluene and eluted in 20% EtOAc/Hexanes then 40% 
EtOAc/Hexanes to isolate the protected indole as a light yellow oil (5.26 g, 62% yield). 
IR (film) 1770.3, 1708.8, 1467.4, 1533.5, 1395.4, 1363.8, 1179.6, 1136.8, 1021.8, 916.2, 
717.5 cm–1; 1H NMR (300 MHz, CDCl3) ∂ 7.82 – 7.81 (m, 2H, ArH), 7.69 – 7.68 (m, 2H, 
ArH), 7.31 (d, 1H J = 8.1 Hz, ArH), 7.15 (t, 1H, J = 7.1 Hz, ArH), 7.08 (t, 1H, J = 7.8 
Hz, ArH), 5.95 (ddt, 1H, J = 17.7, 10.2, 5.62 Hz, CH=CH2), 5.05 (d, 1H, J = 10.1 Hz 
CH=CH cis), 4.98 (d, 1H, J = 17.1 Hz, CH=CH trans), 4.84 (t, 1H, J = 4.37 Hz, OCHO), 
4.19 (t, 2H, J = 7.59 Hz, CH2NPhth), 4.00 (t, 2H, J = 7.1 Hz, indNCH2), 3.87 – 3.83 (m, 
4H, OCH2CH2O), 3.59 (d, 2H, J = 5.6 Hz, CH2CH=CH2), 3.05 (t, 2H, J = 8.23 Hz, 
CH2CH2NPhth), 2.09 – 2.05 (m, 2H, ind.NCH2CH2); 13C NMR (75 MHz, CDCl3) ∂ 
168.3, 136.0, 135.2, 134.4, 133.8, 132.2, 127.8, 123.1, 121.1, 119.2, 118.3, 116.4, 109.1, 
108.4, 102.2, 38.6, 34.0, 28.5, 23.8; HRMS (EI+) exact mass calculated for [M]+ 
(C25H26N2O4) requires m/z 430.1892, found m/z 430.1891. 
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Indole dimer (48)  To a clear solution of the diene (100 mg, 0.232 mmol) in CH2Cl2 (50 
mL) was added Grubbs II catalyst (19 mg, 0.023 mmol).  The resulting brown soution 
was refluxed for 21 hours until judged complete by TLC analysis.  The reaction was 
concentrated and then passed through a plug of florisil with the aid of EtOAc.  The crude 
material was applied to a silica gel column and eluted in 25% EtOAc/hexanes to provide 
the dimer as a white solid (35 mg, 36% yield). 
IR (film) 3425. 2931, 1611, 1512, 1496, 1465, 1453, 1418, 1356, 1302, 1246, 1175, 
1109, 1032, 916, 818, 741, 697 cm–1; 1H NMR (300 MHz, CDCl3) ∂ 7.59 – 7.56 (m, 1H, 
ArH), 7.16 – 7.06 (m, 2H, ArH), 6.84 – 7.89 (d, 1H, ArH), 6.0 (t, 1H, C=CH), 5.26 (bt, 
1H, O=C=CH), 5.17 – 5.14 (m, 2H, CH2CH=CH), 4.91 (bt, 1H, O=C=CH), 3.45 (dt, 1H,  
17.1 NHCH2), 3.25 (s, 2H, NCH2Ph), 2.89 (t, 2H, CH2CH2NH), 1.73 (s, 2H, CH2SiMe3); 
13C NMR (75 MHz, CDCl3) ∂ 170.8, 145.3, 139.6, 138.4, 136.5, 130.4, 130.1, 129.5, 
128.9, 127.5, 123.1, 121.1, 119.9, 115.9, 111.2, 111.1, 48.2, 42.2, 29.0, 26.0, 24.5, 0.0; 
HRMS (EI+) exact mass calculated for [M–2× CH2SiMe3]2+ (C44H44N2O2) requires m/z 
632.3531, found m/z 632.3589. 
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2-(1-(2-(1,3-diololan-2-yl)ethyl)-2-allyl-1H-indol-3-yl)ethanaminc)  To a solution of 2-
(2-(1-(2-(1,3-dioxolan-2-yl)ethyl)-2-allyl-1H-indol-3-yl)ethyl)isoindoline-1,3-dione (5.26 
g, 12.2 mmol) in benzene (4.8 mL) was added methylhydrazine (6.49 mL, 122 mmol).  
The reaction proceeded for 16 hours at room temperature until judged complete by TLC 
analysis.  Filtration of the precipitate followed by rotary evaporation of benzene provided 
the desired material as a crude light yellow solid that was used as is in the next step. IR 
(film) 2931, 2886, 1737, 1637, 1562, 1468, 1417, 1364, 1314, 1228, 1216, 1178, 1136, 
1055, 1016, 942, 915, 869, 744, 734, 701 cm–1; 1H NMR (500 MHz, CDCl3) ∂ 7.58 (d, 
1H, J = 6.5 Hz, ArH), 7.38 – 7.36, (bm, 1H, ArH), 7.19 (t, 1H, J = 6.67 Hz, ArH), 7.10 (t, 
1H, J = 6.5 Hz), 5.99 – 5.90 (m, 1H, CH2=CH), 5.10 (bd, 1H, J = 8.58 Hz, CH=CH2), 
4.99 – 4.06 (bm, 1H, CH=CH2), 4.89 (t, 1H, J = 9.97 Hz, OCHO), 4.24 – 4.22 (bm, 2H, 
CH2NH2), 4.05 – 4.01 (m, 2H, OCH2CH2O), 3.92 – 3.87 (m, 2H, OCH2CH2O), 3.63 – 
3.58 (bm, 2H, IndNCH2), 2.91 – 2.89 (bm, 2H, CH2CH2NH2), 2.15 – 2.09 (bm, 2H, 
ind.NCH2CH2); 13C NMR (75 MHz, CDCl3) ∂ 136.0, 135.5, 134.2, 128.0, 121.0, 118.9, 
118.4, 109.3, 102.2, 65.0, 42.8, 38.1, 34.0, 28.6, 28.4;  HRMS (EI+) exact mass 
calculated for [M]+ (C18H24N2O2) requires m/z 300.1837, found m/z 300.1842. 
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N-(2-(1-(2-(1,3-dioxolan-2-yl)ethyl)-2-allyl-1H-indol-3-yl)ethyl)acrylamide  To a light 
yellow solution of crude 2-(1-(2-(1,3-diololan-2-yl)ethyl)-2-allyl-1H-indol-3-
yl)ethanaminc) (12.2 mmol) in dry CH2Cl2 (24 mL) under Ar and cooled to 0 °C was 
added triethylamine (1.78 mL, 12.8 mmol).  Next, acryloyl chloride (1.04 mL, 12.8 
mmol) was slowly added dropwise and the reaction stirred for 8 hours until judged 
complete by TLC analysis.  The reaction was concentrated, applied to a silica gel column 
in toluene, and eluted in 60% EtOAc/Hexanes (2 ×) to provide the product as a clear oil 
(2.8 g, 65% yield, 2 steps).  IR (film) 3273, 2970, 1738, 1657, 1625, 1545, 1469, 1409, 
1366, 1229, 1217, 1138, 1055, 1016, 987, 943, 745 cm–1; 1H NMR (500 MHz, CDCl3) ∂ 
7.59 (d, 1H, J = 7.82 Hz, ArH), 7.39 (d, 1H, J = 8.1Hz, ArH), 7.22 (t, 1H, J = 7.05 Hz, 
ArH), 7.13 (t, 1H, J = 7.01 Hz, ArH), 6.27 (dd, 1H, J = 16.9, 1.4 Hz, O=CH=CH), 6.03 
(m, 1H, O=CH), 5.65 (bt, 1H, NH), 5.61 (dd, 1H, J = 10.3, 1.4 Hz, O=CH=CH), 5.13 
(dd, 1H, J = 10.1, 1.5 Hz, CH2CH=CH), 4.97 (dd, 1H, J = 18.7, 1.6 Hz, CH2CH=CH), 
4.90 (t, 1H, J = 4.36 Hz, OCHO), 4.25 (t, 2H, J = 7.59 Hz, CH2NH), 4.02 – 4.03 (m, 2H, 
OCH2CH2O), 3.92 – 3.90 (m, 2H, OCH2CH2O), 3.58 (dt, 2H, J = 3.65, 1.68 Hz, 
ind.CH2CH2NH), 2.15 – 2.11 (m, 2H, NCH2CH2CH); 13C NMR (75 MHz, CDCl3) ∂ 
165.4, 136.1, 135.6, 130.9, 127.8, 126.2, 121.3, 119.7, 119.2, 118.2, 116.4, 109.3, 108.9, 
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102.2, 65.1, 65.0, 40.0, 38.2, 33.9, 28.4, 24.5; HRMS (EI+) exact mass calculated for 
[M]+ (C21H26N2O3) requires m/z 354.1943, found m/z 354.1944. 
 
 
 
 
 
 
 
t-butyl-2-(1-(2-(1,3-dioxolan-2-yl)ethyl)-2-allyl-1H-indol-3yl)ethylacryloylcarbamate  
To a light yellow solution of N-(2-(1-(2-(1,3-dioxolan-2-yl)ethyl)-2-allyl-1H-indol-3-
yl)ethyl)acrylamide (2.7 g, 7.62 mmol) in dry CH2Cl2 (7.7 mL), under Ar and cooled to 0 
°C, was added DMAP (971 mg, 7.62 mmol), triethylamine (1.06 mL, 7.62 mmol), then 
(BOC)2O (1.75 mL, 7.62 mmol).  The resulting mixture was warmed to room 
temperature and stirred for 12 hours.  In order to drive the reaction more of each reagent 
(0.5 eq.) was added at room temperature and the reaction stirred for 10 hours until judged 
complete by TLC analysis.  After concentrating, the crude solid was applied to a silica 
gel column in toluene and eluted in 30% EtOAc/Hexanes to provide the desired product 
as a light yellow oil (2.5 g, 72% yield). IR (film) 2977, 2886, 1727, 1678, 1469, 1405, 
1368, 1351, 1293, 1250, 1205, 1178, 1145, 1058, 979, 944, 854, 745 cm–1; 1H NMR (500 
MHz, CDCl3) ∂ 7.67 (d, 1H, J = 7.72 Hz, ArH), 7.31 (d, 1H, J = 8.09 Hz, ArH), 7.15 (t, 
1H, J = 7.03 Hz, ArH), 7.10 (t, 1H, J = 7.81 Hz, ArH), 7.0 (d, 1H, J = 10.4 Hz, ArH), 
6.97 (d, 1H, J = 10.4 Hz, O=CH=CH2), 6.31 (dd, 1H, J = 16.8, 1.7 Hz, O=CCH=CH 
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trans), 5.93 (ddt, 1H, J = 17.6, 10.2, 5.5 Hz, CH2CH=CH2), 5.66 (dd, 1H, J = 10.4, 1.7, 
O=C=CHCH cis), 5.06, (dd, 1H, J = 10.1, 1.5 Hz, CH2CH=CH cis) 4.94 (dd, 1H, J = 
17.0, 1.5 Hz, CH2CH=CH trans), 4.85 (t, 1H, J = 4.37 Hz, OCHO), 4.18 (t, 2H, J = 7.65 
Hz CH2CH2NC=O), 3.99 – 3.96 (m, 2H, OCH2CH2O), 3.86 (m, 2H, OCH2CH2O), 3.57 
(d, 2H, J = 5.6 Hz, CH2CH=CH2), 2.96 (t, 2H, J = 7.75 Hz, CH2CH2NC=O), 2.09 – 2.05 
(m, 2H, ind.NCH2CH2), 1.45 (s, 9H, BOC); 13C NMR (75 MHz, CDCl3) ∂ 168.8, 153.3, 
136.0, 135.4, 134.4, 127.9, 127.2, 121.06, 119.0, 118.4, 116.3, 109.1, 108.8, 102.2, 83.2, 
65.0, 45.6, 38.1, 33.9, 28.5, 27.9, 23.7; HRMS (EI+) exact mass calculated for [M]+ 
(C28H35N2O5) requires m/z 454.2467, found m/z 454.2469 
 
 
 
 
 
 
 
(Z)-tert-butyl-8-(2-(1,3-dioxolan-2-yl)ethyl)-1,2-dihydro-4-oxoazonino[5,4-b]indole-
3(4H,7H,8H)-carboxylate  To a solution of tert-butyl-2-(1-(2-(1,3-dioxolan-2-yl)ethyl)-
2-allyl-1H-indol-3-yl)ethylacryloylcarbamate (500 mg, 1.09 mmol) in dry CH2Cl2 (1090 
mL), under Ar, was added Grubbs II catalyst (278 mg, 0.327 mmol).  The resulting 
brown mixture was refluxed for 12 hours and was judged complete by TLC analysis.  
After concentrating, the crude material was passed through a plug of florisil with the aid 
of EtOAc.  The brown residue was applied to a silica gel column in toluene and eluted 
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with 30% EtOAc/hexanes (2 ×).  The resulting material was passed through another plug 
of florisil with the aid of EtOAc and concentrated to provide the desired material as a 
foamy light brown solid (311 mg, 67% yield, average is about 60%). IR (film) 1724, 
1682, 1470, 1444, 1415, 1366, 1323, 1230, 1146, 1085, 1024, 857, 770, 740 cm–1; 1H 
NMR (500 MHz, CDCl3) ∂ 7.52 (d, 1H, J = 7.76 Hz, ArH), 7.28 (d, 1H, ArH), 7.17 (t, 
1H, J = 7.02 Hz, ArH), 7.11 (t, 1H, J = 7.89 Hz, ArH), 6.31 – 6.29 (m, 1H, 
HC=CHC=O), 6.22 – 6.29 (m, 1H, HC=CHC=O), 4.89 (t, 1H, J = 4.12 Hz, OCHO), 
4.23-4.14 (m, 2H, indNCH2), 4.06 – 4.02 (m, 2H, OCH2CH2O), 3.96 – 3.91 (m, 2H, 
OCH2CH2O), 3.86 – 3.84 (bm, 2H, (BOC)NCH2), 3.54 (bd, 2H, J = 5.89 Hz 
CH2CH=CH), 3.13 (bt, 2H, J = 5.63 Hz, CH2CH2N(BOC)), 2.18 – 2.09 (m,, 2H, 
ind.NCH2CH2,), 1.49 (bs, 9H, BOC); 13C NMR (75 MHz, CDCl3) ∂ 172.4, 153.5, 136.8, 
135.9, 131.6, 127.1, 121.7, 119.1, 118.2, 109.1, 108.7, 102.1, 82.8, 65.1, 45.4, 38.5, 33.5, 
28.0, 23.4, 22.8, 21.1 ; HRMS (EI+) exact mass calculated for [M]+ (C24H31N2O5) requires 
m/z 426.2154, found m/z 426.2154. 
  
 
 
 
 
 
 
(Z)-8-(2-(1,3-dioxolan-2-yl)ethyl)-2,3-dihydroazonino[5,4-b]indol-4-(1H,7H,8H)-one 
(80)  A light brown solution of (Z)-tert-butyl-8-(2-(1,3-dioxolan-2-yl)ethyl)-1,2-dihydro-
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4-oxoazonino[5,4-b]indole-3(4H,7H,8H)-carboxylate (311 mg, 0.729 mmol) and (271 
mg, 0.437 mmol) in THF (14.6 mL) was stirred at room temperature for 12 hours until 
judged complete by TLC analysis.  The mixture was concentrated to a brown residue and 
filtered through a plug of celite with the aid of CH2Cl2.  After concentrating, the crude 
material was purified by silica gel chromatography with 1:1 EtOAc/acetone (2 ×).  The 
resulting material was passed through a plug of florisil with the aid of EtOAc to afford 
the desired material as a white solid (233 mg 98% yield, typical yields are > 90%). IR 
(film) 3405, 2954, 2887, 1648, 1604, 1557, 1525, 1467, 1417, 1277, 1256, 1224, 1144, 
1030, 945, 891, 816, 792, 746, 709 cm–1; Amide ring flip7 occurs and complicates the 
NMR, tried DMSO, THF-D8, CDCl3, obtained in CD2Cl2 as the spectra is the cleanest.  It 
seems to be a 2:1 mixture of trans/cis isomers (500 MHz, CDCl3) ∂ 7.5 (d, 1H, ArH), 
7.33 (d, 1H, ArH), 7.17 (t, 1H, ArH), 7.08 (m, 1H, ArH), 6.44 – 6.42 (m, 1H, 
HC=CHC=O), 6.07 – 6.00 (m, 1H, HC=CHC=O), 5.39 (bs, 1H, NH), 4.86 – 4.82 (m, 
1H, OCHO), 4.27 – 4.21 (m, 2H, indNCH2), 4.00 – 3.97 (m, 2H, OCH2CH2O), 3.87 – 
3.82 (m, 2H, OCH2CH2O), 3.62 – 3.61 (bm, 2H, O=CHNCH2), 3.56 – 3.54 (m, 2H, 
CH2CH=CH), 3.17 – 3.02 (m, 2H, CH2CH2NHC=O), 2.07 – 2.05 (m, 2H, 
ind.NCH2CH2,); 13C NMR (75 MHz, CDCl3) ∂ 171.6, 136.7, 136.2, 132.4, 128.8, 124.1, 
121.9, 119.5, 118.4, 109.7, 43.3, 39.1, 34.6, 34.3, 33.3, 32.2, 26.9, 25.4; HRMS (EI+) 
exact mass calculated for [M]+ (C19H23N2O3) requires m/z 326.1630, found m/z 326.1634. 
 
 
 
 
                                                
(7) Borgen, G. Mag. Res. Chem. 1991, 29, 805. 
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Dihydro-9a,4a-(iminoethano)-9H-carbazole derivative (81)  To a solution of 2,3,6,7-
tetrahydroazonino[5,4-b]indol-4(1H,5H,8H)-one (30 mg, 0.131 mmol) in 10% i-
PrOH/CH2Cl2 (1.1 mL) cooled to –60 °C was added the 2,4-dinitrobenzoic acid salt of 
(2R,5R)-2-tert-butyl-5-benzyl-3-methylimidazolidin-4-one (12, 0.062 mmol) and then 
acrolein (11 mg, 0.197 mmol).  The resulting solution was stirred for 32 hours until the 
reaction was judged complete by TLC analysis.  To this light yellow solution was added 
EtOH (1:1 v/v, 1.1 mL).  The resulting solutuion was transferred to an ice bath.  
Treatment with NaBH4 (25 mg, 0.655 mmol) for 30 minutes induced vigorous bubbling 
and the light yellow solution turned clear.  Quenching the excess NaBH4 was performed 
by the dropwise addition of 5% HCl (0.1 mL).  The layers were separated and the 
aqueous phase was extracted with CH2Cl2 (3 × 1 mL), dried over Na2SO4, filtered, and 
concentrated.  The crude material was purified on a Gilsen-215 Liquid Handler by 
preparatory high-pressure liquid chromatography to afford the desired product as a foamy 
solid (12 mg, 32% yield, 32% ee).  Enantiomeric excess was determined by SFC analysis 
using an ADH column in a 5-50% gradient of MeOH (major tr = 5.83 min., minor tr = 
7.43 min.)  IR (film) 3407, 2947, 2878, 1658, 1599, 1491, 1453, 1436, 1387, 1322, 1261, 
1218, 1137, 1055, 874, 817, 744 cm–1; 1H NMR (500 MHz, CDCl3) ∂ 7.04 (t, 1H, J = 7.5 
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Hz, ArH), 6.95 (d, 1H, J = 7.79 Hz, ArH), 6.63 – 6.59 (m, 2H, ArH, CH=CHCO), 6.35 
(d, 1H, J = 7.79 Hz, ArH), 6.02 (dd, 1H, J = 9.84 Hz, 2.84 Hz, ArH), 4.78 (t, 1H, J = 4.30 
Hz, OCHO), 4.06 – 4.00 (m, 1H, NCH), 3.81 – 3.76 9m, 2H, OCH2CH2O), 3.54 – 3.51 
(m, 2H, OCH2CH2O), 3.52 (t, 2H, J = 6.21 Hz, CH2OH), 3.30 – 3.21 (m, 2H, NCH2), 
2.86 – 2.21 (m, 2H, CHCH=CH, NCH), 2.56 – 2.51 (m, 1H, CHCH=CH), 2.11 – 2.04 
(m, 1H, NCH2CH), 1.79 – 1.74 (m, 5H, CH2CH2CH2OH, NCH2CH2CHO(O), 
NCH2CCH), 1.52 – 1.50 (m, 1H, CHCH2OH), 1.32 – 1.29 (m, 1H, CHCH2OH); 13C 
NMR (75 MHz, CDCl3) ∂ 161.9, 148.8, 136.6, 130.8, 128.6, 124.0, 122.8, 117.5, 105.0, 
102.8, 88.9, 65.0, 63.0, 60.0, 43.4, 38.9, 32.3, 31.1, 31.0, 27.8; HRMS (EI+) exact mass 
calculated for [M]+ (C22H29N2O4) requires m/z 384.2049, found m/z 384.2044; 
! 
["]
D
22  = -
5.47 ° (c = 0.37, CHCl3). 
   
 
 
 
 
 
Carbazole silyl ether (82)  To an ice-cold solution of dihydro-9a,4a-(iminoethano)-9H-
carbazole derivative 29 (116 mg, 0.302 mmol) in dry CH2Cl2 (1.5 mL, 0.2 M), under  
Ar, was added DMAP (15 mg, 0.121 mmol), triethylamine (88 ul, 0.634 mmol), and then 
TBSCl (91 mg, 0.604) dropwise as a solution in CH2Cl2 (100 ul).  The resulting solution 
was stirred at 0 °C for 3.5 hours until judged complete by TLC analysis.  The title 
compound was isolated as a light yellow oil (134 mg, 89% yield) after purification by 
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flash chromatography on silica gel (100% EtOAc). IR (film) 2952, 2929, 2856, 1663, 
1603, 1490, 1426, 1387, 1359, 1251, 1218, 1135, 1093, 1045, 940, 835, 814, 776, 740 
cm–1; 1H NMR (500 MHz, CDCl3) ∂ 7.08 (t, 1H, J = 7.61 Hz, ArH), 6.99 (d, 1H, J = 7.21 
Hz, ArH), 6.69 – 6.63 (m, 2H, ArH, CH2CH=CH), 6.39 (d, 1H, J = 7.84 Hz, ArH), 6.08 
(d, 1H, J = 9.84 Hz, ArH), 4.85 – 4.82 (m, 1H, OCHO), 4.08 – 4.04 (m, 1H, NCNCH), 
3.97 – 3.94 (m, 2H, OCH2CH2O), 3.85 – 3.82 (m, 2H, OCH2CH2O), 3.52 – 3.49 (m, 2H, 
CH2OTBS), 3.38 – 3.27 (m, 2H, indNCH2), 2.96 – 2.87 (m, 2H, NCNCH, CHCH=CH), 
2.58 – 2.54 (m, 1H, CHCH=CH), 2.10 – 2.07 (m, 1H, NCH2CH), 1.87 – 1.79 (m, 5H, 
CH2CH2CH2OTBS, NCH2CH, ind.NCH2CH2), 1.53 – 1.47 (m, 1H, CHCH2OTBS), 1.34 
– 1.28 (m, 1H, CHCH2OTBS); 13C NMR (75 MHz, CDCl3) ∂ 161.9, 148.6, 136.6, 131.2, 
128.5, 124.0, 122.7, 117.4, 104.9, 102.8, 89.1, 64.9, 63.0, 59.2, 43.3, 39.1, 38.9, 32.3, 
31.1, 31.0, 27.9, 25.9, -5.3; HRMS (EI+) exact mass calculated for [M–CH2]+ 
(C28H42O4Si) requires m/z 498.2913, found m/z 498.2911. 
 
 
 
 
 
 
 
Carbazole silyl ether diol (83)  To a solution of carbazole silyl ether (300 mg, 0.60 
mmol) in CH3CN (8.6 mL) was added NMO (156 mg, 1.2 mmol) and OsO4 (76 ul, 0.012 
mmol, 4% w/v solution in H2O), and the resulting black reaction was stirred at room 
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temperature.  After 21 hours, additional NMO (156 mg, 1.2 mmol) and OsO4 (76 ul, 
0.012 mmol) were added to drive the reaction that had stalled by LCMS analysis.  After 
24 hours, the reaction was complete by LCMS and was then concentrated.  The title 
compound was isolated as a light orange oil (200 mg, 63% yield) after purification by 
flash chromatography on silica gel (1:1 EtOAc/acetone). IR (film) 3437, 2953, 2929, 
2886, 2857, 1651, 1603, 1493, 1462, 1373, 1250, 1229, 1129, 1049, 945, 894, 837, 777, 
739 cm–1; 1H NMR (500 MHz, CDCl3) ∂ 7.07 (t, 1H, J = 7.7 Hz, ArH), 7.21 (d, 1H, J = 
7.29 Hz, ArH), 6.65 (t, 1H, J = 7.4 Hz, ArH), 6.36 (d, 1H, J = 7.79 Hz, ArH), 4.78 (t, 1H, 
J = 4.24 Hz, OCHO), 4.33 – 4.32 (m, 2H, HOCHCHOHC=O), 4.23 (dd, 1H, J = 13.95, 
2.54 Hz, NHCH2), 3.96 – 3.92 (m, 2H, OCH2CH2O), 3.85 – 3.84 (m, 2H, OCH2CH2O), 
3.59 – 3.45 (m, 2H, CH2OTBS), 3.29 – 3.15 (m, 1H, ind.NCH), 2.80 (dd, 1H, J = 11.5, 
5.13 Hz, HOCHCH), 2.61 (dt, 1H, J = 11.5, 6.29 Hz, NCHCH2), 2.11 – 2.07 (m, 1H, 
HOCHCH), 1.97 – 1.81 (m, 6H, NCH2CH2, CH2CH2CH2OTBS, ind.NCH2CH2), 1.16 – 
1.15 (m, 1H, CH2CH2OTBS), 1.43 – 1.38 (m, 1H, CH2CH2OTBS), 0.86 (s, 9H, OTBS), 
0.0 (s, 6H, OTBS); 13C NMR (75 MHz, CDCl3) ∂ 169.8, 148.7, 131.7, 128.3, 123.5, 
117.7, 105.2, 102.5, 91.4, 69.8, 67.7, 65.12, 65.10, 63.1, 60.1, 43.4, 39.4, 37.8, 32.6, 31.7, 
31.5, 28.3, 25.9, 18.4, –5.0; HRMS (EI+) exact mass calculated for [M–CH2]+ 
(C28H44N2O6Si) requires m/z 166.1358, found m/z 166.1359. 
 
 
 
 
